Professional Documents
Culture Documents
Medula Continum
Medula Continum
Medula Continum
Cauda Equina C O N T I N U UM A U D I O
I NT E R V I E W A V A I L AB L E
ONLINE
By Samantha LoRusso, MD
Downloaded from http://journals.lww.com/continuum by wqLe/H3/oM2vx1Qs5A5qMemKKHLPqE4qkmGNpdheG3ikf1o85ttJSkFL2oTkgOkhMEmawHvsuTTE5xJG2ZjqccytIAhVn2qegy060KLcKJuPZsx5htaYiopRjp2zor2egUzWJAEWYNo65TEub0G9tZtPaMachiqn on 04/28/2022
ABSTRACT
PURPOSE OF REVIEW: Cauda equina dysfunction (often referred to as cauda
equina syndrome) is caused by a diverse group of disorders that affect the
lumbosacral nerve roots. It is important to recognize dysfunction of the
cauda equina quickly to minimize diagnostic delay and lasting neurologic
symptoms. This article describes cauda equina anatomy and the clinical
features, differential diagnosis, and management of cauda equina
disorders.
Address correspondence to
INTRODUCTION Dr Samantha LoRusso, 395 W
D
ysfunction of the lumbosacral nerve roots within the cauda equina 12th Ave, Columbus, OH 43210,
samantha.lorusso@osumc.edu.
can lead to symptoms of urinary retention and incontinence,
constipation, bowel incontinence, sexual dysfunction, sensory RELATIONSHIP DISCLOSURE:
changes (particularly saddle anesthesia), back pain, and lower Dr LoRusso receives
research/grant support from
extremity weakness; this is often referred to as cauda equina the National Institute of
syndrome. The first description of cauda equina syndrome in the literature is Neurological Disorders and
attributed to Mixter and Barr,1 who described a case due to disk herniation in Stroke NeuroNEXT.
1934. The exact incidence of cauda equina syndrome is not known, but it is UNLABELED USE OF
thought to be somewhere between 1 per 33,000 and 1 per 100,000,2 which is PRODUCTS/INVESTIGATIONAL
consistent with an estimate from the United Kingdom of 1.9 per 100,000.3 USE DISCLOSURE:
Dr LoRusso reports no
However, a study from Slovenia estimated an annual incidence of 3.4 per 1 million disclosure.
people.4 The variability in the epidemiologic data may be partly because of poor
consensus regarding the precise definition of cauda equina syndrome. As many © 2021 American Academy
as 17 different definitions were found in a literature review on the topic.5 Still, it of Neurology.
CONTINUUMJOURNAL.COM 205
is accepted that the most common cause is lumbar disk herniation, representing
about 45% of cases.5 Other etiologies include, but are not limited to,
nondiskogenic structural changes, neoplasm, trauma, infection, inflammatory
disorders, vascular disorders, and iatrogenic causes. Timely diagnosis is
important since delays may result in worse neurologic outcomes. This article
discusses the anatomy, clinical presentation, diagnosis, and management of
disorders of the cauda equina.
ANATOMY
The last segment of the spinal cord, termed the conus medullaris, ends around
vertebral level T12-L2. The nerve roots that exit via foramina below the conus
medullaris (L2 through L5, S1 through S5, and the coccygeal nerve roots) create
the cauda equina (FIGURE 9-16), which was named for its resemblance to a
horse’s tail by French anatomists Andre du Laurens and Andreas Lazarius in the
1600s.7 Damage to these nerve roots can cause symptoms of weakness,
numbness, sexual dysfunction, and changes in urinary and bowel function since
they control lower extremity movement and sensation (L2 through S3), external
genitalia and perineal sensation (S2 through S4), sensation overlying the coccyx
(S4-S5 and coccygeal nerve roots), bladder function (S2 through S4), and the
external anal sphincter (S2 through S4).8
The cauda equina is located in the thecal sac inside the spinal canal. Similar to
the spinal cord itself, it is surrounded by the vertebral bodies, intervertebral
disks, and posterior longitudinal ligament anteriorly and the ligamentum flavum
and spinous processes posteriorly.9 The blood supply is not as well defined as that
of the spinal cord.10 One study found that each nerve root obtains blood supply
from proximal and distal radicular arteries, with the ventral and dorsal proximal
radicular arteries receiving blood supply from the anterior and posterior spinal
arteries, respectively. This group also found the cauda equina to be an area of
relative hypovascularity, which may make it more likely to be damaged by
ischemia.10,11
CLINICAL PRESENTATION
Despite a lack of consensus
regarding the precise definition
of cauda equina syndrome, the
clinical features of bladder or
bowel disturbance, sexual
dysfunction, saddle anesthesia,
weakness or numbness in the
legs, and pain in the lower back
or legs are well recognized. An
individual patient with cauda
equina dysfunction may have
any of these symptoms to
varying degrees, so high clinical
suspicion is required. Symptoms
FIGURE 9-1 may come on suddenly or
Cauda equina anatomy. Lumbar, sacral, and
develop over days to weeks.12,13
coccygeal nerve roots of the cauda equina.
Reprinted with permission from Stewart JD.6 © 2010 JBJ Some patients even describe a
Publishing. more chronic course in which
Urinary Symptoms
Symptoms of urinary dysfunction include decreased urethral sensation and
urinary stream, urinary retention, and incontinence. Urinary incontinence in
cauda equina syndrome is thought to be overflow incontinence that occurs
secondary to the retention.8,18 At least some of these symptoms occur in the
majority of patients with cauda equina syndrome.14 Careful history taking is
important since patients may not fully recognize their symptoms.19
Bowel Dysfunction
Bowel dysfunction in cauda equina syndrome can range from constipation to
incontinence, with the former usually preceding the latter.17 Overall, bowel
incontinence is not as commonly reported as urinary dysfunction.14 The reason
for this is not entirely clear but may be because of a reporting bias, or bowel
CONTINUUMJOURNAL.COM 207
Sexual Dysfunction
Of patients with cauda equina syndrome, 12% to 96% will report sexual
dysfunction if asked.14,21 The symptoms of sexual dysfunction are variable and can
include erectile or ejaculatory impairment, impotence, priapism, dyspareunia,
and urination during intercourse.14,19 Asking specific questions about these
symptoms is important but often omitted or not documented by physicians.5,22
Weakness
Weakness in the lower extremities can occur in any distribution (proximal or
distal, symmetric or asymmetric) in cauda equina syndrome.5 However, it is not
necessary for weakness to be present since a process affecting only the lower
sacral and coccygeal roots will not cause weakness. On examination, motor
strength should be assessed in detail and reflexes evaluated since lower extremity
reflexes may be reduced.
DIAGNOSIS
The diagnosis of cauda equina syndrome can be challenging since many of the
symptoms are common in the general population and could be secondary to
other causes. For example, urinary retention and constipation are common side
effects of medications. Delays in diagnosis are not infrequent, with one study
citing a median of 11 days from the onset of symptoms to diagnosis and another
citing an average of 9 days until diagnosis.2,18 Furthermore, no single symptom or
sign has been found to have consistently high sensitivity and specificity in
diagnosing MRI-positive cauda equina syndrome.23-25 In one study, bowel
dysfunction, reduced perineal sensation, and abnormal rectal tone were the most
specific findings but had low sensitivity.17,26 That being said, measuring the
postvoid residual volume may be a helpful early step (and can be done as an
adjunct to the examination) in evaluating a patient with suspected cauda equina
syndrome. A postvoid residual of 200 mL or more was found to have a sensitivity
of 94% and specificity of 72% in predicting MRI-positive cauda equina syndrome
in one study.27
CONTINUUMJOURNAL.COM 209
can occur earlier in those with a congenitally narrow spinal canal.42 Symptoms ● Disk herniations are the
usually start with pain that radiates from the low back and is made better by most common cause of
flexion of the low back. This can eventually progress and cause bladder dysfunction cauda equina dysfunction,
(and cauda equina syndrome), but this is rare.42,43 Similar to the way that occurring the majority of the
time at the L4-L5 or L5-S1
degenerative lumbar spinal stenosis can lead to cauda equina dysfunction, cases levels.
of spinal epidural lipomatosis directly causing cauda equina dysfunction have also
been reported.44,45 Spinal epidural lipomatosis may be idiopathic or secondary to
obesity, chronic corticosteroid use, or other endocrinopathies.44
Vascular Causes
People with aortic disease, especially abdominal aortic disease, can rarely present
with symptoms of cauda equina dysfunction, which is thought to be secondary to
nerve root ischemia from hypoperfusion or embolization.46 From these case
reports, it is not always entirely clear if the lumbosacral roots or the lumbosacral
spinal cord were actually affected. Still, in cases in which patients present with
symptoms of cauda equina dysfunction and MRI of the lumbosacral spine is
unrevealing, imaging of the abdominal aorta with MRA or CT angiography
should be considered. Symptoms similar to cauda equina dysfunction may also
be seen after a severe hypotensive event such as cardiac arrest. One study
evaluating pathology specimens from patients who died after a cardiac arrest or
severe hypotension found that neurons in the lumbosacral spinal cord were
actually much more susceptible to ischemic injury than those in other spinal cord
levels (even midthoracic), but the nerve roots were not examined.47
Spinal hematomas, either intradural or epidural, can cause compression of the
lumbosacral nerve roots and cauda equina dysfunction. In some cases, neurologic
symptoms may be preceded by hours or days of back pain.48 Spinal hematomas
can occur spontaneously; may be secondary to coagulopathy, trauma, or vascular
anomalies; or may occur after intervention from a surgery or procedure.
Asymptomatic spinal epidural hematomas are common after lumbosacral spine
surgery, occurring in 33% to 100% of people, whereas symptomatic postoperative
spinal epidural hematomas are rare, occurring in only 0.1% to 0.2% of cases.49
However, in one large retrospective study of 15,668 patients in whom the etiology
was known, 6.3% of cauda equina syndrome cases were listed as secondary to
postoperative hematoma.50 For this reason, clinicians should have a high index of
suspicion and patients should be rescanned after surgery if any concern exists.
One case report describes engorgement of the epidural venous plexus
occurring postoperatively, leading to dural sac shift and cauda equina
dysfunction.51 In this particular case, the dural sac shift was treated with
laminoplasty and had a good clinical outcome.51 Epidural venous plexus
CONTINUUMJOURNAL.COM 211
enlargement (seen as signal flow voids on MRI of the lumbosacral spine) leading
to cauda equina dysfunction can also occur secondary to occlusion of the inferior
vena cava.52 This most commonly occurs because of thrombosis in the inferior
vena cava but can occur secondary to occlusion from a mass or from pregnancy.
Occlusion of the inferior vena cava can be visualized on MRI of the lumbosacral
spine but is usually confirmed with Doppler ultrasound. In one case series, all
◆ Ankylosing spondylitis
◆ Graft versus host disease
Infectious
◆ Spinal epidural abscess
◆ Lyme disease
◆ Elsberg syndrome (herpes simplex virus type 2)
◆ Cytomegalovirus
◆ Varicella-zoster virus
◆ Human immunodeficiency virus (HIV)
◆ Herpes simplex virus type 1
◆ Epstein-Barr virus
◆ Syphilis
◆ Tuberculosis
◆ Cysticercosis
◆ Schistosomiasis
◆ Hydatid cysts
◆ Cryptococcosis
◆ Nocardiosis
◆ Brucellosis
◆ Tick-borne encephalitis
Iatrogenic
◆ Radiation induced
◆ Arachnoiditis
◆ Epidural pneumorrhachis (entrapment of air/gas within spinal column)
◆ Intrathecal cytarabine or methotrexate
◆ Complication of spinal anesthesia
Other
◆ Trauma
◆ Extramedullary hematopoiesis
◆ Calcifying non-neoplastic pseudoneoplasm
CONTINUUMJOURNAL.COM 213
Infectious Causes
Constitutional symptoms, such as fevers, night sweats, and weight loss, should
lead to consideration of an infectious etiology of cauda equina dysfunction in the
appropriate clinical setting. Spinal epidural abscesses are a potential infectious
cause of cauda equina dysfunction. Back pain at the level of the abscess (present
in 75% of patients) and fever (present in 50% of patients) are the most common
symptoms.55 The symptoms may be present for days or up to 2 months in some
cases. Predisposing factors include, but are not limited to, diabetes, alcohol use
disorder, human immunodeficiency virus (HIV), spine abnormality or recent
intervention, sepsis or other current infection, and IV drug use.55 Two-thirds of
cases are caused by Staphylococcus aureus; other common pathogens include
Staphylococcus epidermidis, Escherichia coli, and Pseudomonas aeruginosa.55
Infection from other pathogens, such as tuberculosis, fungi, or parasites, is
rare.55-57 If infection is present, erythrocyte sedimentation rate and C-reactive
protein will be elevated, and blood cultures should be obtained. Diagnosis is
CASE 9-1 A 35-year-old man with a history of chronic back pain presented to the
emergency department with worsening back pain, lower extremity and
saddle paresthesia, urinary retention, and a feeling of weakness in his
feet. He said he had been playing basketball 4 days prior and “twisted”
his back, causing worsening of his typical back pain. He thought the pain
was improving, but shortly before coming to the emergency department,
he stood up and felt a sudden worsening of low back pain and developed
numbness and tingling in his legs and perineum. He felt the need to
urinate but had been unable to do so; he denied bowel symptoms. He had
no other significant past medical history except for morbid obesity.
Neurologic examination revealed normal strength, left greater than
right perianal numbness and patchy distal lower extremity numbness to
pinprick, a reduced left ankle reflex, and normal rectal tone. MRI of the
lumbosacral spine (FIGURE 9-2) revealed a large disk herniation at L5-S1
compressing the cauda equina. Underlying central spinal stenosis existed
secondary to significant ventral epidural fat.
Emergent L5-S1 microdiskectomy was performed within 24 hours of
symptom onset. At a follow-up visit 8 months later, he reported a
continued pins and needles sensation in his feet, saddle paresthesia, and
a feeling of weakness in his feet that was still gradually improving. He
denied any residual bladder dysfunction.
FIGURE 9-2
Imaging of the patient in CASE 9-1. Sagittal (A) and axial (B) T2-weighted MRIs of the
lumbosacral spine show a large extruded disk fragment (arrows) compressing the thecal
sac. The prominent epidural fat seen in this patient is not shown in these T2-weighted
images.
This case illustrates a typical case of cauda equina dysfunction secondary to COMMENT
lumbosacral disk herniation at the L5-S1 level. This patient had a risk factor of
obesity with central canal stenosis that was already present to some degree
because of epidural lipomatosis. None of the hospital notes for this patient
commented on sexual dysfunction, but this should be discussed with every
patient in whom cauda equina dysfunction is suspected. Surgery was
performed within 24 hours of symptom onset in this patient. At follow-up,
the patient reported improvement but still had some neurologic symptoms,
which is not uncommon.
CONTINUUMJOURNAL.COM 215
Neoplastic Causes
In one large retrospective study, cauda equina syndrome was secondary to tumor
in 3.1% of patients (478 of 15,668 patients with a reported etiology).50 Neoplastic
disease can lead to cauda equina dysfunction by direct compression from
primary or metastatic lesions or secondary to nerve root invasion from
meningeal-based disease. It is more common for cauda equina dysfunction from
tumors to present in a subacute or chronic fashion compared to cauda equina
dysfunction resulting from other causes.
Ependymomas are the most common primary tumor of the spinal cord in adults
and the most common primary tumor to affect the cauda equina. Specifically,
myxopapillary ependymomas are more likely to occur below the conus medullaris
than other types of ependymomas.74 These tumors grow slowly, arising from
the ependymal cells in the central canal. On MRI, they typically enhance with
Iatrogenic Causes
As discussed above, spinal hematomas occurring after surgery may cause cauda
equina syndrome. Epidural injections of anesthetics and analgesics have also
CONTINUUMJOURNAL.COM 217
CASE 9-2 A 45-year-old man with no significant past medical history presented
with several weeks of worsening low back pain, progressive lower
extremity weakness and sensory changes, saddle anesthesia, and urinary
retention. He had also noticed shortness of breath and arthralgia over the
past 2 months.
Neurologic examination showed normal cranial nerves and upper
extremity strength, 4/5 strength diffusely in the lower extremities,
reduced lower extremity reflexes, and reduced sensation in the perineum
and in a length-dependent pattern in the lower extremities. MRI of the
lumbosacral spine showed nodular enhancement in the cauda equina and
in the vertebrae, similar to the MRI example in FIGURE 9-3.81 CSF
analysis showed a protein of 101 mg/dL, white blood cell count
of 50 cells/mm3, low glucose, and a normal angiotensin-converting
enzyme level. Cytology was negative for malignant cells, and all
infectious studies were
negative. Nerve conduction
study/EMG was also
performed and showed
abnormal spontaneous
activity in the lumbar
paraspinal muscles and a
length-dependent
sensorimotor axonal
neuropathy. CT of the
chest showed hilar
lymphadenopathy, which was
ultimately biopsied and
consistent with sarcoidosis.
He was treated with IV FIGURE 9-3
methylprednisolone followed Nodular enhancement of the cauda equina
and vertebrae.
by oral prednisone and started Reprinted from Hoyle JC, et al, Neurohospitalist.81 © 2014
on mycophenolate mofetil. SAGE Publications.
COMMENT The progression of symptoms over several weeks in this patient was
suspicious for an inflammatory process, and the symptoms of arthralgia
and shortness of breath were clues to the diagnosis. The possibility of
infection should be evaluated fully, especially since CSF findings in
sarcoidosis can appear similar to an infection, with a high white blood cell
count and low glucose. In addition, given the CSF findings and nodular
enhancement on MRI, it was also necessary to ensure that no signs of
malignancy were present in the CSF or elsewhere in this patient. The
diagnosis of sarcoidosis is made from tissue biopsy. If no lung involvement
had been found in this patient, then biopsy of the meninges would have
been considered.
Other Causes
Trauma, especially from motor vehicle accidents, falls, and gunshot wounds, is a
potential cause of cauda equina dysfunction. Often this is because of low lumbar
or transverse sacral fractures.95,96 No prospective trials have evaluated the best
treatment for such fractures. A 2018 meta-analysis of case reports and
retrospective case series that included a total of 521 patients with transverse sacral
fractures found that surgically treated and nonoperatively treated patients
showed no significant difference in neurologic recovery. In patients who were
surgically treated, fracture fixation in addition to decompression resulted in
greater neurologic recovery.97
Several case reports have described extramedullary hematopoiesis as a cause
of cauda equina dysfunction. Extramedullary hematopoiesis is hematopoiesis
that occurs outside of the bone marrow, which is normal during embryonic and
fetal development. However, it can occur as a pathologic process in people with
thalassemia and, less commonly, myelofibrosis, polycythemia, and sickle cell
disease. The spleen, liver, and lymph nodes are common sites of extramedullary
hematopoiesis, but rarely extramedullary hematopoiesis can occur in the spinal
canal, leading to neurologic symptoms.98 On MRI of the spine, this may appear as
multiple rounded masses or a single mass in the epidural space, typically contrast
enhancing with variable signal characteristics.98,99 No clear treatment of choice
has been identified, but surgical decompression, transfusion, hydroxyurea, and
radiation therapy have all been tried.98
Although not technically a disorder of the cauda equina, pudendal neuropathy
can closely mimic cauda equina dysfunction since the pudendal nerve originates
from the S2 through S4 nerve roots and innervates the perineum.100 It most
commonly presents as a neuralgia, with perineal pain that is worse with sitting
because of pressure on the perineum.75 Sensory symptoms of numbness can
occur, as can bowel, bladder, and sexual dysfunction if the neuropathy is
bilateral.75,101 A key difference between pudendal neuropathy and true cauda
CONTINUUMJOURNAL.COM 219
equina syndrome is that the pain in cauda equina syndrome is more commonly in
the lower back and legs and less often described as in the perineum. Pudendal
neuralgia occurs secondary to compression or entrapment from pelvic fractures,
bicycle seats, neoplasm, childbirth, or muscle or iatrogenic injury.101-103 The
diagnosis is challenging since objective findings can be difficult to demonstrate.
Nerve conduction studies of the pudendal nerve are not often performed and are
of unclear sensitivity and specificity for identifying a nerve injury.75 Denervation
of the external anal sphincter would be supportive of nerve injury; however,
external anal sphincter EMGs are technically challenging, and if the EMG is
normal, pudendal nerve dysfunction still cannot be ruled out (the same is true
when using these techniques to assess for cauda equina dysfunction in general).
MRI, especially MRI neurography, may be helpful in some cases.104 Symptoms of
pudendal neuropathy can be treated symptomatically with medications or
sometimes with pudendal nerve block.105 Surgery should generally not be
performed unless a clear etiology is identified or if the patient is severely
affected.75,106
CONCLUSION
Cauda equina syndrome is a neurologic emergency requiring timely diagnosis
and treatment. Important clinical characteristics include radiating low back pain,
perineal and lower extremity sensory disturbances, urinary and bowel
dysfunction, and lower extremity weakness. Although diskogenic causes account
for most cases, nondiskogenic etiologies must also be considered. An
understanding of cauda equina anatomy; clinical presentation; and the value of
diagnostic studies such as MRI, CSF evaluation, and nerve conduction studies
and EMG is necessary to provide the best chance for neurologic recovery.
REFERENCES
1 Mixter W, Barr J. Rupture of the intervertebral 6 Stewart JD. Focal peripheral neuropathies,
disc with involvement of the spinal canal. 4th ed. JBJ Publishing, 2010.
N Engl J Med 1934;211:210-215. doi:10.1056/
7 Ridley LJ, Han J, Ridley WE, Xiang H. Cauda
NEJM193408022110506
equina: normal anatomy. J Med Imaging
2 Fuso FAF, Dias ALN, Letaif OB, et al. Radiat Oncol 2018;62 Suppl 1:123.
Epidemiological study of cauda equina doi:10.1111/1754-9485.04_12786
syndrome. Acta Ortop Bras 2013;21(3):159-162.
8 Tarulli AW. Disorders of the cauda equina.
doi:10.1590/S1413-78522013000300006
Continuum (Minneap Minn) 2015;21(1 Spinal Cord
3 Woodfield J, Hoeritzauer I, Jamjoom AAB, et al. Disorders):146-158. doi:10.1212/01.
Understanding cauda equina syndrome: CON.0000461090.09736.45
protocol for a UK multicentre prospective
9 McNamee J, Flynn P, O'Leary S, et al. Imaging in
observational cohort study. BMJ Open 2018;8(12):
cauda equina syndrome—a pictorial review.
e025230. doi:10.1136/bmjopen-2018-025230
Ulster Med J 2013;82(2):100-108.
4 Podnar S. Epidemiology of cauda equina and
10 Spector LR, Madigan L, Rhyne A, et al.
conus medullaris lesions. Muscle Nerve 2007;
Cauda equina syndrome. J Am Acad Orthop Surg
35(4):529-531. doi:10.1002/mus.20696
2008;16(8):471-479. doi:10.5435/
5 Fraser S, Roberts L, Murphy E. Cauda equina 00124635-200808000-00006
syndrome: a literature review of its definition and
11 Parke WW, Gammell K, Rothman RH. Arterial
clinical presentation. Arch Phys Med Rehabil
vascularization of the cauda equina. J Bone Joint
2009;90(11):1964-1968. doi:10.1016/j.
Surg Am 1981;63(1):53-62.
apmr.2009.03.021
CONTINUUMJOURNAL.COM 221
38 Korse NS, Jacobs WCH, Elzevier HW, 51 Maki Y, Takayama M, Hayashi H, et al. Cauda
Vleggeert-Lankamp CL. Complaints of equina syndrome due to dural sac shift with
micturition, defecation and sexual function in engorgement of the epidural venous plexus: rare
cauda equina syndrome due to lumbar disk complication after lumbar microdiscectomy.
herniation: a systematic review. Eur Spine J 2013; World Neurosurg 2017;104:1048.e15-1048.e18.
22(5):1019-1029. doi:10.1007/s00586-012-2601-8 doi:10.1016/j.wneu.2017.05.078
39 Hazelwood JE, Hoeritzauer I, Pronin S, 52 Paksoy Y, Gormus N. Epidural venous plexus
Demetriades AK. An assessment of enlargements presenting with radiculopathy and
patient-reported long-term outcomes following back pain in patients with inferior vena cava
surgery for cauda equina syndrome. Acta obstruction or occlusion. Spine (Phila Pa 1976)
Neurochir (Wien) 2019;161(9):1887-1894. doi: 2004;29(21):2419-2424. doi:10.1097/01.
10.1007/s00701-019-03973-7 brs.0000144354.36449.2f
40 Cushnie D, Urquhart JC, Gurr KR, et al. Obesity 53 Mull M, Othman A, Dafotakis M, et al. Spinal
and spinal epidural lipomatosis in cauda equina epidural arteriovenous fistula with perimedullary
syndrome. Spine J 2018;18(3):407-413. doi:10.1016/ venous reflux: clinical and neuroradiologic
j.spinee.2017.07.177 features of an underestimated vascular disorder.
AJNR Am J Neuroradiol 2018;39(11):2095-2102.
41 Venkatesan M, Uzoigwe CE, Perianayagam G,
doi:10.3174/ajnr.A5854
et al. Is cauda equina syndrome linked with
obesity? J Bone Joint Surg Br 2012;94(11):1551-1556. 54 Zalewski NL. Vascular myelopathies. Continuum
doi:10.1302/0301-620X.94B11.29652 (Minneap Minn) 2021;27(1, Spinal Cord Disorders):
30-61.
42 Storm PB, Chou D, Tamargo RJ. Lumbar spinal
stenosis, cauda equina syndrome, and multiple 55 Darouiche RO. Spinal epidural abscess. N Engl J
lumbosacral radiculopathies. Phys Med Rehabil Med 2006;355(19):2012-2020. doi:10.1056/
Clin N Am 2002;13(3):713-733, ix. doi:10.1016/ NEJMra055111
s1047-9651(02)00013-x
56 Hasan GA, Kani SM, Alqatub A. Tuberculous
43 Sheehan JM, Shaffrey CI, Jane JA Sr. lumbar spinal epidural abscess in a young adult
Degenerative lumbar stenosis: the neurosurgical (case report). SICOT J 2018;4:5. doi:10.1051/
perspective. Clin Orthop Relat Res 2001(384): sicotj/2018005
61-74.
57 Shweikeh F, Zyck S, Sweiss F, et al. Aspergillus
44 Kim YS, Ju CI, Kim SW, Kim HS. Cauda equina spinal epidural abscess: case presentation and
syndrome caused by idiopathic epidural review of the literature. Spinal Cord Ser Cases
lipomatosis. Korean J Spine 2015;12(4):272-274. 2018;4:19. doi:10.1038/s41394-018-0046-y
doi:10.14245/kjs.2015.12.4.272
58 Corral I, Quereda C, Casado JL, et al. Acute
45 Wells AJ, McDonald MJ, Sandler SJ, Vrodos NJ. polyradiculopathies in HIV-infected patients.
Lumbosacral epidural lipomatosis causing rapid J Neurol 1997;244(8):499-504. doi:10.1007/
onset cauda equina syndrome. J Clin Neurosci s004150050132
2014;21(7):1262-1263. doi:10.1016/j.jocn.2013.
59 Panos G, Watson DC, Karydis I, et al. Differential
09.027
diagnosis and treatment of acute cauda equina
46 He F, Xing T, Yu F, et al. Cauda equina syndrome: syndrome in the human immunodeficiency virus
an uncommon symptom of aortic diseases. Int J positive patient: a case report and review of the
Clin Exp Med 2015;8(7):10760-10766. literature. J Med Case Rep 2016;10:165.
doi:10.1186/s13256-016-0902-y
47 Duggal N, Lach B. Selective vulnerability of the
lumbosacral spinal cord after cardiac arrest and 60 Benatar MG, Eastman RW. Human
hypotension. Stroke 2002;33(1):116-121. doi:10.1161/ immunodeficiency virus-associated pure motor
hs0102.101923 lumbosacral polyradiculopathy. Arch Neurol
2000;57(7):1034-1039. doi:10.1001/
48 Bhatt D, Bhatt D, Bhatt N. Cauda equina
archneur.57.7.1034
syndrome caused by a spontaneous spinal
haematoma. BMJ Case Rep 2015;2015: 61 Maschke M, Kastrup O, Diener HC. CNS
bcr2014208583. doi:10.1136/bcr-2014-208583 manifestations of cytomegalovirus infections:
diagnosis and treatment. CNS Drugs 2002;16(5):
49 Kaner T, Sasani M, Oktenoglu T, et al.
303-315. doi:10.2165/00023210-200216050-00003
Postoperative spinal epidural hematoma
resulting in cauda equina syndrome: a case 62 Savoldi F, Kaufmann TJ, Flanagan EP, et al.
report and review of the literature. Cases J 2009; Elsberg syndrome: a rarely recognized cause
2:8584. doi:10.4076/1757-1626-2-8584 of cauda equina syndrome and lower
thoracic myelitis. Neurol Neuroimmunol
50 Hogan WB, Kuris EO, Durand WM, et al. Timing of
Neuroinflamm 2017;4(4):e355. doi:10.1212/
surgical decompression for cauda equina
NXI.0000000000000355
syndrome. World Neurosurg 2019;132:e732-e738.
doi:10.1016/j.wneu.2019.08.030 63 Halperin JJ. Lyme disease and the peripheral
nervous system. Muscle Nerve 2003;28(2):
133-143. doi:10.1002/mus.10337
CONTINUUMJOURNAL.COM 223
91 Bourne IH. Lumbo-sacral adhesive arachnoiditis: 99 Das D, Andi AC, van der Walt JD, Houghton R. MRI
a review. J R Soc Med 1990;83(4):262-265. appearances of extramedullary haematopoiesis
presenting with cauda equina syndrome in sickle
92 Khan MU, Devlin JAJ, Fraser A. Adhesive
cell disease. Clin Radiol 2011;66(12):1219-1222.
arachnoiditis in mixed connective tissue disease:
doi:10.1016/j.crad.2011.07.043
a rare neurological manifestation. BMJ Case Rep
2016;2016:bcr2016217418. doi:10.1136/ 100 Kaur J, Singh P. Pudendal nerve entrapment
bcr-2016-217418 syndrome. In: StatPearls. Treasure Island,
FL: StatPearls Publishing StatPearls Publishing
93 Bowen J, Gregory R, Squier M, Donaghy M. The
LLC, 2019.
post-irradiation lower motor neuron syndrome
neuronopathy or radiculopathy? Brain 1996; 101 Silbert PL, Dunne JW, Edis RH, Stewart-Wynne
119(pt 5):1429-1439. doi:10.1093/brain/119.5.1429 EG. Bicycling induced pudendal nerve pressure
neuropathy. Clin Exp Neurol 1991;28:191-196.
94 Feistner H, Weissenborn K, Münte TF, et al.
Post-irradiation lesions of the caudal roots. Acta 102 Insola A, Granata G, Padua L. Alcock canal
Neurol Scand 1989;80(4):277-281. doi:10.1111/ syndrome due to obturator internus muscle
j.1600-0404.1989.tb03878.x fibrosis. Muscle Nerve 2010;42(3):431-432.
doi:10.1002/mus.21735
95 Li P, Qiu D, Shi H, et al. Isolated decompression
for transverse sacral fractures with cauda equina 103 Andersen KV, Bovim G. Impotence and nerve
syndrome. Med Sci Monit 2019;25:3583-3590. entrapment in long distance amateur cyclists.
doi:10.12659/MSM.916483 Acta Neurol Scand 1997;95(4):233-240. doi:
10.1111/j.1600-0404.1997.tb00104.x
96 Thongtrangan I, Le H, Park J, Kim DH. Cauda
equina syndrome in patients with low lumbar 104 Wadhwa V, Hamid AS, Kumar Y, et al. Pudendal
fractures. Neurosurg Focus 2004;16(6):e6. nerve and branch neuropathy: magnetic
resonance neurography evaluation. Acta Radiol
97 Kempen DHR, Delawi D, Altena MC, et al.
2017;58(6):726-733. doi:10.1177/0284185116668213
Neurological outcome after traumatic transverse
sacral fractures: a systematic review of 521 105 Hough DM, Wittenberg KH, Pawlina W, et al.
patients reported in the literature. JBJS Rev 2018; Chronic perineal pain caused by pudendal nerve
6(6):e1. doi:10.2106/JBJS.RVW.17.00115 entrapment: anatomy and CT-guided perineural
injection technique. AJR Am J Roentgenol 2003;
98 Soman S, Tharadara GD, Chhatrala N, Jain S. A
181(2):561-567. doi:10.2214/ajr.181.2.1810561
case report of extramedullary haematopoeisis in
lumbosacral region presenting as cauda equina 106 Hruby S, Dellon L, Ebmer J, et al. Sensory
syndrome. Int J Spine Surg 2016;10:25. recovery after decompression of the distal
doi:10.14444/3025 pudendal nerve: anatomical review and
quantitative neurosensory data of a prospective
clinical study. Microsurgery 2009;29(4):270-274.
doi:10.1002/micr.20615
By John K. Fink, MD C O N T I N U UM A U D I O
I NT E R V I E W A V A I L AB L E
ONLINE
Downloaded from http://journals.lww.com/continuum by wqLe/H3/oM2vx1Qs5A5qMemKKHLPqE4qkmGNpdheG3ikf1o85ttJSkFL2oTkgOkhMEmawHvsuTTE5xJG2ZjqccytIAhVn2qegy060KLcKJuPZsx5htaYiopRjp2zor2egUzWJAEWYNo/R1NuKT7SYsuBdzpo0ePV on 04/28/2022
ABSTRACT
PURPOSE OF REVIEW: This article guides clinicians in the clinical recognition and
differential diagnosis of hereditary myelopathies.
RELATIONSHIP DISCLOSURE:
INTRODUCTION Dr Fink has served as a medical
H
advisor for the Spastic
ereditary myelopathies are diverse genetic disorders in which the Paraplegia Foundation and as a
major clinical features are due to disturbance of elements that occur consultant for Cure AP-4, Inc.
entirely within, emanate from, or traverse the spinal cord. Although Dr Fink receives research/grant
support from the Spastic
the word hereditary implies genetic causation as the disease Paraplegia Foundation and
mechanism, the term myelopathy is strictly a clinical syndromic patent royalties and has
designation describing particular signs and symptoms localizing to the spinal provided expert medicolegal
consultation.
cord and therefore does not imply common neuropathologic processes or
radiographic findings. As with most neurologic syndromes, correlation between UNLABELED USE OF
PRODUCTS/INVESTIGATIONAL
the distribution of neuropathology, radiographic findings, and nature of the USE DISCLOSURE:
clinical disorder is imperfect. For example, some forms of “pure” cerebellar Dr Fink reports no disclosure.
ataxia have postmortem evidence of more widespread neurodegeneration
involving dorsal columns. Conversely, not all inherited disorders that cause © 2021 American Academy
radiographic abnormalities involving the spinal cord in fact manifest as of Neurology.
CONTINUUMJOURNAL.COM 185
Spinocerebellar Degeneration
The prefix spino- of spinocerebellar degeneration indicates involvement of one or
more of the following: corticospinal tracts in the spinal cord, dorsal columns (or
dorsal root ganglia), or anterior horn cells. As clinical syndromes, spinocerebellar
disorders are contrasted with much less common “isolated” or “pure” cerebellar
ataxia syndromes (eg, spinocerebellar ataxia type 15 [SCA15, Mendelian
Inheritance in Man (MIM) 606658] and SCA41 [MIM 616410])20 and
distinguished from clinical olivopontocerebellar disorders that involve the
cerebellum and other brainstem structures (eg, multiple system atrophy,
cerebellar type) and disorders involving the cerebellum and other areas of the
nervous system that do not have clinical manifestations of spinal cord
involvement (eg, Niemann-Pick disease type C). Classifications of spastic ataxias
(in which ataxia is prominent)1 and complicated forms of hereditary spastic
paraplegia (HSP) associated with cerebellar involvement (in which spastic
paraparesis is prominent) overlap.15,16
Inherited spinocerebellar degenerations (eg, Friedreich ataxia, SCA3 [also
known as Machado-Joseph disease] [CASE 8-1], Bassen-Kornzweig syndrome,
and vitamin E deficiency [occasionally familial]) are recognized by a
combination of progressive cerebellar ataxia, peripheral neuropathy, dorsal
column impairment, and variable corticospinal tract involvement.
It is important to recognize that both between individuals who share the same
disorder and between individuals with genetically unrelated types of
CONTINUUMJOURNAL.COM 187
Spinocerebellar ataxias SCA 1 through 48 Genetic testing for specific SCA gene
(SCAs)3 mutation; neuroimaging to demonstrate
cerebellar atrophy
Motor neuron disorders4-8 Spinal muscular atrophy Survival motor neuron (SMN1, SMN2) gene
analysis
Familial amyotrophic lateral sclerosis C9orf72, SOD1, and other gene analysis
Primary lateral sclerosis (rarely familial) ALSIN gene analysis (for juvenile familial
primary lateral sclerosis); FIG4, C9orf72,
SPG7 analysis
Spinal bulbar muscular atrophy (Kennedy Androgen receptor gene mutation (CAG
disease) repeats)
Leukodystrophies9-11 Subacute combined degeneration (rarely Serum vitamin B12, methylmalonic acid
familial)
Multiple sclerosis (occasionally familial) MRI of brain and spinal cord, CSF analysis,
clinical course
Leukoencephalopathy with brainstem and spinal DARS2 gene analysis, spinal MRI
cord involvement and lactate elevation (DARS2
mutation) (FIGURE 8-1A)18
Autosomal dominant leukodystrophy (multiple Brain and spinal cord MRI, LMNB1 gene
sclerosis mimic)19 analysis (including copy number analysis);
LMNB1 quantification in white blood cells
Adult polyglucosan body disease due to GBE1 Brain and spinal cord MRI, nerve
gene mutation conduction studies and EMG, GBE1 gene
analysis
Von Hippel-Lindau (hereditary hemangiomata) MRI scan and VHL gene analysis
CSF = cerebrospinal fluid; CT = computed tomography; EMG = electromyography; MRI = magnetic resonance imaging.
a
Updated from Fink JK, Continuum (Minneap Minn).2 © 2008 American Academy of Neurology.
CONTINUUMJOURNAL.COM 189
differ in the relative combination of upper motor neuron versus lower motor
neuron involvement and the variable occurrence of additional neurologic
disturbance. In PLS, for example, progressive spastic weakness, usually beginning
in the legs and later involving the arms, speech, and swallowing, reflects
corticospinal and corticobulbar tract involvement and, to a lesser extent, loss of
cortical motor neurons (CASE 8-4). In PLS, in contrast to amyotrophic lateral
sclerosis (ALS), there is either no evidence of lower motor neuron involvement
or, at most, minimal evidence on EMG of chronic denervation late in the disease.
Conversely, spinal muscular atrophy is characterized by muscular weakness and
atrophy due to anterior horn cell degeneration with relative preservation of
corticospinal tracts.
CASE 8-1 A 30-year-old woman presented for an initial neurologic evaluation for
difficulty with balance and handwriting. She first noted the insidious
onset of a very slowly progressive balance disturbance at approximately
age 26, followed several years later by mildly impaired handwriting.
Although she was fully able to ascend and descend stairs and walk long
distances independently, neurologic examination at age 30 showed
slightly wide-based gait and impaired ability to walk in tandem. Ocular
dysmetria and saccadic intrusions into pursuit eye movements were also
noted. The remainder of neurologic examination, including finger-to-
nose, heel-to-shin, sensory, and reflex testing, was normal.
Serial evaluations were performed over the next 20 years. During this
time, her balance impairment slowly worsened, her speech became
increasingly dysarthric, and she gradually lost the ability to stand and
walk (requiring a walker by age 48 and a wheelchair in her fifties). In
addition, progressive dystonia, axial rigidity, impaired distal sensation,
and generalized hyperreflexia gradually emerged.
By age 47, she had begun to experience involuntary movements of her
face, neck, and upper extremities. Examination at this time showed
prominent axial rigidity, particularly affecting neck movements; dystonia
affecting the neck, face, and bilateral upper extremities; and cogwheel
rigidity in her upper extremities. In addition to ataxic dysarthria and ataxia
affecting upper and lower extremities, she had grade 3 hyperreflexia
throughout except at the ankles, which were hyporeflexic, and
decreased sensation to pinprick and vibration in a stocking distribution
below the knees. She was able to stand with great difficulty and was
able to take a few steps but had marked balance impairment and
tendency to fall.
Neurologic examination at age 53 showed facial bradykinesia,
generally reduced movements of the extremities, marked ataxic
dysarthria, marked saccadic intrusions into smooth pursuit, very slow
ocular saccades, and generalized hyperreflexia (grade 3) except
absent ankle deep tendon reflexes. She required significant assistance
to stand, had a wide-based stance, and required maximum assistance
to take a couple of steps.
CONTINUUMJOURNAL.COM 191
repeat. More than 50 other genes have been implicated in familial ALS.8 Genetic
factors also contribute to the disease in many individuals with apparently sporadic
ALS (ie, ALS ascertained in individuals who do not have ALS-affected first-degree
relatives). Specifically, among individuals with apparently sporadic ALS, 1% to 3%
have SOD1 mutations and approximately 5% have pathogenic C9orf72 expansions.
Additional genes (eg, TARDBP, FUS, HNRNPA1, SQSTM1, VCP, OPTN, and
PFN1) have also been implicated in apparently sporadic ALS.8
Overlap exists between the classifications of motor neuron disorder and distal
motor-sensory axonopathy affecting the CNS (eg, HSP). The primary differences
are the degree to which anterior horn cells are lost (a major aspect of spinal muscular
CASE 8-2 A 13-year-old girl presented with very slowly worsening gait and balance.
She reported some stumbling and occasionally dropping things. She had
a history of mild clumsiness in childhood that did not rise to the level of
medical concern. A heart murmur had been discovered at age 10.
Echocardiography identified hypertrophic cardiomyopathy.
Examination was notable for pes cavus, mild scoliosis, mild hypophonia
and dysarthria, mild nystagmus, mild weakness of intrinsic hand muscles
and tibialis anterior muscles, mildly ataxic heel-to-shin and finger-to-nose
movements, mild truncal titubation, and markedly impaired vibration
perception (absent below the knees and absent in her hands). Deep
tendon reflexes were absent throughout. Although she was able to
ambulate independently, her gait was mildly ataxic. Romberg sign was
present.
Her gait and balance slowly worsened, and she required the use of a
wheelchair at approximately age 17. Examination at age 21 showed mild
ataxic dysarthria; saccadic intrusions into smooth pursuit; and weakness of
hip flexion, foot dorsiflexion, and wrist extension. She had mild hypotonia
in the legs, generalized areflexia, ataxia in upper and lower extremities,
and pes cavus with hammer toe formation. She could stand with assistance
but was not able to walk even with support. Localization indicated deficits
referable to the cerebellar midline, cerebellar hemispheres, and dorsal
columns serving the upper and lower extremities.
Genetic analysis showed expansions in both FXN alleles (FXN [GAA]766
and [GAA] 533). The normal GAA repeat number is approximately 8 to 30,
with pathologic expansions measuring 170 to 1700 repeats.22 The patient
was diagnosed with Friedreich ataxia.
CONTINUUMJOURNAL.COM 193
CASE 8-4 A 64-year-old man began experiencing initially subtle but slowly
worsening gait disturbance. Neurologic examination showed generalized
hyperreflexia (3+) and mild symmetric weakness and spasticity in his legs.
Speech articulation; swallowing ability; and upper extremity strength,
tone, and dexterity were normal. Sensation was normal throughout. Brain
MRI showed areas of T2 signal intensity in periventricular regions
consistent with chronic small vessel ischemia and age-related changes.
Cervical and thoracic spine MRI showed degenerative changes but no
evidence of spinal cord compression or spinal cord signal change.
One year later (approximately 6 years after symptom onset [age 70]),
he began to experience subtle difficulty speaking, slight impairment of
handwriting and hand dexterity, and emotional lability. Neurologic
examination at that time showed mild slowing of finger tapping, the
presence of Hoffman and Trömner signs, generalized hyperreflexia, and
continued weakness and spasticity in the legs. Worsening gait
disturbance required use of a walker.
By age 74 (approximately 10 years after symptom onset), the patient
reported dysphagia, emotional lability (suggestive of pseudobulbar
affect), and worsened ability to use his upper extremities. Examination
demonstrated marked spastic dysarthria and hypophonia, very slow hand
opening and closing, the emergence of spasticity in the upper
extremities, and worsening of spasticity to a marked degree in the legs.
Marked spastic gait required intermittent use of a wheelchair. There was
no family history of similar disorder.
EMG within approximately 1 year of symptom onset and again after
symptoms had progressed for at least 5 years showed only mild
sensory-motor neuropathy without evidence of amyotrophic lateral
sclerosis.
Leukodystrophies
Leukodystrophies are disorders in which the primary or major abnormality
involves myelin development (dysmyelination) or myelin degeneration
(demyelination) of central nerves occurring alone or in combination with
CONTINUUMJOURNAL.COM 195
● Demyelinating peripheral
neuropathy, which may
accompany childhood-
onset leukodystrophies (eg,
Krabbe disease and
metachromatic
leukodystrophy), may be
absent in the rare
adolescent- and adult-onset
forms of these disorders.
● Childhood-onset
adrenoleukodystrophy and
adolescent- and adult-onset
adrenomyeloneuropathy are
X-linked disorders in which
ABCD1 gene mutation leads
to impaired peroxisomal
beta-oxidation and
accumulation of very long
chain fatty acids
systemically.
● Adrenoleukodystrophy/
adrenomyeloneuropathy
phenotypes include rapidly
progressive childhood,
adolescent, and adult
cerebral forms; slowly
progressive myelopathic
forms (characterized by
slowly progressive spastic
FIGURE 8-1 paraparesis and peripheral
MRI examples of hereditary myelopathies. Sagittal (A) and axial (B) T2-weighted images neuropathy, often with
of the cervical spine show spinal cord atrophy accompanied by dorsal T2 hyperintensity complete sparing of the
(A, B, arrows) in a patient with a leukoencephalopathy with brainstem and spinal cord brain); and isolated adrenal
involvement and high lactate associated with the DARS2 gene mutation. Sagittal (C) and insufficiency.
axial (D) T2-weighted images of the cervical spine show moderate cervical cord atrophy
in a young man with X-linked adrenomyeloneuropathy. Sagittal (E) and axial (F)
T2-weighted images of the thoracic spine show diffuse spinal cord atrophy in a patient
with hereditary spastic paraplegia accompanied by a mutation in the SPG7 gene.
Figure courtesy of Eoin Flanagan, MBBCh.
long chain fatty acids, lactate, pyruvate, serum copper, plasma amino acids
(including homocysteine and methionine), urine amino acids, and serum
cholestanol should be checked in all patients with unexplained spastic paraplegia
and those with leukodystrophy.
CONTINUUMJOURNAL.COM 197
CASE 8-5 A 46-year-old man presented with a 13-year history of progressive gait
disturbance, urinary urgency, dementia, and dysphagia. He first noted
symptoms at age 33, when he noticed difficulty driving because his foot
would “jump” repetitively when pressing the gas and brake pedals. This was
followed by very slowly progressive gait impairment and urinary urgency.
Within the previous year, he had quit working (after age 46) because of
progressive inability to walk and stand and frequent urinary incontinence.
Over the 6 months before presentation, he developed new symptoms of
progressive dementia and dysphagia. These symptoms began at
approximately age 46 and became severe over the next 6 months.
His family history was significant for a brother who died at age 12 and a
maternal cousin (son of his mother’s sister) who died in childhood of a
neurodegenerative disorder.
Neurologic examination at age 46 demonstrated full alertness, markedly
impaired cognition with very slow verbal replies, and difficulty following
simple commands. Cranial nerves, including extraocular movements, were
normal. Muscle strength was preserved. He had mild spasticity in the arms
and moderate to marked spasticity in the legs. Sensory testing was
considered unreliable. Deep tendon reflexes were hyperactive (3+)
throughout his upper and lower extremities. He was able to stand and take
steps (consistent with mild spastic gait) but was quite unsteady and required
a wheelchair.
Brain MRI showed diffuse white matter abnormality, including areas of
contrast enhancement. Laboratory studies demonstrated increased plasma
very long chain fatty acids.
CONTINUUMJOURNAL.COM 199
CASE 8-7 A 13-year-old girl presented for evaluation of gait disturbance, upper
extremity tremor and declining hand dexterity. She had been born at
35 weeks gestation after an induced delivery because of premature
placental aging. Her speech and developmental milestones had been mildly
delayed, and she had mild cognitive impairment that required special
education. She was nonetheless fully ambulatory, social, and able to
perform self-care activities. By the age of 13 she was noted to have a gait
disturbance with incomplete extension of her knees and a tendency to keep
her arms flexed while walking. She also was noted to have upper extremity
tremors and slowed hand dexterity with impaired ability to write.
Initial neurologic examination at age 13 showed upper extremity tremor,
mild dysarthria, and increased tone in the upper and lower extremities, with
preserved strength, generalized hyperreflexia, and ankle clonus. Sensory
and cerebellar testing were normal. Her balance was impaired, and her gait
was slow, narrow-based, and associated with dystonic arm postures.
Slowly, over many years, her cognition, speech, swallowing, gait, and
functional use of the upper extremities progressively declined, ultimately
causing profound disability. Examination at age 22 showed marked cognitive
impairment, marked hypophonia, very slow arm movements, coarse tremor
in the hands, mild spasticity in the arms, and marked spasticity in the legs.
She had marked weakness in the legs and was unable to lift her legs against
gravity or bend her knees. She had generalized hyperreflexia, including a
hyperactive jaw jerk, and was nonambulatory. EMG and nerve conduction
studies showed only left median neuropathy. Brain MRI at age 23 showed a
thin corpus callosum (FIGURE 8-2A) and focal T2 signal hyperintensity anterior
to the anterior horns of the lateral ventricles consistent with the ears of the
lynx sign (FIGURE 8-2B).34 At age 31, she was nearly aphonic and was only able
to very slowly move her right arm, turn her head, and slowly partially open
and close her hands. She had dystonia in her hands and marked spasticity in
upper and lower extremities. Progressive dysphagia and weight loss
necessitated gastrostomy feeding. Repeat EMG and nerve conduction
studies showed length-dependent motor-predominant neuropathy.
The diagnosis of SPG11 autosomal recessive hereditary spastic paraplegia
was made. Genetic testing at age 28 revealed compound heterozygous
SPG11/spatacsin mutations each causing protein truncation (c.6299 T>A,
pLeu2100Stop and c.6598 A>T, p.Lys2200Stop).
FIGURE 8-2
Imaging of the patient in CASE 8-7. A, Sagittal T1-weighted MRI shows a thin corpus callosum.
B, Axial fluid-attenuated inversion recovery (FLAIR) MRI shows the ears of the lynx sign.
CONTINUUMJOURNAL.COM 201
CONCLUSION
The clinical and genetic diversity of hereditary myelopathies limits useful
generalizations. Nonetheless, it is notable that in the patients described in the
ACKNOWLEDGMENTS
The author would like to thank the Spastic Paraplegia Foundation, the Paul and
Lois Katzman family, and the Susan Parkinson Foundation, without whom his
investigations would not be possible.
REFERENCES
1 Marelli C, Salsano E, Politi LS, Labauge P. Spinal 12 Gales A, Masingue M, Millecamps S, et al.
cord involvement in adult-onset metabolic and Adolescence/adult onset MTHFR deficiency
genetic diseases. J Neurol Neurosurg Psychiatry may manifest as isolated and treatable distinct
2019;90(2):211-218. doi:10.1136/jnnp-2018-318666 neuro-psychiatric syndromes. Orphanet J Rare
Dis 2018;13:29. doi:10.1186/s13023-018-0767-9
2 Fink JK. Hereditary myelopathies. Continuum
(Minneap Minn) 2008;14(3):58-70. doi:10.1212/ 13 Cui J, Wang Y, Zhang H, et al. Isolated subacute
01.CON.0000324124.55065.09 combined degeneration in late-onset cobalamin
C deficiency in children: two case reports and
3 Klockgether T, Mariotti C, Paulson HL.
literature review. Medicine (Baltimore) 2019;
Spinocerebellar ataxia. Nat Rev Dis Primers 2019;
98(39):e17334. doi:10.1097/MD.0000000000017334
5(1):24. doi:10.1038/s41572-019-0074-3
14 Messing A. Alexander disease. Handb Clin Neurol
4 Garg N, Park SB, Vucic S, et al. Differentiating
2018;148:693-700. doi:10.1016/B978-0-444-
lower motor neuron syndromes. J Neurol
64076-5.00044-2
Neurosurg Psychiatry 2017;88(6):474-483.
doi:10.1136/jnnp-2016-313526 15 Fink JK. Upper motor neuron disorders:
hereditary spastic paraplegia and primary lateral
5 Tiryaki E, Horak HA. ALS and other motor neuron
sclerosis. In: Johnston MV, Adams HP, Fatemi A,
diseases. Continuum (Minneap Minn) 2014;
editors. Neurobiology of disease. 2nd ed. Oxford
20(5 Peripheral Nervous System Disorders):
University Press, 2016: 236-240.
1185-1207. doi:10.1212/01.CON.0000455886.
14298.a4 16 Fink JK. The hereditary spastic paraplegias. In:
Rosenberg RN, Pascual JM, editors. Rosenberg's
6 Verschueren A. Motor neuropathies and lower
molecular and genetic basis of neurologic and
motor neuron syndromes. Rev Neurol (Paris) 2017;
psychiatric disease. 6th ed. Academic Press,
173(5):320-325. doi:10.1016/j.neurol.2017.03.018
2020:891-902.
7 Peters OM, Ghasemi M, Brown RH Jr. Emerging
17 Scheper GC, van der Klok T, van Andel RJ, et al.
mechanisms of molecular pathology in ALS. J Clin
Mitochondrial aspartyl-tRNA synthetase
Invest 2015;125(5):1767-1779. doi:10.1172/JCI71601
deficiency causes leukoencephalopathy with
8 Taylor JP, Brown RH Jr, Cleveland DW. Decoding brain stem and spinal cord involvement and
ALS: from genes to mechanism. Nature 2016; lactate elevation. Nat Genet 2007;39(4):534-539.
539(7628):197-206. doi:10.1038/nature20413 doi:10.1038/ng2013
9 Raymond GV. Leukodystrophy: basic and clinical. 18 Isohanni P, Linnankivi T, Buzkova J, et al. DARS2
Adv Neurobiol 2017;15:365-382. doi:10.1007/ mutations in mitochondrial leucoencephalopathy
978-3-319-57193-5_14 and multiple sclerosis. J Med Genet 2010;47(1):
66-70. doi:10.1136/jmg.2009.068221
10 Köhler W, Curiel J, Vanderver A. Adulthood
leukodystrophies. Nat Rev Neurol 2018;14:94-105. 19 Padiath QS, Saigoh K, Schiffmann R, et al. Lamin
doi:10.1038/nrneurol.2017.175 B1 duplications cause autosomal dominant
leukodystrophy. Nat Genet 2006;38(10):1114-1123.
11 Lyon G, Fattal-Valevski A, Kolodny EH.
doi:10.1038/ng1872
Leukodystrophies: clinical and genetic aspects.
Top Magn Reson Imaging 2006;17(4):219-242.
doi:10.1097/RMR.0b013e31804c99d4
CONTINUUMJOURNAL.COM 203
20 Bird TD. Hereditary ataxia overview. In: Adam 31 Garbern JY, Yool DA, Moore GJ, et al. Patients
MP, Ardinger HH, Pagon RA, et al, editors. lacking the major CNS myelin protein, proteolipid
GeneReviews. University of Washington, Seattle; protein 1, develop length-dependent axonal
1993-2020. Published October 28, 1998. Updated degeneration in the absence of demyelination
July 25, 2019. Accessed December 7, 2020. ncbi. and inflammation. Brain 2002;125(pt 3):551-561.
nlm.nih.gov/books/NBK1138/ doi:10.1093/brain/awf043
21 Paulson H. Machado-Joseph disease/ 32 Moser HW, Mahmood A, Raymond GV. X-linked
spinocerebellar ataxia type 3. Handb Clin Neurol adrenoleukodystrophy. Nat Clin Pract Neurol
2012;103:437-449. doi:10.1016/B978-0-444-51892- 2007;3(3):140-151. doi:10.1038/ncpneuro0421
7.00027-9
33 Engelen M, Kemp S, de Visser M, et al. X-linked
22 Cossée M, Schmitt M, Campuzano V, et al. adrenoleukodystrophy (X-ALD): clinical
Evolution of the Friedreich's ataxia trinucleotide presentation and guidelines for diagnosis,
repeat expansion: founder effect and follow-up and management. Orphanet J Rare Dis
premutations. Proc Natl Acad Sci U S A 1997; 2012;7:51. doi:10.1186/1750-1172-7-51
94(14):7452-7457. doi:10.1073/pnas.94.14.7452
34 Pascual B, de Bot ST, Daniels MR, et al. “Ears of
23 Cook A, Giunti P. Friedreich's ataxia: clinical the lynx” MRI sign is associated with SPG11 and
features, pathogenesis and management. SPG15 hereditary spastic paraplegia. AJNR Am J
Br Med Bull 2017;124(1):19-30. doi:10.1093/bmb/ Neuroradiol 2019;40(1):199-203. doi:10.3174/
ldx034 ajnr.A5935
24 Greene E, Mahishi L, Entezam A, et al. 35 Stevanin G. Spastic paraplegia 11. In: Adam MP,
Repeat-induced epigenetic changes in intron 1 of Ardinger HH, Pagon RA, et al, editors.
the frataxin gene and its consequences in GeneReviews. University of Washington, Seattle;
Friedreich ataxia. Nucleic Acids Res 2007;35(10): 1993-2020. Published March 27, 2008. Updated
3383-3390. doi:10.1093/nar/gkm271 December 19, 2019. Accessed December 7, 2020.
ncbi.nlm.nih.gov/books/NBK1210/
25 Turner MR, Barohn RJ, Corcia P, et al. Primary
lateral sclerosis: consensus diagnostic criteria. 36 Faber I, Martinez ARM, de Rezende TJR, et al.
J Neurol Neurosurg Psychiatry 2020;91(4): SPG11 mutations cause widespread white matter
373-377. doi:10.1136/jnnp-2019-322541 and basal ganglia abnormalities, but restricted
cortical damage. Neuroimage Clin 2018;19:
26 Yang Y, Hentati A, Deng HX, et al. The gene
848-857. doi:10.1016/j.nicl.2018.05.031
encoding alsin, a protein with three
guanine-nucleotide exchange factor domains, is 37 Wijemanne S, Shulman JM, Jimenez-Shahed J,
mutated in a form of recessive amyotrophic et al. SPG11 mutations associated with a complex
lateral sclerosis. Nat Genet 2001;29(2):160-165. phenotype resembling dopa-responsive
doi:10.1038/ng1001-160 dystonia. Mov Disord Clin Pract 2015;2(2):149-154.
doi:10.1002/mdc3.12144
27 de Vries BS, Spreij LA, Rustemeijer LMM, et al. A
neuropsychological and behavioral study of PLS. 38 Faber I, Martinez ARM, Martins CR Jr, et al.
Amyotroph Lateral Scler Frontotemporal SPG11-related parkinsonism: clinical profile,
Degener 2019;20(5-6):376-384. doi:10.1080/ molecular imaging and l-dopa response.
21678421.2019.1620284 Mov Disord 2018;33:1650-1656. doi:10.1002/
mds.27491
28 Lapchak PA. Neuronal dysregulation in
stroke-associated pseudobulbar affect (PBA): 39 Manole A, Chelban V, Haridy NA, et al. Severe
diagnostic scales and current treatment options. axonal neuropathy is a late manifestation of
J Neurol Neurophysiol 2015;6(5):323. doi:10.4172/ SPG11. J Neurol 2016;263(11):2278-2286. doi:
2155-9562.1000323 10.1007/s00415-016-8254-5
29 Floeter MK, Katipally R, Kim MP, et al. Impaired 40 Branchu J, Boutry M, Sourd L, et al. Loss of
corticopontocerebellar tracts underlie spatacsin function alters lysosomal lipid
pseudobulbar affect in motor neuron disorders. clearance leading to upper and lower motor
Neurology 2014;83(7):620-627. doi:10.1212/ neuron degeneration. Neurobiol Dis 2017;102:
WNL.0000000000000693 21-37. doi:10.1016/j.nbd.2017.02.007
30 Lyon G, Hagberg B, Evrard P, et al. 41 Daoud H, Zhou S, Noreau A, et al. Exome
Symptomatology of late onset Krabbe's sequencing reveals SPG11 mutations causing
leukodystrophy: the European experience. juvenile ALS. Neurobiol Aging 2012;33(4):839.
Dev Neurosci 1991;13(4–5):240-244. e5-839.e9. doi:10.1016/j.neurobiolaging.
doi:10.1159/000112167 2011.11.012
By Michel Toledano, MD C O N T I N U UM A U D I O
I NT E R V I E W A V A I L AB L E
ONLINE
Downloaded from http://journals.lww.com/continuum by wqLe/H3/oM2vx1Qs5A5qMemKKHLPqE4qkmGNpdheG3ikf1o85ttJSkFL2oTkgOkhMEmawHvsuTTE5xJG2ZjqccytIAhVn2qegy060KLcKJuPZsx5htaYiopRjp2zor2egUzWJAEWYNo65TEub0G9tZtPaMachiqn on 04/28/2022
ABSTRACT
PURPOSE OF REVIEW: This
article reviews infectious etiologies of spinal cord
dysfunction, emphasizing the importance of recognizing common
clinicoradiographic syndromes and interpreting them in the context of
exposure risk and individual host susceptibilities.
P
rompt and thorough investigation of spinal cord dysfunction is CONTINUUM (MINNEAP MINN)
2021;27(1, SPINAL CORD DISORDERS):
important as severe impairment may accrue rapidly without a clear 93–120.
diagnostic and treatment plan. Spinal cord dysfunction of any cause,
whether extrinsic or intrinsic, focal or diffuse, is referred to as Address correspondence to
Dr Michel Toledano, Mayo
myelopathy. Myelitis usually designates inflammation of the spinal cord
Clinic, 200 First St SW,
itself. The corollary terms for root pathology are radiculopathy and radiculitis. Rochester, MN 55905, toledano.
Infections can result in spine pathology through direct invasion of neural michel@mayo.edu.
structures, secondary inflammation, or compression, as with an epidural abscess. RELATIONSHIP DISCLOSURE:
Neuroinvasion can lead to downstream inflammatory changes, but inflammation Dr Toledano reports no
can also result from immune-mediated mechanisms triggered by systemic disclosure.
infection in the absence of direct nervous system involvement by the pathogen. UNLABELED USE OF
When this occurs contemporaneously with acute infection, the term PRODUCTS/INVESTIGATIONAL
USE DISCLOSURE:
parainfectious is used, whereas the term postinfectious refers to cases in which
Dr Toledano discusses the
neurologic symptoms develop weeks after systemic infection. unlabeled/investigational use of
Once infection has been identified as a probable cause, it is imperative to corticosteroids and IV
immunoglobulin for the
narrow the range of potential pathogens under consideration. Knowing which treatment of infectious
microorganisms are likely and whether the presentation is primarily driven by myelopathies.
direct infection or secondary immune-mediated mechanisms can prevent
unnecessary testing, mitigate the risk of false-positive results, and guide © 2021 American Academy
appropriate empiric therapy. of Neurology.
CONTINUUMJOURNAL.COM 93
Viruses
Human T-cell lymphotropic South America; the Caribbean; Japan; Papua New Guinea; the Melanesian islands; the
virus type 1 (HTLV-1) Middle East; and West, Central, and Southern Africa
Rabies Lyssavirus Worldwide but most common in Africa, Central and South America, and Asia
Bacteria
Borrelia species Northeast, mid-Atlantic, and northern Midwest of the United States; Europe
Brucella species North Africa, the Mediterranean Basin, Middle East, Indian subcontinent, Mexico
Mycobacterium tuberculosis Central and South America, sub-Saharan and Northern Africa, Indian subcontinent,
Southeast Asia, Micronesia, China, Eastern Europe
Fungi
Blastomyces dermatitidis Areas of the United States and Canada surrounding the Ohio and Mississippi River Valleys
and the Great Lakes
Histoplasma capsulatum Most commonly reported in the United States, particularly areas around the Ohio and
Mississippi River Valleys; also in Central and South America, Africa, Asia, and Australia
Parasites
Echinococcus species South America, the Middle East, Eastern Mediterranean, Western China, and the former
Soviet Union
Schistosoma mansoni Sub-Saharan Africa, South America, and some of the South Caribbean Islands
Taenia solium South and Central America, sub-Saharan Africa, India, and Southeast Asia
(neurocysticercosis)
94 FEBRUARY 2021
Myelitis
Viruses are a common cause of infectious myelitis. Spinal cord injury can be
caused either by direct neural invasion or via immune-mediated parainfectious
or postinfectious mechanisms.
CONTINUUMJOURNAL.COM 95
HERPESVIRUSES. The herpesviruses are a family of DNA viruses that are ubiquitous
worldwide and include herpes simplex virus type 1 (HSV-1), HSV-2, VZV, Epstein-Barr
virus (EBV), and cytomegalovirus (CMV). Although they cause nervous system
disease in a minority of patients who are infected, their pervasiveness makes them one
of the more common infectious causes of myelitis and myeloradiculitis (TABLE 4-6).
Immunodeficiency Microorganism
Cell-mediated dysfunction (eg, human immunodeficiency virus Viral: varicella-zoster virus (VZV) (herpes zoster and
[HIV], DiGeorge syndrome, Hodgkin lymphoma, disseminated infection), cytomegalovirus (CMV), JC virus
glucocorticoids, tacrolimus, methotrexate, mycophenolate
mofetil, cyclophosphamide) Bacterial: Staphylococcus aureus, Mycobacterium
tuberculosis, Nocardia species, Listeria monocytogenes;
coinfection with Treponema pallidum common in patients
with HIV
Neutropenia (eg, intensive chemotherapy, hematopoietic cell Viral: herpes simplex virus types 1 and 2, VZV (herpes zoster
transplantation, solid organ transplantation) and disseminated infection), CMV, Epstein-Barr virus
Parasitic: T. gondii
Humoral immune dysfunction (eg, primary Viral: Enteroviruses, VZV (herpes zoster)
hypogammaglobulinemias, complement deficiency, multiple
myeloma, Waldenström macroglobulinemia, lymphoma, chronic Bacterial: encapsulated bacteria (Streptococcus
lymphocytic leukemia, B-cell–depleting therapies, splenectomy) pneumoniae, Neisseria meningitides, Haemophilus
influenzae)
Barrier disruption (eg, shunts/drains, neurosurgical Bacterial: Cutibacterium acnes, skin/gut-derived bacteria
intervention, lines)
Fungal: Candida species
96 FEBRUARY 2021
OTHER MICROORGANISMS. Other viruses, as well as some atypical bacteria, can also
cause isolated myelitis.
CONTINUUMJOURNAL.COM 97
98 FEBRUARY 2021
FIGURE 4-1
Imaging of the patient in CASE 4-1. A, Axial diffusion-
weighted imaging shows diffusion-restricting lesions
with a ring pattern (arrows). B, Axial gradient recalled
echo (GRE) sequence shows a hemorrhagic lesion in
the left occipital lobe (arrow). Sagittal (C) and axial
(D, E) T2-weighted images show intramedullary
lesions (C, D, E, arrows).
CONTINUUMJOURNAL.COM 99
Myeloradiculitis
Some microorganisms can preferentially affect the nerve roots. Root involvement
with or without associated myelitis can help narrow the differential diagnosis.
HERPES SIMPLEX VIRUS TYPE 2. HSV-2 lays dormant in the sacral dorsal root ganglia,
reactivating to cause recurrent genital lesions. Retrograde migration up the cauda
equina to the conus and lower spinal cord can cause myeloradiculitis. Symptoms
typically involve an anogenital vesicular rash followed by pain, paresthesia,
progressive flaccid paraparesis, and urinary retention. Upper motor neuron signs
may be present on examination and suggest lower thoracic spinal cord
CSF to serum
Protein glucose ratio Nucleated cells (cell predominance) Lactate
3
Normal 15-45 mg/dL >0.6 <5 cells/mm <3.6 mmol/L
a
Lumbar puncture is not recommended in patients with known or suspected epidural abscess both because it is low yield and because of
increased risk of introducing bacteria into CSF.
b
Partially treated meningitis/Listeria monocytogenes can be associated with lymphocytic pleocytosis.
c
Cytomegalovirus and West Nile virus may present with neutrophilic pleocytosis.
d
Coccidioides species can present with eosinophilic pleocytosis; Blastomyces, Candida, and Aspergillus species can cause neutrophilic pleocytosis.
e
Eosinophilic pleocytosis is not always present; lymphocytic and neutrophilic predominance is also seen.
CONTINUUMJOURNAL.COM 101
Viruses
Epstein-Barr virus PCR (CSF, blood), serology (blood), heterophile CSF PCR can be positive in the setting
antibody test (blood) of central nervous system inflammation
or infection by another pathogen
Flaviviruses Serology (blood, CSF), PCR (CSF, blood) In general, serology more sensitive than
PCR, but PCR useful in patients with
congenital or acquired humoral
deficiency because of cross-reactivity
confirmatory testing can be done with
plaque reduction neutralization test
Cytomegalovirus PCR (CSF, blood), serology (blood), serum Serology: IgG appears within weeks
IgG avidity testing (blood) following primary infection and remains
positive for life; IgM is positive during
primary infection but can be
persistently positive or positive during
reactivation; serum IgG avidity assay
can disambiguate between primary and
past infection when both IgM and IgG
are positive
Varicella-zoster virus CSF PCR, serum to CSF IgG ratio CSF PCR sensitivity decreases >1 wk
from symptom onset
Bacteria
Borrelia burgdorferi Traditional algorithm is enzyme immunoassay followed Modified algorithm may be more
by Western blot; modified algorithm is two sequential sensitive for early disease but not yet
enzyme immunoassays; serum/CSF IgG index widely available; CSF PCR is insensitive
Brucella species Culture (blood, CSF, tissue), serology (blood) PCR not widely available
Mycobacterium Culture (blood, CSF, tissue), acid-fast bacilli stain, PCR Interferon gamma release assays can
tuberculosis (CSF, tissue), histopathology confirm exposure, but a negative test
does not rule out the diagnosis
Treponema pallidum Treponemal tests (fluorescent treponemal antibody A negative CSF Venereal Disease
absorption, treponema pallidum agglutination assay, Research Laboratory test does not rule
enzyme immunoassay), nontreponemal tests (rapid out neurosyphillis
plasma reagin [RPR], Venereal Disease Research
Laboratory test)
Fungi
Aspergillus species Antigen: galactomannan (CSF, blood, bronchoalveolar Galactomannan can be falsely positive
lavage [BAL]), (1,3)-β-D-glucan (CSF, blood, BAL), culture in patients receiving piperacillin-
(CSF, BAL, blood, tissue), PCR (CSF, BAL, tissue), tazobactam and IV immunoglobulin
histopathology (IVIg); (1,3)-β-D-glucan not specific for
Aspergillus; limited availability of PCR;
low sensitivity and specificity
Blastomyces Antigen (blood, urine, CSF), serology (blood, CSF), PCR Serology and antigen studies are more
dermatitidis and (CSF, BAL, tissue), culture (CSF, BAL), histopathology sensitive than PCR
Histoplasma
capsulatum
Coccidioides species Serology (CSF, blood), antigen (CSF, blood, urine), PCR
(CSF, tissue), culture (CSF, tissue), histopathology
Cryptococcus species Antigen (CSF, blood), culture (CSF, blood) Antigen most sensitive and specific test
Parasite
Toxoplasma gondii CSF PCR, histopathology CSF PCR is diagnostic but lacks
sensitivity; serology confirms past
exposure
CONTINUUMJOURNAL.COM 103
Meningitis/encephalitis panel Real-time multiplex polymerase chain Fast turnaround time with potential to
reaction (PCR) that can simultaneously decrease unnecessary antimicrobial
detect 14 pathogens: Escherichia coli exposure
K1, Haemophilus influenzae, Listeria
Sensitivities and specificities comparable
monocytogenes, Neisseria
to individual pathogens but low sensitivity
meningitidis, Streptococcus
for Cryptococcus species
pneumoniae, Streptococcus
agalactiae, cytomegalovirus, Standalone herpes simplex virus PCR has
varicella-zoster virus, herpes simplex higher sensitivity compared to panel
virus types 1 and 2, human herpesvirus 6,
No antibiotic susceptibilities
Enterovirus, human parechovirus, and
Cryptococcus neoformans/
Cryptococcus gattii
16S rRNA PCR with reflex sequencing Detection of 16S rRNA gene Useful for identifying bacteria in patients
(CSF or tissue sample) polymerase, which is highly preserved who have already received antibiotics
in bacteria (including mycobacteria), is
Can be run on paraffin-embedded tissue
followed by sequencing of the
amplified DNA, enabling a diagnosis No antibiotic susceptibilities
Fungal 18S and 28S rRNA/internal Detection of highly preserved fungal Fast turnaround time compared to fungal
transcribed spacer (ITS1 and ITS2) ribosomal genes is followed by cultures
PCR with reflex sequencing (CSF or sequencing of the amplified DNA,
Useful when fungal elements are seen on
tissue sample) enabling diagnosis
paraffin-embedded tissue but fresh tissue
sample no longer available
(1,3)-β-D-Glucan (serum or CSF) (1,3)-β-D-Glucan is a cell wall Sensitivity and specificity in serum varies
polysaccharide present in most fungi depending on population (highest among
(except Cryptococcus species, the patients with hematopoietic stem cell
Zygomycetes, and Blastomyces transplantation)
dermatitidis)
Few studies assessing utility in CSF
Not sufficient to rule out central nervous
system fungal infection if negative
Exposure to antibiotics such as
piperacillin-tazobactam and ampicillin can
cause false-positive results
Metagenomic next-generation All DNA and RNA in CSF or brain tissue Potential to detect any pathogen (bacteria,
sequencing (CSF or tissue sample) sample are sequenced without need virus, fungus, parasite) in a clinical sample,
for prior culturing; results can be including unsuspected pathogens
compared to databases of all known
Sensitivity likely low for pathogens for
microorganisms
which PCR is insensitive
A negative result does not rule out infection
CSF = cerebrospinal fluid; DNA = deoxyribonucleic acid; RNA = ribonucleic acid; rRNA = ribosomal ribonucleic acid.
a
Modified with permission from Yost MD, Toledano M.1 © 2020 Springer Nature.
Leukomyelitis
Certain pathogens can preferentially affect the white matter of the spinal cord,
causing a leukomyelitis (leukos means white in Greek). Infections that primarily
affect the lateral columns result in spastic paraparesis, whereas those with
prominent dorsal column involvement result in sensory ataxia.
Herpes simplex virus Sacral myelopolyradiculitis; can be associated with vesicular rash Acyclovir or valacyclovir,
type 2 along sacral dermatomes; isolated myelitis (rare) adjunctive corticosteroids
Varicella-zoster virus Longitudinally extensive or multifocal myelitis, myeloradiculitis, or IV acyclovir with or without
spinal cord infarct; thoracic most common adjunctive corticosteroids
Cytomegalovirus Painful myeloradiculitis in patients who are immunocompromised Ganciclovir and/or foscarnet;
because of virus reactivation; postinfectious myelitis following immunomodulatory therapies
primary infection, can present as poliomyelitis for postinfectious cases
Herpes simplex virus Rare reports of myelitis, mostly in immunocompromised hosts IV acyclovir
type 1
Human herpesvirus 6 Few case reports in patients following allogeneic hematopoietic Ganciclovir, foscarnet,
stem cell transplantation cidofovir
CONTINUUMJOURNAL.COM 105
Brucella species Spondylodiskitis, intramedullary and extramedullary abscess, Ceftriaxone plus rifampin and
granulomatous meningoradiculitis, arachnoiditis doxycycline
Taenia solium Subarachnoid lesions, intramedullary lesion Corticosteroids with or without surgery for
arachnoiditis; albendazole with or without
corticosteroids for intramedullary disease
CONTINUUMJOURNAL.COM 107
CASE 4-2 A 72-year-old man presented with a 4-month history of lumbar pain with
radicular features and urinary retention. He also reported headache,
fatigue, and myalgia. He had reportedly completed treatment for
pulmonary histoplasmosis 5 years earlier.
Neurologic examination was notable for bilateral proximal greater than
distal lower extremity weakness, which was 4/5 in affected muscles;
absent deep tendon reflexes; and decreased sensation to pinprick up to
the left thigh and right knee.
MRI of the thoracic and lumbar spine revealed leptomeningeal
enhancement around the thoracic cord and conus medullaris as well as
smooth enhancement of the roots without clumping (FIGURE 4-2). CSF
analysis revealed a protein of 127 mg/dL, lymphocytic pleocytosis with 94
cells/mm3, and a low glucose of 21 mg/dL. Urine Histoplasma antigen was
strongly positive. CSF Histoplasma serology, polymerase chain reaction
(PCR), and fungal cultures were negative, but Histoplasma antigen was
positive. CSF and blood (1,3)-β-D-glucan were positive. Imaging and
symptoms improved significantly after completing induction with IV
liposomal amphotericin B.
52,53
OTHER VIRUSES. Adenoviruses have also been associated with poliomyelitis. In
addition, flaviviruses, a family of arthropod-borne RNA viruses more commonly
associated with meningoencephalitis, can also cause poliomyelitis (TABLE 4-10).
FIGURE 4-2
Imaging of the patient in CASE 4-2. Sagittal (A) and axial (B, C) postcontrast T1-weighted MRIs
show smooth leptomeningeal enhancement of the thoracic cord and conus medullaris (A, B,
arrows), as well as enhancement of the cauda equina roots (A, asterisks; C, arrow).
CONTINUUMJOURNAL.COM 109
WEST NILE VIRUS. West Nile virus is now endemic throughout the continental
United States. One percent of infections are neuroinvasive, including an acute
poliomyelitis or ventral root infection that manifests as acute flaccid paralysis.54
The latter commonly presents as acute flaccid monoparesis and fever with or
without associated meningoencephalitis and occurs in summer and early fall,
months in which the Culex mosquito thrives.
POWASSAN VIRUS. Powassan virus, which is carried by ticks and found in the
Northeast and Great Lakes regions of the United States, can also cause flaccid
paresis, usually between late spring and midfall, when ticks are most active
(CASE 4-3).55 Viremia is short-lived, and CSF PCR is an insensitive diagnostic
test unless performed early in the course of the disease.56 IgM-captured
enzyme-linked immunosorbent assay (ELISA) in either blood or CSF during the
acute phase is diagnostic. Although highly sensitive, the ELISA has poor
specificity given significant cross-reactivity with other flaviviruses.57
Confirmatory plaque reduction neutralization testing can be performed,
although the clinical utility may be limited in the absence of targeted antiviral
Endemic fungi
Coccidioides Adhesive arachnoiditis, Pneumonia, fever, drenching night Oral fluconazole for life
species spondylodiskitis, intramedullary and sweats, weight loss, arthralgia,
extramedullary abscess erythema nodosum
Opportunistic fungi
RABIES. Paralytic rabies can also present with flaccid paresis. Rabies is caused by
a number of different species of viruses in the Rhabdoviridae family, genus
Lyssavirus, and usually transmitted to humans by bites from animal vectors. The
onset of clinical disease is between 20 and 90 days from exposure. Although a
majority of patients present with the more common encephalitic form, about
20% of patients develop paralytic rabies.59 These patients typically have early
progressive flaccid weakness that initially may affect only the bitten limb but
invariably spreads to other limbs and bulbar muscles. Sphincter dysfunction,
pain, piloerection, and sensory disturbances can occur, but hydrophobia is rare.
Several tests are required to confirm the diagnosis, including virus isolation
from saliva or skin via reverse transcriptase PCR or detection of antibodies in
serum and CSF.59 Once symptoms arise, no treatment has been found to be
effective and the disease is invariably fatal.60
West Nile virus Neuroinvasive Anterior horn cells and Culex species North America, the Caribbean, Africa,
roots mosquitoes the Middle East, parts of Europe and
the former Soviet Union
Powassan virus Neuroinvasive Anterior horn cells Ixodes Minnesota, Wisconsin, New York,
species ticks Massachusetts, Ontario, Manitoba,
Nova Scotia
St. Louis Neuroinvasive Anterior horn cells Culex species North and South America, but most
encephalitis mosquitoes cases reported in the eastern and
virus central United States
Tick-borne Probably Anterior horn cells Ixodes Baltic States, Russia, the Balkans,
encephalitis neuroinvasive species ticks Nordic countries
virus
Japanese Neuroinvasive Anterior horn cells Culex species Temperate regions of China, Japan,
encephalitis mosquitoes the Korean peninsula, the Indian
virus subcontinent, Southeast Asia
Dengue virus Neuroinvasive Longitudinally extensive Aedes species Central and South America, the
parainfectious/ or multifocal leukomyelitis mosquitoes Caribbean, Southeast Asia, the
postinfectious Pacific Islands; rarely, the southern
United States
Zika virus Neuroinvasive Longitudinally extensive Aedes species Outbreaks have occurred in Central,
parainfectious/ or multifocal mosquitoes North, and South America; the
postinfectious leukomyelitis, anterior Caribbean; Africa; Southeast Asia;
horn cells, roots and the Pacific Islands
CONTINUUMJOURNAL.COM 111
Intramedullary Abscess
Intramedullary abscess of the spinal cord is a rare clinical entity. This is partly
because normal spinal cord tissue appears to be remarkably resistant to
hematogenous spread from infection, which is a common cause of abscess
formation. When hematogenous spread does occur, a predisposing spinal cord
abnormality is common.65 Another mechanism is contiguous spread of infection
through a dermal sinus tract, more commonly in the lumbar region. In these
cases, pathogens reflect the microorganisms colonizing the skin surrounding the
sinus tract opening, including Staphylococcus species as well as gram-negative
rods and anaerobes. Most patients present with weakness, back pain with
radicular features, and bladder dysfunction. Fever occurs in less than 50% of
patients.65 MRI shows rim enhancement and surrounding edema and can be
associated with internal restricted diffusion.
Empiric antimicrobial therapy should be based on the presumed mechanism
of infection. Myelotomy and abscess drainage are usually required and help guide
antimicrobial therapy. Ampicillin should be initiated empirically in cryptogenic
cases to cover for Listeria monocytogenes.65 Mortality occurs in less than 10% of
cases, but residual neurologic deficits are common.65
FIGURE 4-3
Nerve conduction study and EMG results of the patient in CASE 4-3. A, Nerve conduction
studies show low-amplitude compound muscle action potentials (CMAPs) in the right arm
(box). B, Needle EMG demonstrates dense fibrillation potentials (box) and reduced motor
unit action potential recruitment in right upper extremity muscles.
CONTINUUMJOURNAL.COM 113
EXTRAMEDULLARY INFECTION
Pyogenic bacteria are a common cause of extramedullary infection, but atypical
bacteria, fungi, and parasites can also seed extramedullary sites, leading to
compressive myelopathy and radiculopathy.
Viral
◆ Cytomegalovirus
Bacterial
◆ Pyogenic bacteria
◆ Mycobacterium tuberculosis (tuberculoma)
◆ Brucella species
Fungal
◆ Endemic fungi
◇ Blastomyces dermatitidis
◇ Coccidioides species
◇ Histoplasma capsulatum
◆ Opportunistic fungi
◇ Aspergillus species
◇ Cryptococcus species (cryptococcoma)
Parasitic
◆ Schistosoma species
◆ Taenia solium (neurocysticercosis)
◆ Toxoplasma gondii
CONTINUUMJOURNAL.COM 115
CASE 4-4 A 75-year-old man with a prosthetic mechanical aortic valve developed
severe lumbar back pain days after successful cardioversion for
incidentally discovered atrial
fibrillation. A week later,
he noted radicular features
followed by a right footdrop.
He denied fevers but
reported having chills.
On examination, he had
tenderness with percussion
of his lumbar spine. C-reactive
protein was elevated at
92 mg/L, and he had a mild
leukocytosis at 11.3 cells/mm3.
MRI of the lumbar spine
showed evidence of
spondylodiskitis at L5-S1 and
associated epidural abscess
extending from the distal
margin of the thecal sac to L1
(FIGURE 4-4). He was started
on empiric antimicrobials and
underwent lumbar
decompression and washout.
Blood and tissue cultures FIGURE 4-4
grew Enterococcus faecalis. Imaging of the patient in CASE 4-4. Sagittal
Given his cardiac history, he T2-weighted (A) and postcontrast T1-weighted (B)
MRIs of the lumbar spine show L5-S1 disk edema
underwent a transesophageal
with faint enhancement (A, B, arrows) as well as a
echocardiogram, which rim-enhancing epidural fluid collection extending
demonstrated endocarditis. from the thecal sac to L1 (A, B, asterisks).
CONTINUUMJOURNAL.COM 117
CONCLUSION
When evaluating patients with suspected infectious myelopathies and
radiculopathies, it is important to narrow the range of pathogens under consideration.
Specific clinicoradiographic features and careful attention to exposure, travel history,
and immunocompetence can help narrow the differential. Direct infection is
responsible for the neural injury in many cases; however, in others a parainfectious or
postinfectious immune-mediated process is likely. Antimicrobial therapy is the
mainstay of treatment, although effective antiviral therapies are lacking. Given that
injury to the spinal cord usually involves both infectious and inflammatory
mechanisms, strategies targeting each separately are often justified.
REFERENCES
1 Yost MD, Toledano M. Severe infections of the 10 Davies NWS, Brown LJ, Gonde J, et al. Factors
central nervous system. In: Rabinstein AA, ed. influencing PCR detection of viruses in
Neurological emergencies: a practical approach. cerebrospinal fluid of patients with suspected
Springer; 2020:121-149. CNS infections. J Neurol Neurosurg Psychiatry
2 Gilden D, Nagel MA, Cohrs RJ. Varicella-zoster. 2005;76(1):82-87 doi:10.1136/jnnp.2004.045336
Handb Clin Neurol 2014;123:265-283. doi:10.1016/ 11 Martelius T, Lappalainen M, Palomäki M, Anttila
B978-0-444-53488-0.00012-2
VJ. Clinical characteristics of patients with
3 Nagel MA, Cohrs RJ, Mahalingam R, et al. The Epstein Barr virus in cerebrospinal fluid. BMC Infect
varicella zoster virus vasculopathies: clinical, CSF, Dis 2011;11:281. doi:10.1186/1471-2334-11-281
imaging, and virologic features. Neurology 2008;
70(11):853-860. doi:10.1212/01. 12 Andrade P, Figueiredo C, Carvalho C, et al.
wnl.0000304747.38502.e8 Transverse myelitis and acute HIV infection: a
case report. BMC Infect Dis 2014;14:149.
4 Haanpää M, Dastidar P, Weinberg A, et al. CSF
doi:10.1186/1471-2334-14-149
and MRI findings in patients with acute herpes
zoster. Neurology 1998;51(5):1405-1411. doi:10.1212/ 13 Canestri A, Lescure FX, Jaureguiberry S, et al.
wnl.51.5.1405 Discordance between cerebral spinal fluid and
plasma HIV replication in patients with
5 Ahmed SV, Hamada H, Jayawarna C, Chandra S.
Shingles with secondary asymptomatic CNS neurological symptoms who are receiving
involvement! BMJ Case Rep 2012;2012: suppressive antiretroviral therapy. Clin Infect Dis
bcr0320126041. doi:10.1136/bcr.03.2012.6041 2010;50(5):773-778. doi:10.1086/650538
24 Halperin JJ. Neuroborreliosis. Neurol Clin 2018; 39 Nagai M, Osame M. Human T-cell lymphotropic
36(6):821-830. doi:10.1007/s00415-016-8346-2 virus type I and neurological diseases. J Neurovirol
2003;9(2):228-235. doi:10.1080/13550280390194028
25 Stanek G, Strle F. Lyme disease: European
perspective. Infect Dis Clin North Am 2008;22(2): 40 De Castro-Costa CM, Araújo AQ, Barreto MM,
327-339, vii. doi:10.1016/j.idc.2008.01.001 et al. Proposal for diagnostic criteria of tropical
spastic paraparesis/HTLV-I-associated myelopathy
26 Centers for Disease Control and Prevention (TSP/HAM). AIDS Res Hum Retroviruses 2006;22
(CDC). Recommendations for test performance (10):931-935. doi:10.1089/aid.2006.22.931
and interpretation from the Second National
Conference on Serologic Diagnosis of Lyme 41 Enose-Akahata Y, Jacobson S. Immunovirological
Disease. MMWR Morb Mortal Wkly Rep 1995; markers in HTLV-1-associated myelopathy/tropical
44(31):590-591. spastic paraparesis (HAM/TSP). Retrovirology 2019;16
(1):35. doi:10.1186/s12977-019-0499-5
27 Blanc F, Jaulhac B, Fleury M, et al. Relevance
of the antibody index to diagnose Lyme 42 Sato T, Coler-Reilly ALG, Yagishita N, et al.
neuroborreliosis among seropositive patients. Mogamulizumab (Anti-CCR4) in HTLV-1-
Neurology 2007;69(10):953-958. doi:10.1212/ Associated Myelopathy. N Engl J Med 2018;
01.wnl.0000269672.17807.e0 378(6):529-538. doi:10.1056/NEJMoa1704827
28 Halperin JJ, Shapiro ED, Logigian E, et al. Practice 43 Di Rocco A. Diseases of the spinal cord in human
parameter: treatment of nervous system Lyme immunodeficiency virus infection. Semin Neurol
disease (an evidence-based review): report of 1999;19(2):151-155. doi:10.1055/s-2008-1040832
the Quality Standards Subcommittee of the
American Academy of Neurology. Neurology 44 Platt LR, Estívariz CF, Sutter RW. Vaccine-
2007;69(1):91-102. doi:10.1212/01. associated paralytic poliomyelitis: a review of
the epidemiology and estimation of the global
wnl.0000265517.66976.28
burden. J Infect Dis 2014;210 suppl 1:S380-S389.
29 Ferrari TCA, Moreira PRR. Neuroschistosomiasis: doi:10.1093/infdis/jiu184
clinical symptoms and pathogenesis. Lancet 45 Kew O, Morris-Glasgow V, Landaverde M, et al.
Neurol 2011;10(9):853-864. doi:10.1016/S1474- Outbreak of poliomyelitis in Hispaniola
4422(11)70170-3 associated with circulating type 1 vaccine-
derived poliovirus. Science 2002;296(5566):
30 Joshi TN, Yamazaki MK, Zhao H, Becker D. Spinal
356-359. doi:10.1126/science.1068284
schistosomiasis: differential diagnosis for acute
paraparesis in a U.S. resident. J Spinal Cord Med 46 Aylward RB, Alwan A. Polio in Syria. Lancet
2010;33(3):256-260. doi:10.1080/10790268. 2014;383(9916):489-491. doi:10.1016/S0140-
2010.11689703 6736(14)60132-X
31 Saleem S, Belal AI, El-Ghandour NM. Spinal cord 47 McLaren N, Lopez A, Kidd S, et al. Characteristics
schistosomiasis: MR imaging appearance with of patients with acute flaccid myelitis, United
surgical and pathologic correlation. AJNR Am J States, 2015-2018. Emerg Infect Dis 2020;26(2):
Neuroradiol 2005;26(7):1646-1654. 212-219. doi:10.3201/eid2602.191453
CONTINUUMJOURNAL.COM 119
48 Knoester M, Helfferich J, Poelman R, et al. 63 Ng KS, Abdul Halim S. Anterior spinal cord
Twenty-nine cases of enterovirus-D68-associated syndrome as a rare complication of acute bacterial
acute flaccid myelitis in Europe 2016: a case meningitis in an adult. BMJ Case Rep 2018;2018:
series and epidemiologic overview. Pediatr bcr2018226082. doi:10.1136/bcr-2018-226082
Infect Dis J 2019;38(1):16-21. doi:10.1097/
64 Kleinschmidt-DeMasters BK. Central nervous
INF.0000000000002188
system aspergillosis: a 20-year retrospective
49 Jang S, Suh SI, Ha SM, et al. Enterovirus 71-related series. Hum Pathol 2002;33(1):116-124. doi:10.1053/
encephalomyelitis: usual and unusual magnetic hupa.2002.30186
resonance imaging findings. Neuroradiology
2012;54(3):239-245. doi:10.1007/s00234-011-0921-8 65 Chan CT, Gold WL. Intramedullary abscess of the
spinal cord in the antibiotic era: clinical features,
50 Schubert RD, Hawes IA, Ramachandran PS, et al. microbial etiologies, trends in pathogenesis, and
Pan-viral serology implicates enteroviruses in outcomes. Clin Infect Dis 1998;27(3):619-626.
acute flaccid myelitis. Nat Med 2019;25(11): doi:10.1086/514699
1748-1752. doi:10.1038/s41591-019-0613-1
66 Ulu-Kilic A, Karakas A, Erdem H, et al. Update on
51 Murphy OC, Pardo CA. Acute flaccid myelitis: a treatment options for spinal brucellosis. Clin
clinical review. Semin Neurol 2020;40(2):211-218. Microbiol Infect 2014;20(2):O75-O82.
doi:10.1055/s-0040-1705123 doi:10.1111/1469-0691.12351
52 Ooi MH, Wong SC, Clear D, et al. Adenovirus type 67 Pappas G, Papadimitriou P, Akritidis N, et al. The new
21-associated acute flaccid paralysis during an global map of human brucellosis. Lancet Infect Dis
outbreak of hand-foot-and-mouth disease in 2006;6(2):91-99. doi:10.1016/S1473-3099(06)70382-6
Sarawak, Malaysia. Clin Infect Dis 2003;36(5): 68 Prabhakar MM, Acharya AJ, Modi DR, Jadav B.
550-559. doi:10.1086/367648 Spinal hydatid disease: a case series. J Spinal
Cord Med 2005;28(5):426-431. doi:10.1080/
53 Haddad-Boubaker S, Joffret ML, Pérot P, et al. 10790268.2005.11753843
Metagenomic analysis identifies human
adenovirus 31 in children with acute flaccid 69 Torda AJ, Gottlieb T, Bradbury R. Pyogenic
paralysis in Tunisia. Arch Virol 2019;164(3): vertebral osteomyelitis: analysis of 20 cases and
747-755. doi:10.1007/s00705-018-04141-5 review. Clin Infect Dis 1995;20(2):320-328.
doi:10.1093/clinids/20.2.320
54 Sejvar JJ. West Nile virus infection. Microbiol
Spectr 2016;4(3). doi:10.1128/microbiolspec. 70 Strauss SB, Gordon SR, Burns J, et al.
EI10-0021-2016 Differentiation between tuberculous and
pyogenic spondylodiscitis: the role of the
55 Picheca C, Yogendrakumar V, Brooks JI, et al. anterior meningovertebral ligament in patients
Polio-like manifestation of Powassan virus with anterior epidural abscess. AJNR Am J Neuroradiol
infection with anterior horn cell involvement, 2020;41(2):364-368. doi:10.3174/ajnr.A6370
Canada. Emerg Infect Dis 2019;25(8):1609-1611.
doi:10.3201/eid2508.190399 71 Khanna RK, Malik GM, Rock JP, Rosenblum ML.
Spinal epidural abscess: evaluation of factors
56 Lanciotti RS, Kerst AJ. Nucleic acid influencing outcome. Neurosurgery 1996;39(5):
sequence-based amplification assays for rapid 958-964. doi:10.1097/00006123-199611000-00016
detection of West Nile and St. Louis encephalitis
viruses. J Clin Microbiol 2001;39(12):4506-4513. 72 MRC Working Party on Tuberculosis of the Spine,
doi:10.1128/JCM.39.12.4506-4513.2001 Darbyshire J. Five-year assessment of controlled
trials of short-course chemotherapy regimens of
57 Shi PY, Wong SJ. Serologic diagnosis of West Nile 6, 9 or 18 months' duration for spinal tuberculosis
virus infection. Expert Rev Mol Diagn 2003;3(6): in patients ambulatory from the start or
733-741. doi:10.1586/14737159.3.6.733 undergoing radical surgery. Fourteenth report of
the Medical Research Council Working Party on
58 Goates C, Tsuha S, Working S, et al. Seronegative
Tuberculosis of the Spine. Int Orthop 1999;
West Nile virus infection in a patient treated with
23(2):73-81. doi:10.1007/s002640050311
rituximab for rheumatoid arthritis. Am J Med 2017;
130(6):e257-e258. doi:10.1016/j.amjmed.2017.01.014 73 Marra CM. Neurosyphilis. Continuum (Minneap
59 Jackson AC. Human rabies: a 2016 update. Curr Minn) 2015;21(6 Neuroinfectious Disease):
Infect Dis Rep 2016;18(11):38. doi:10.1007/s11908- 1714-1728. doi:10.1212/CON.0000000000000250
016-0540-y
74 Gavito-Higuera J, Mullins CB, Ramos-Duran L,
60 Zeiler FA, Jackson AC. Critical appraisal of the et al. Fungal infections of the central nervous
Milwaukee protocol for rabies: this failed system: a pictorial review. J Clin Imaging Sci 2016;
approach should be abandoned. Can J Neurol Sci 6:24. doi:10.4103/2156-7514.184244
2016;43(1):44-51. doi:10.1017/cjn.2015.331
75 Garg RK, Malhotra HS, Gupta R. Spinal cord
61 Orme HT, Smith AG, Nagel MA, et al. VZV spinal involvement in tuberculous meningitis. Spinal
cord infarction identified by diffusion-weighted Cord 2015;53(9):649-657. doi:10.1038/sc.2015.58
MRI (DWI). Neurology 2007;69(4):398-400.
doi:10.1212/01.wnl.0000266390.27177.7b 76 Alsina GA, Johnson JP, McBride DQ, et al. Spinal
neurocysticercosis. Neurosurg Focus 2002;12(6):
62 Terry PM, Glancy GR, Graham A. e8. doi:10.3171/foc.2002.12.6.9
Meningovascular syphilis of the spinal cord
presenting with incomplete Brown-Séquard 77 Del Brutto OH. Neurocysticercosis. Handb Clin
syndrome: case report. Genitourin Med 1989; Neurol 2014;121:1445-1459. doi:10.1016/B978-0-
65(3):189-191. doi:10.1136/sti.65.3.189 7020-4088-7.00097-3
Myelopathies C O N T I N U UM AUDIO
INTERVIEW AVAILABLE
ONLINE
By Natalie Elizabeth Parks, MD
Downloaded from http://journals.lww.com/continuum by wqLe/H3/oM2vx1Qs5A5qMemKKHLPqE4qkmGNpdheG3ikf1o85ttJSkFL2oTkgOkhMEmawHvsuTTE5xJG2ZjqccytIAhVn2qegy060KLcKJuPZsx5htaYiopRjp2zor2egUzWJAEWYNrnNdb1tgu/p0M6EMGzm2Aj on 04/28/2022
ABSTRACT
PURPOSE OF REVIEW: This article describes the clinical presentation, relevant
diagnostic investigations, and treatment of metabolic and toxic myelopathies.
RELATIONSHIP DISCLOSURE:
Dr Parks has served as an
INTRODUCTION advisory board member/
I
t is important for clinicians to recognize metabolic and toxic myelopathies, as consultant for Biogen; EMD
Serono, Inc; F. Hoffmann-
almost all are preventable or treatable. Accurate diagnosis relies on a complete La Roche Ltd; Novartis AG;
neurologic history and neurologic examination accompanied by relevant and Sanofi Genzyme. Dr Parks
has received personal
diagnostic investigations, including MRI of the spinal cord. Metabolic compensation for speaking
myelopathies typically have an insidious onset and a chronic progressive engagements from Biogen and
course, whereas toxic myelopathies have a more variable time course. Accurate Bristol Myers Squibb and
research/grant support from
diagnosis relies on symptom recognition in the appropriate context, such as living Biogen, MedDay
in an endemic area, dietary habits, recreational drug use, and medical comorbidities. Pharmaceuticals, Novartis AG,
and Sanofi Genzyme.
CONTINUUMJOURNAL.COM 143
Nutrient
deficiency Etiologies Symptoms/signs MRI Diagnostic tests Treatment
Vitamin B12 Vegetarian diet, Subacute T2 Serum cobalamin: low Cyanocobalamin
pernicious anemia, combined hyperintensity 1000 mcg IM or
Plasma methylmalonic
stomach/small bowel degeneration of in posterior subcutaneous
acid: high
surgery, Crohn disease, spinal cord columns with daily for 5 days
gastritis, medications beginning with inverted V sign; Plasma homocysteine: followed by
(H2 blockers, proton paresthesia and may extend high 1000 mcg IM or
pump inhibitors, sensory ataxia over several subcutaneous
Complete blood cell
metformin, colchicine), (positive Romberg levels in monthly
count: macrocytic
tapeworm, nitrous sign, cervical or indefinitely;
anemia,
oxide pseudoathetosis) thoracic cord; 1000 mcg orally
hypersegmented
followed by rarely daily is a possible
neutrophils
pyramidal gadolinium alternative
symptoms and enhancement Intrinsic factor chronic regimen
signs; frequent antibodies: high
mixture of central specificity, low
and peripheral sensitivity for
sensory and motor pernicious anemia
signs due to among those with
coexisting vitamin B12 deficiency
peripheral axonal
neuropathy; may
be associated with
optic neuropathy
and cognitive
impairment
Nutrient
deficiency Etiologies Symptoms/signs MRI Diagnostic tests Treatment
Folic acid Alcoholism, small Same as vitamin B12 Same as vitamin Serum folate: low Folic acid 3 mg
bowel surgery, celiac deficiency B12 deficiency; orally daily until
Red blood cell folate:
disease, inflammatory no reports of hematologic
low
bowel disease, gadolinium parameters
medications enhancement Plasma homocysteine: normalize and
(methotrexate, high then folic acid
pyrimethamine, 1 mg orally daily
Complete blood cell
trimethoprim,
count: macrocytic
sulfasalazine)
anemia,
hypersegmented
neutrophils
Copper Bariatric surgery, partial Same as vitamin B12 Same as vitamin Serum copper: low Copper 2-4 mg
gastrectomy, zinc deficiency B12 deficiency; orally daily with
Serum ceruloplasmin:
excess (supplements, no reports of repeat serum
low
denture cream), celiac gadolinium copper to adjust
disease, Menkes enhancement Complete blood cell dose; avoid zinc
disease count: anemia,
leukopenia
Assess serum zinc and
celiac serology
CONTINUUMJOURNAL.COM 145
FIGURE 6-2
Vitamin B12 absorption. Vitamin B12 binds to intrinsic factor secreted by gastric parietal cells
while in the duodenum. Vitamin B12 bound to intrinsic factor is absorbed in the ileum.
Absorbed vitamin B12 binds to transcobalamin II for systemic transport.
Reprinted with permission from Oh R, Brown DL, Am Fam Physician.6 © 2003 American Academy of
Family Physicians.
FIGURE 6-3
Vitamin B12 biochemistry. Vitamin B12 is an essential cofactor in the conversion of
homocysteine to methionine, methylmalonic acid to succinyl-coenzyme A, and
methyltetrahydrofolate to tetrahydrofolate. These reactions are necessary for myelin
production, DNA synthesis, and the Krebs cycle, all of which contribute to nervous system
function. Nitrous oxide causes inactivation of vitamin B12, interfering with the ability of
methionine synthase to convert homocysteine to methionine or methyltetrahydrofolate
to tetrahydrofolate.
ATP = adenosine triphosphate; FADH2 = flavin adenine dinucleotide; NADH = nicotinamide adenine
dinucleotide.
CONTINUUMJOURNAL.COM 147
FIGURE 6-4
Subacute combined degeneration due to vitamin B12 deficiency. Axial (A) and sagittal (B)
T2-weighted images of the spinal cord show hyperintensity in the posterior columns
affecting the thoracic spinal cord on sagittal image (B), with an inverted V appearance on
axial image (A, arrow).
Reprinted with permission from Matsuura H, Nakamura T, QJM.13 © 2017 Oxford University Press.
NITROUS OXIDE. Nitrous oxide (laughing gas) is an anesthetic gas used in surgical and ● Nitrous oxide causes
dental procedures. In addition, it is used in aerosol cans that dispense whipped inactivation of vitamin B12,
which may result in subacute
cream; inhaling nitrous oxide from these aerosol devices is called “doing whippets.”
combined degeneration of
Nitrous oxide has been exploited as a recreational drug as it causes euphoria. the spinal cord.
Nitrous oxide causes irreversible inactivation of vitamin B12, resulting in an
identical clinical presentation to that of vitamin B12 deficiency. Nitrous oxide ● Folate deficiency is
results in oxidation of the cobalt center of methylcobalamin from monovalent to uncommon since the
introduction of national
bivalent and trivalent forms.7 This inactivated form of vitamin B12 cannot be fortification programs aimed
used by methionine synthase to convert homocysteine to methionine or at improving folate levels
methyltetrahydrofolate to tetrahydrofolate (FIGURE 6-3), which results in among reproductive-age
interference with DNA and myelin synthesis. women to reduce neural
tube defects in their
The subacute combined degeneration of the spinal cord associated with offspring.
nitrous oxide toxicity is clinically and radiographically identical to vitamin B12
deficiency.17,18 Subacute combined degeneration of the spinal cord may result
from relatively brief exposure to nitrous oxide during routine surgical
procedures in as little as 30 minutes (CASE 6-1).19 Subacute combined
degeneration of the spinal cord may also be caused by habitual recreational
exposure to nitrous oxide from whippets.20
The diagnosis of nitrous oxide myelopathy requires a high index of suspicion
as no single diagnostic test has been established. Among those with nitrous oxide
toxicity, serum cobalamin level is low in approximately 70%, whereas plasma
methylmalonic acid or plasma homocysteine, or both, are elevated in more than
90%.17 Nitrous oxide toxicity is treated with vitamin B12 supplementation and
cessation of nitrous oxide use.20
Folate Deficiency
Folate deficiency is encountered much less frequently since national fortification
programs resulted in an increase in dietary folate.21 Folate fortification was
CONTINUUMJOURNAL.COM 149
introduced in many countries, including the United States and Canada, because
of a strong association between folate deficiency among reproductive-age women
and neural tube defects in their offspring. In adults, the neurologic complications
of folate (vitamin B9) deficiency include myelopathy, peripheral neuropathy,
optic neuropathy, and cognitive dysfunction.22,23 Neurologic manifestations of
folate deficiency (including myelopathy) are rare, and the myelopathy takes the
form of a subacute combined degeneration of the spinal cord.22,24,25
COMMENT The patient in this case had multiple risk factors for vitamin B12 deficiency,
including age older than 70 years, a diet low in animal protein, and atrophic
gastritis secondary to H. pylori. The neurologic examination features were
consistent with involvement of the dorsal and lateral columns (subacute
combined degeneration of the spinal cord). Parenteral (subcutaneous or
IM) cyanocobalamin is recommended to treat vitamin B12 deficiency with
neurologic manifestations.
Copper Deficiency
Copper deficiency is an underrecognized cause of myelopathy that mimics
vitamin B12 deficiency. The prevalence of copper deficiency is as high as 10% in
individuals having undergone bariatric surgery with a Roux-en-Y gastric
bypass.27 The best characterized neurologic complication is myelopathy with or
without neuropathy (CASE 6-2).
Copper deficiency myelopathy is almost identical to the subacute combined
degeneration of the spinal cord encountered with vitamin B12 deficiency, often
resulting in sensory ataxia and spasticity.28,29 An associated length-dependent
axonal peripheral neuropathy is frequently seen. Additional neurologic
manifestations that may be associated with copper deficiency are isolated
peripheral neuropathy, optic neuropathy, and cognitive dysfunction.
CONTINUUMJOURNAL.COM 151
CASE 6-2 A 56-year-old man presented with a 3-year history of gradually increasing
difficulty with balance while walking and numbness that began in his feet
and gradually ascended to the knees. Over the previous year, he had
started to note paresthesia in his fingers. His past medical history was
remarkable for a Roux-en-Y gastric bypass at age 49 for medically
complicated obesity.
Neurologic examination was remarkable for absent vibration distal to
the tibial tuberosity, diminished proprioception at the great toes, brisk
reflexes, wide-based gait, and positive Romberg sign. MRI of the spinal
cord demonstrated T2 hyperintensity in the posterior columns extending
from C3 to C6, with an inverted V configuration. MRI of his brain was
normal. Nerve conduction studies were normal. A complete blood cell
count was also normal, as were serum cobalamin, serum folate, and
plasma methylmalonic acid levels. Serum copper was 8.7 µmol/L (lower
limit of normal 11.2 µmol/L), and serum ceruloplasmin was 54 mg/L (lower
limit of normal 232 mg/L); serum zinc was normal.
He was diagnosed with copper deficiency myelopathy resulting from
decreased copper absorption following bariatric surgery and was treated
with oral copper 2 mg/d for 3 months, with improvement in balance and
paresthesia. At 3 months, a repeat serum copper level was normal. He
was advised to continue with oral copper 2 mg/d indefinitely.
Vitamin E Deficiency
Vitamin E deficiency is rare in the general population of developed countries
such as the United States.30 Specific populations, including those with cystic
fibrosis, are at increased risk of vitamin E deficiency with a clinical phenotype
similar to Friedreich ataxia, including ataxia, reduced proprioception, absent
reflexes, and upgoing plantar responses.31 Pathology demonstrates degeneration
of the posterior columns with accumulation of lipofuscin in the dorsal root
ganglia.32
Vitamin E is a fat-soluble vitamin absorbed in the small intestine primarily as
α-tocopherol. Vitamin E is absorbed bound to bile salt, which is part of a micelle
composed of fatty acids. Fatty acids are formed from the breakdown of lipids by
pancreatic lipase. In the enterocyte, vitamin E is incorporated into a chylomicron
for transportation to the liver. Vitamin E is then transported from the liver in
very-low-density lipoprotein (VLDL) particles that become low-density
lipoprotein (LDL) particles that are absorbed by body tissues.
Vitamin E deficiency may be caused by inadequate intake, decreased
absorption, or impaired metabolism.30 Vitamin E is found in high amounts in
green vegetables and nuts. Decreased absorption occurs in cholestatic liver
disease, cystic fibrosis, and extensive resection of the small intestine. In
cholestatic liver disease, the production of bile salts that are needed for vitamin E
absorption is impaired. In cystic fibrosis, fat absorption is decreased because of
thickened pancreatic secretions interfering with pancreatic lipase function.
Genetic conditions, including ataxia with vitamin E deficiency (AVED) and
abetalipoproteinemia, interfere with vitamin E metabolism. AVED is the result of
a mutation in α-tocopherol transfer protein, which is needed to incorporate
vitamin E into VLDL for transport out of the liver.33 Abetalipoproteinemia is the
result of a mutation in microsomal triglyceride transfer protein, resulting in
impaired formation of chylomicra, VLDL, and LDL.
CONTINUUMJOURNAL.COM 153
TOXIC MYELOPATHIES
Toxic myelopathies often result in permanent neurologic deficits. If avoidance of
the provoking factor is not possible, identifying risk factors for developing
myelopathy may be helpful in creating a risk-mitigation strategy (TABLE 6-2).
Dietary Toxicity
Neurolathyrism is a toxic myelopathy that occurs in populations in which
diet consists largely of grass peas (Lathyrus sativus), red chickling vetch
(Lathyrus cicera), or purple Spanish vetchling (Lathyrus clymenum).35 Cases of
neurolathyrism have been reported in Europe, Asia, and Africa. Lathyrus species
are hearty plants that grow in conditions unfavorable to other crops, leading
to preferential consumption in socioeconomically disadvantaged populations,
particularly during famine. Risk factors for neurolathyrism include malnutrition,
male sex, and physical exertion.36 These plants contain the neurotoxin
β-N-oxalyl-L-α,β-diaminopropionic acid (ODAP). ODAP is a glutamate receptor
agonist, leading to glutamate toxicity in the central nervous system, particularly
in the longest axons in the corticospinal tract.36 Pathology demonstrates
degeneration of the lateral and ventral corticospinal tracts. Neurolathyrism
results in spastic paraparesis that develops over a variable period of time ranging
from acute (hours) to subacute (10 to 15 days) to chronic (months), with acute
onset being the most common.36,37 Typically, patients have upper motor neuron
findings with preserved sensation and sphincter function. The severity of
neurolathyrism is graded based on the patient’s ability to ambulate. Spasticity is
often out of proportion to weakness, and the upper extremities are rarely
affected. Diagnosis is based on history of exposure, clinical features, and
exclusion of alternative causes. MRIs of the brain and spinal cord of a limited
number of affected individuals were unremarkable.38 Treatment of
neurolathyrism includes discontinuing Lathyrus consumption. After the
discontinuation of Lathyrus consumption, symptoms typically stabilize, although
neurologic deficits are often permanent.
Medication Toxicity
Methotrexate is a chemotherapy drug that acts as a folate antagonist by inhibiting
dihydrofolate reductase. Methotrexate administered intrathecally has been
associated with myelopathy presenting as subacute combined degeneration of
the spinal cord (CASE 6-3).42,43 Methotrexate toxicity is an increased risk among
individuals with C667T polymorphism in the gene for methylenetetrahydrofolate
reductase (MTHFR), which may also contribute to an increased risk of
methotrexate myelopathy.44 Additional risk factors include higher total
intrathecal methotrexate exposure, systemic methotrexate, radiation therapy,
and hematologic malignancy affecting the brain or spinal cord.42 Neurologic
examination demonstrates features in keeping with subacute combined
degeneration of the spinal cord.43 Diagnosis is based on exposure to intrathecal
methotrexate and may be supported by low serum folate and elevated plasma
homocysteine. MRI of the spinal cord demonstrates T2 signal abnormalities in
the dorsal and lateral columns consistent with subacute combined degeneration
of the spinal cord. Treatment of methotrexate myelopathy includes folate
supplementation and discontinuation of methotrexate.25 Methotrexate
myelopathy often results in permanent neurologic deficits with poor
prognosis.25,42,43
Tumor necrosis factor-α (TNF-α) inhibitors and immune checkpoint
inhibitors are associated with transverse myelitis.45-47 TNF-α inhibitors
(eg, adalimumab, etanercept, infliximab) bind to the cytokine TNF to inhibit
binding to TNF receptors for the treatment of rheumatologic conditions
(eg, rheumatoid arthritis) and inflammatory bowel disease (eg, Crohn disease).
TNF-α inhibitors are associated with demyelinating disease, including rare cases
of isolated myelitis.45 Immune checkpoint inhibitors upregulate the activity
of T cells by blocking targets such as anti–programmed cell death 1 (PD1)
(eg, nivolumab) and anti–cytotoxic T-lymphocyte associated protein 4 (CTLA4)
CONTINUUMJOURNAL.COM 155
Diagnostic
Toxin Etiology Symptoms/signs MRI tests Treatment
Nitrous oxide Inactivation of Subacute combined T2 Low serum IM or subcutaneous
vitamin B12 by degeneration of hyperintensity in cobalamin, cyanocobalamin
nitrous oxide used spinal cord beginning posterior high plasma 1000 mcg/d for
as anesthetic gas with sensory ataxia columns with methylmalonic 5 days followed by IM
or whippets (positive Romberg inverted V sign; acid, high or subcutaneous
(recreational use sign, pseudoathetosis) may extend over plasma 1000 mcg monthly
of aerosol used in followed by pyramidal several levels in homocysteine indefinitely;
dispensing symptoms and signs, cervical or 1000 mcg/d orally is a
whipped cream) with or without thoracic cord possible alternative
peripheral axonal chronic regimen;
neuropathy avoid nitrous oxide
Neurolathyrism Diet largely Spastic paraparesis MRI spinal cord, Diagnosis relies Improved nutrition;
caused by consisting of grass typically developing no specific on history of avoid consumption
neurotoxin β-N- pea (Lathyrus over hours findings exposure along of Lathyrus plants
oxalyl-L-α,β- sativus), red with exclusion
diaminopropionic chickling vetch of other causes
acid (Lathyrus cicera) or
purple Spanish
vetchling (Lathyrus
clymenum)
Konzo caused by Diet largely Spastic paraparesis MRI spinal cord, Diagnosis relies Improved nutrition,
cyanogens consisting of bitter typically developing no specific on history of wetting method for
cassava (Manihot over <1 week, with findings exposure along cassava preparation
esculenta Crantz) or without optic with exclusion or avoid
neuropathy of other causes; consumption of
estimate bitter cassava
cyanogen
exposure by
measuring
urine or plasma
thiocyanate
Tumor necrosis Bind cytokine TNF Transverse myelitis Variable, Exposure to TNF-α inhibitor
factor-α (TNF-α) to inhibit binding short-segment TNF-α inhibitor, cessation, IV
inhibitors (eg, to TNF receptors, eccentric T2 with or without methylprednisolone
adalimumab, promoting hyperintensity or CSF oligoclonal 1000 mg/d for 5 days,
etanercept, neuroinflammation longitudinally banding with or without
infliximab) extensive plasma exchange
transverse
myelitis, with or
without
gadolinium
enhancement
Diagnostic
Toxin Etiology Symptoms/signs MRI tests Treatment
Immune Upregulate T cells Transverse myelitis Variable, Exposure to Immune checkpoint
checkpoint by blocking anti– short-segment immune inhibitor cessation, IV
inhibitors (eg, programmed cell eccentric T2 checkpoint methylprednisolone
ipilimumab, death 1 (PD1)/ hyperintensity or inhibitor, with 1000 mg/d for 5 days,
nivolumab) programmed longitudinally or without CSF with or without
death ligand 1 extensive oligoclonal plasma exchange
(PD-L1) and anti– transverse banding
cytotoxic myelitis, with or
T-lymphocyte without
associated protein gadolinium
4 (CTLA4) enhancement
Hepatic Chronic liver Spastic paraparesis MRI spinal cord Features in Liver transplant,
myelopathy due disease with no specific keeping with shunt-limiting
to accumulation portosystemic findings; MRI chronic liver surgery
of toxins, likely shunting brain T1 disease
nitrogen hyperintensity in
products globus pallidus
Decompression Diving for Flaccid paralysis, MRI spinal cord; Recent diving Hyperbaric
myelopathy likely prolonged sensory alteration, often no specific oxygen
due to nitrogen duration with rapid sphincter dysfunction findings
bubbles ascent within 1 hour of diving although T2
hyperintensity
may be seen in
posterior and
lateral columns
CONTINUUMJOURNAL.COM 157
(eg, ipilimumab) for the treatment of cancer (eg, melanoma, lung cancer).
Combination therapy with nivolumab and ipilimumab results in greater than 10%
risk of experiencing immune-related adverse events, including rare cases of
transverse myelitis.46,47 Treatment includes stopping the immunomodulatory
drug (TNF-α inhibitor or immune checkpoint inhibitor) along with administration
of high-dose IV steroids, typically IV methylprednisolone 1000 mg/d for 5 days. If
no improvement is seen with steroids, plasma exchange should be considered.
Clioquinol is a metal chelator that was developed as an antimicrobial.
Clioquinol has been associated with the syndrome of subacute myelo-optico-
neuropathy that occurred in Japan before 1970, when the medication was
removed from the market.48 Individuals with subacute myelo-optico-neuropathy
experienced primarily lower extremity sensory symptoms, gait instability, and
visual impairment. Neurologic examination demonstrates primarily lower
extremity reduced tactile sensation/vibration, lower extremity weakness with
spasticity, and visual impairment. Around the time of clioquinol exposure, green
deposits may be seen in the mouth (“green hairy tongue”) due to an iron
chelate.49 The mechanism of clioquinol toxicity is speculated to be because of
CASE 6-3 A 23-year-old man was diagnosed with acute lymphoblastic leukemia. He
was treated with cyclophosphamide, vincristine, doxorubicin, and
dexamethasone (hyper-CVAD) induction chemotherapy. In addition, he
received intrathecal methotrexate and cytarabine for prevention of
central nervous system involvement. After three rounds of intrathecal
methotrexate, he began to report numbness and weakness in his legs.
Neurologic examination demonstrated reduced pin sensation below
T10, reduced proprioception at the great toes, absent vibration distal to
the iliac crests, hyporeflexia, and upgoing plantar responses. MRI of his
spinal cord demonstrated T2 hyperintensity in the posterior columns
extending from T8 to the conus medullaris without contrast
enhancement. MRI of his brain was normal. CSF analysis demonstrated
no evidence of malignant cells, a white blood cell count of 2 cells/mm3
(normal 0 cells/mm3 to 5 cells/mm3), and elevated protein. Serum
cobalamin and plasma methylmalonic acid were normal. Serum folate
was 4.3 nmol/L (lower limit of normal 7.0 nmol/L).
He was diagnosed with methotrexate myelopathy secondary to
intrathecal methotrexate, which acts as a folate antagonist. Intrathecal
chemotherapy was discontinued, and he was treated with oral folic acid
3 mg/d. Despite folic acid replacement, he continued to experience
increasing leg weakness over several weeks, requiring the use of a
wheelchair.
myelopathy have a complete spinal cord syndrome with flaccid paralysis, sensory ● Radiation myelopathy is a
level, and sphincter dysfunction. MRI of the spinal cord typically demonstrates delayed effect of radiation
T2 hyperintensity affecting the complete cross section of the spinal cord over occurring 6 to 24 months
several levels, with a predilection for the thoracic region. Diagnosis is based on after radiation exposure.
clinical assessment and prior exposure to heroin with exclusion of other causes.
● Hepatic myelopathy
Treatment is discontinuation of heroin, consideration of administering an opiate occurs in chronic liver
reversal agent, and steroids, including IV methylprednisolone 1000 mg/d for disease with portosystemic
5 days.50,51 Neurologic deficits are typically severe and largely permanent. shunting.
Iatrogenic Toxicity
Radiation myelopathy is a delayed complication of radiation therapy used in the
treatment of malignancy. The risk of permanent spinal cord injury is believed to
be less than 1%, provided the cumulative dose of fractionated radiation to which
the spinal cord is exposed does not exceed 45 Gy to 50 Gy administered in 1.8 Gy
to 2 Gy daily fractions.52 Stereotactic body radiation therapy has emerged as a
treatment for spinal and paraspinal tumors given very focused administration
of high-dose radiation. Lhermitte syndrome after radiation therapy refers to
transient spinal cord symptoms that may occur 2 to 4 months following
radiation, with paresthesia in the back and extremities with neck flexion that
resolves over months without permanent myelopathy. Radiation myelopathy
typically develops approximately 6 to 24 months following exposure.52,53 Clinical
symptoms range in severity, and patients may present with hemicord symptoms
consistent with Brown-Séquard syndrome. MRI of the spinal cord demonstrates
focal T2 hyperintensity associated with contrast enhancement.52 In radiation
myelopathy, reactive gliosis, demyelination, and necrosis of white matter are
seen, along with vascular injury.52,53 Treatment typically includes a course of a
steroid such as dexamethasone. The role of hyperbaric oxygen is controversial.
Bevacizumab, a vascular endothelial growth factor (VEGF) inhibitor, may be
beneficial in the treatment of radiation myelopathy.53 Prognosis is variable, although
median survival following diagnosis of radiation myelopathy is 8 months.52
Hepatic myelopathy occurs in chronic liver disease with portosystemic shunting,
typically because of a transjugular intrahepatic portosystemic shunt (TIPS) used
to reduce portal hypertension.54 The mechanism of hepatic myelopathy is not
fully known, but nitrogen products bypassing the liver may have a toxic effect on
the spinal cord. Progressive spastic paraparesis is seen, without significant
sensory symptoms or sphincter dysfunction. Rarely, patients may have a spastic
quadriparesis. MRI of the spinal cord typically is normal, whereas MRI of the
brain may demonstrate T1 hyperintensity in the globus pallidus from manganese
deposition that accumulates with liver failure. Treatment includes liver
CONTINUUMJOURNAL.COM 159
CONCLUSION
Metabolic myelopathies are important to recognize as they are preventable and
typically respond to supplementation, particularly if treatment is initiated soon
after symptom onset. Toxic myelopathies often lead to more fixed neurologic
impairment but are important to recognize for future risk mitigation.
REFERENCES
1 Allen LH. How common is vitamin B-12 7 Flippo TS, Holder WD Jr. Neurologic degeneration
deficiency? Am J Clin Nutr 2009;89(2):693S-696S. associated with nitrous oxide anesthesia in
doi:10.3945/ajcn.2008.26947A patients with vitamin B12 deficiency. Arch Surg
1993;128(12):1391-1395. doi:10.1001/
2 Healton EB, Savage DG, Brust JC, et al. Neurologic
archsurg.1993.01420240099018
aspects of cobalamin deficiency. Medicine
(Baltimore) 1991;70(4):229-245. 8 Hunt A, Harrington D, Robinson S. Vitamin B12
doi:10.1097/00005792-199107000-00001 deficiency. BMJ 2014;349:g5226. doi:10.1136/
bmj.g5226
3 Agamanolis DP. Nutritional CNS disorders. In:
Neuropathology: an illustrated interactive course 9 Devalia V, Hamilton MS, Molloy AM. Guidelines
for medical students and residents. Accessed for the diagnosis and treatment of cobalamin
December 3, 2020. neuropathology-web.org/ and folate disorders. Br J Haematol 2014;166(4):
chapter8/chapter8Nutritional.html#b12 496-513. doi:10.1111/bjh.12959
4 Pant SS, Asbury AK, Richardson EP Jr. The 10 Solomon LR. Cobalamin-responsive disorders in
myelopathy of pernicious anemia. A the ambulatory care setting: unreliability of
neuropathological reappraisal. Acta Neurol cobalamin, methylmalonic acid, and
Scand 1968;44(S35):7-36. homocysteine testing. Blood 2005;105(3):
978-985. doi:10.1182/blood-2004-04-1641
5 Hemmer B, Glocker FX, Schumacher M, et al.
Subacute combined degeneration: clinical, 11 Wolffenbuttel BHR, Wouters HJCM, Heiner-
electrophysiological, and magnetic resonance Fokkema MR, van der Klauw MM. The many faces
imaging findings. J Neurol Neurosurg Psychiatry of cobalamin (vitamin B12) deficiency. Mayo Clin
1998;65(6):822-827. doi:10.1136/jnnp.65.6.822 Proc Innov Qual Outcomes 2019;3(2):200-214.
doi:10.1016/j.mayocpiqo.2019.03.002
6 Oh R, Brown DL. Vitamin B12 deficiency. Am Fam
Physician 2003;67(5):979-986. 12 Stabler SP. Clinical practice. Vitamin B12
deficiency. N Engl J Med 2013;368(2):149-160.
doi:10.1056/NEJMcp1113996
CONTINUUMJOURNAL.COM 161
40 Nhassico D, Bradbury JH, Cliff J, et al. Use of the 48 Konagaya M, Matsumoto A, Takase S, et al.
wetting method on cassava flour in three konzo Clinical analysis of longstanding subacute myelo-
villages in Mozambique reduces cyanide intake optico-neuropathy: sequelae of clioquinol at 32
and may prevent konzo in future droughts. Food years after its ban. J Neurol Sci 2004;218(1-2):
Sci Nutr 2016;4(4):555-561. doi:10.1002/fsn3.317 85-90. doi:10.1016/j.jns.2003.11.007
41 Tylleskar T, Howlett WP, Rwiza HT, et al. Konzo: a 49 Schaumburg H, Herskovitz S. Copper deficiency
distinct disease entity with selective upper myeloneuropathy: a clue to clioquinol-induced
motor neuron damage. J Neurol Neurosurg subacute myelo-optic neuropathy? Neurology
Psychiatry 1993;56(6):638-643. doi:10.1136/ 2008;71(9):622-623. doi:10.1212/01.
jnnp.56.6.638 wnl.0000324620.86645.c1
42 Gosavi T, Diong CP, Lim SH. Methotrexate- 50 Ivanovski T, Espino Ibañez AM, Barcelo Martin B,
induced myelopathy mimicking subacute Gomila Muñiz I. Acute extensive myelopathy
combined degeneration of the spinal cord. J Clin after single heroin and cocaine exposure in a
Neurosci 2013;20(7):1025-1026. patient with toxicological evidence of long-term
doi:10.1016/j.jocn.2012.06.018 drug abstinence. BMJ Case Rep 2019;12(3):
e228335. doi:10.1136/bcr-2018-228335
43 Pinnix CC, Chi L, Jabbour EJ, et al. Dorsal column
myelopathy after intrathecal chemotherapy for 51 Mahoney KW, Romba M, Gailloud P, et al. Acute
leukemia. Am J Hematol 2017;92(2):155-160. progressive paraplegia in heroin-associated
doi:10.1002/ajh.24611 myelopathy. J Clin Neurosci 2018;51:69-71.
doi:10.1016/j.jocn.2018.02.005
44 Juster-Switlyk K, Smith AG, Kovacsovics T, et al.
MTHFR C677T polymorphism is associated with 52 Wong CS, Fehlings MG, Sahgal A. Pathobiology of
methotrexate-induced myelopathy risk. radiation myelopathy and strategies to mitigate
Neurology 2017;88(6):603-604. doi:10.1212/ injury. Spinal Cord 2015;53(8):574-580.
WNL.0000000000003590 doi:10.1038/sc.2015.43
45 Barreras P, Mealy MA, Pardo CA. TNF-alpha 53 Cañedo G, Solis I, González-San Segundo C, et al.
inhibitor associated myelopathies: a neurological Treatment of radiation-induced myelopathy with
complication in patients with rheumatologic bevacizumab. Clin Transl Oncol 2020;22(6):
disorders. J Neurol Sci 2017;373:303-306. 957-960. doi:10.1007/s12094-019-02209-5
doi:10.1016/j.jns.2017.01.023
54 Zhao H, Yue Z, Wang L, et al. Benefits of early
46 Spain L, Tippu Z, Larkin JM, et al. How we treat treatment for patients with hepatic myelopathy
neurological toxicity from immune checkpoint secondary to TIPS: a retrospective study in
inhibitors. ESMO Open 2019;4(suppl 4):e000540. Northern China. Sci Rep 2018;8(1):15184.
doi:10.1136/esmoopen-2019-000540 doi:10.1038/s41598-018-33216-1
47 Liao B, Shroff S, Kamiya-Matsuoka C, Tummala S. 55 Saadi A, Ferenczi EA, Reda H. Spinal
Atypical neurological complications of decompression sickness in an experienced
ipilimumab therapy in patients with metastatic scuba diver: a case report and review of
melanoma. Neuro Oncol 2014;16(4):589-593. literature. Neurohospitalist 2019;9(4):235-238.
doi:10.1093/neuonc/nou001 doi:10.1177/1941874419828895
Myelitis and Other
C O N T I N UU M A U D I O
INTERVIEW AVAILABLE
ONLINE
Autoimmune
Myelopathies
Downloaded from http://journals.lww.com/continuum by wqLe/H3/oM2vx1Qs5A5qMemKKHLPqE4qkmGNpdheG3ikf1o85ttJSkFL2oTkgOkhMEmawHvsuTTE5xJG2ZjqccytIAhVn2qegy060KLcKJuPZsx5htaYiopRjp2zor2egUzWJAEWYNo65TEub0G9tZtPaMachiqn on 04/28/2022
ABSTRACT
PURPOSE OF REVIEW: This article provides an update on the clinical diagnosis
and management of immune-mediated myelopathies, including the
relevance of imaging, ancillary testing with an emphasis on autoantibody
biomarkers, recognition of myelitis mimics, and therapeutic approach.
T
unlabeled/investigational use of he differential diagnosis of immune-mediated myelopathies is broad
azathioprine, corticosteroids,
and includes noninflammatory myelopathies from compressive,
cyclophosphamide, IV
immunoglobulin, methotrexate, vascular, neoplastic, metabolic, nutritional, infectious, toxic, and
mycophenolate mofetil, plasma inherited causes.1 Age, sex, ethnicity, risk factors, and comorbidities
exchange, and rituximab for the
treatment of myelitis and other
can help narrow the differential diagnosis, but careful attention
autoimmune myelopathies. to the clinical history with focus on the temporal profile of symptom onset,
neuroimaging features, and comprehensive serologic and CSF evaluation is
© 2021 American Academy necessary to distinguish immune-mediated myelopathies from other causes and
of Neurology. achieve a definitive diagnosis.2,3 This article focuses on recent advances
62 FEBRUARY 2021
CONTINUUMJOURNAL.COM 63
CLINICAL FEATURES
When evaluating patients with suspected myelitis, a detailed clinical history with
focus on the temporal evolution is one of the most important aspects that can
help narrow the differential diagnosis.
Time to Nadir
The time from onset to maximal neurologic deficit is the most important feature
to determine when evaluating a myelopathy as it helps narrow the differential
diagnosis (TABLE 3-1).2,3
The time to nadir can be classified as hyperacute (<12 hours), acute/subacute
(1 to 21 days), or chronic progressive (progression beyond 21 days). In spinal cord
infarction, the rapid onset of severe deficits reaching nadir within a few hours
(up to 12 hours) is typical and occurs in approximately 80% of patients with
spinal cord infarction.12 Most patients with idiopathic or disease-associated
myelitis reach nadir in 1 to 21 days. Symptoms that progress beyond 21 days are
more suggestive of an alternative etiology, such as spondylotic myelopathy, dural
arteriovenous fistula, metabolic myelopathy, paraneoplastic myelopathy,
neoplasms, or primary progressive MS.
Presenting Features
The classic clinical feature of myelitis is the development of sensorimotor deficits
in one or more extremities. Ascending numbness, often accompanied by a
sensory level across the trunk, is a characteristic presentation. Autonomic
dysfunction is frequent, with a combination of neurogenic bladder (usually
urinary retention), neurogenic bowel, and sexual dysfunction potentially
encountered; these features are particularly common with MOG-IgG–associated
disorder, perhaps reflecting conus involvement radiologically. Clinical features
supportive of a demyelinating etiology include the Lhermitte phenomenon
(an electrical sensation that radiates down the spine and to the extremities on
neck flexion) and the Uhthoff phenomenon (transient worsening of neurologic
symptoms from excessive heat). Tonic spasms (recurrent short-lived episodes of
involuntary painful flexor contractions lasting 30 seconds to a few minutes) are
64 FEBRUARY 2021
CONTINUUMJOURNAL.COM 65
Acute
Vascular
Spinal cord infarct (anterior or posterior spinal artery) Vascular risk factors
Structural/trauma
Subacute
Myelin oligodendrocyte glycoprotein (MOG) Long or short T2 lesion; conus involvement; nonenhancing
antibody–associated disorder
Spinal cord sarcoidosis Milder deficit despite large lesion, linear dorsal subpial/trident
enhancement
Connective tissue disease associated (Behçet Systemic features of connective tissue disease
disease, lupus, Sjögren syndrome)
Infectious
Bacterial (Lyme disease, syphilis, tuberculosis) Recent tick bite/rash; high-risk behavior
Viral (varicella-zoster virus, herpes simplex virus Zoster rash, genital herpes, endemic region for enterovirus/
type 1, herpes simplex virus type 2 [may be associated West Nile virus; high-risk behavior
with lumbar myeloradiculitis, Elsberg syndrome],
cytomegalovirus, West Nile virus,
enterovirus-associated acute flaccid myelitis; human
immunodeficiency virus [HIV])
CONTINUED ON PAGE 67
66 FEBRUARY 2021
Vascular
Dural arteriovenous fistula Clinical worsening after exertion or steroids, thoracic longitudinally
extensive lesion, flow voids
Inflammatory or demyelinating
Progressive solitary sclerosis Single multiple sclerosis lesion in lateral columns or pyramids of medulla
Spinal cord sarcoidosis Milder deficit despite large lesion, linear dorsal subpial/trident
enhancement
Infectious
Bacterial (syphilis, tuberculosis); epidural abscess High-risk behavior, endemic region, IV drug use
Viral (HIV, human T-cell lymphotropic virus High-risk behavior, endemic region, dorsal/lateral column signal
type 1 [HTLV-1]) abnormality
Neoplastic
Primary spinal cord gliomas (astrocytoma, ependymoma) Prior radiation, expansile, mass effect, cap signb
Primary intramedullary spinal cord lymphoma Expansile lesion; persistent enhancement (>3 months), steroid
responsive, immunosuppressed
Structural
Hereditary
Hereditary spastic paraplegia Spasticity disproportionate to weakness; progressive spinal cord atrophy
Mitochondrial disorders (eg, DARS2 gene) Dorsal/lateral signal abnormality; elevated lactate
Other genetic
Toxic/metabolic
Nutritional deficiency (vitamin B12, copper, vitamin E) Gastric bypass, zinc supplements, malabsorption
Iatrogenic
IV = intravenous.
a
Popcorn appearance: mixed intensity at the center of the lesion from vascular components with a T2 hypointense rim from blood products.
b
A cap of T2 hypointensity secondary to hemosiderin is present at the top or bottom of the lesion.
CONTINUUMJOURNAL.COM 67
NEUROIMAGING IN MYELITIS
MRI with and without gadolinium is the imaging modality of choice in the
evaluation of myelopathies; in those with contraindications for MRI, CT
myelography can be considered to exclude extrinsic compression.
Diffusion-weighted images should be requested in hyperacute and acute
myelopathy, which are not part of the usual MRI spine protocol. Confirmation of
68 FEBRUARY 2021
CONTINUUMJOURNAL.COM 69
Length on Appearance on
Typical sagittal axial
spinal Number of T2-weighted T2-weighted Postcontrast
location T2 lesions imagesa images pattern Other feature(s)
Inflammatory/autoimmune
Aquaporin-4-IgG– Cervical or Single Long 85%; Central (gray and Ringlike, patchy Bright spotty
seropositive thoracic short 15% white matter) T2b, prominent
neuromyelitis swelling
optica spectrum
disorder (NMOSD)
Myelin Cervical or Multiple Long 70%; Central (30% gray Faint or no Conus
oligodendrocyte thoracic short 30% matter enhancement
glycoprotein–IgG- restricted/H
associated disorder signc)
Sarcoidosis Cervical or Single or, Usually long Central Almost universal: Swelling, may
thoracic less often, dorsal subpiald see enlarged
multifocal or axial tridente lymph nodes in
carina or hilum
on thoracic MRI
CONTINUED ON PAGE 71
70 FEBRUARY 2021
Length on Appearance on
Typical sagittal axial
spinal Number of T2-weighted T2-weighted Postcontrast
location T2 lesions imagesa images pattern Other feature(s)
Spondylosis Cervical Single Long or short Central owl eyef Sagittal: Cervical canal
pancakelikeg; stenosis, other
axial: spondylotic
circumferential changes; slow
sparing gray resolution of
matter enhancement
after surgery
(1-2 years)
Spinal cord infarct Cervical or Single Long or short Owl eyef Linear striph; Diffusion
thoracic owl eyef restriction;
vertebral body
infarct; adjacent
artery dissection
Dural arteriovenous Thoracic Single Long Central Patchy, missing Flow voids
fistula piece,i dorsal to cord
enhancing large
veins; 40% no
enhancement
CONTINUUMJOURNAL.COM 71
FIGURE 3-1
Comparison of acute myelitis MRI findings in multiple sclerosis, aquaporin-4 (AQP4) IgG–
seropositive neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte
glycoprotein autoantibody (MOG-IgG)–associated disorder. Sagittal MRI of an adult patient
with multiple sclerosis shows a short T2 hyperintensity at C2 extending 1.5 vertebral
segments in length (A, arrow). Axial image shows the lesion is located peripherally in the
right lateral column (B, arrow). Sagittal (C) and axial (D) images show accompanying ring
enhancement of the spinal cord lesion (C, D, arrows) on postcontrast T1-weighted images.
Sagittal (E) and axial (F) images of AQP4-IgG–seropositive NMOSD–associated myelitis
show a longitudinally extensive T2 hyperintense lesion extending more than three vertebral
segments (E, F, arrows). Accompanying ring enhancement of the cord lesion is seen on
sagittal (G, lower arrow) and axial (H, arrow) postcontrast T1-weighted images along with
more homogeneous enhancement (G, upper arrow). In myelitis accompanying MOG-IgG–
associated disorder, a longitudinally extensive T2-hyperintense lesion extending more than
three vertebral segments is seen on sagittal imaging (I, arrows). On axial images, the lesion
involves predominantly gray matter, forming an H sign (J, arrow). No postcontrast
enhancement is seen on postcontrast T1-weighted images (K, L).
72 FEBRUARY 2021
CONTINUUMJOURNAL.COM 73
74 FEBRUARY 2021
disease, brainstem and internal capsule lesions can be encountered, as can ● Obtaining an MRI of the
cerebral venous sinus thrombosis. brain is standard in the
evaluation of autoimmune
NEURAL AND NON-NEURAL AUTOANTIBODIES myelopathy, and the
features of the lesions
Serum and CSF biomarkers of myelitis discovered in the past 2 decades have detected can help suggest
aided in the diagnosis and understanding of the pathogenesis of myelitis. the underlying diagnosis.
AQP4-IgG is an antibody that binds to a water channel on the end feet of
astrocytes, whereas MOG-IgG binds the MOG protein on the surface of
oligodendrocytes. AQP4-IgG and MOG-IgG are two important antibody
CONTINUUMJOURNAL.COM 75
CASE 3-1 A 20-year old right-handed woman developed a sore throat, rhinorrhea,
and headache 5 days after receiving the injectable influenza vaccine.
Over the subsequent 3 to 4 days, she developed ascending numbness and
weakness in her lower extremities with difficulty urinating and the
Lhermitte phenomenon. At her neurologic nadir 7 days from onset, she
had weakness in both legs (resulting in wheelchair dependence), bilateral
numbness from her knees to toes, and urinary retention that required an
indwelling urinary catheter.
Neurologic examination at that time revealed a moderately severe
paraparesis with brisk reflexes in the lower extremities but downgoing
plantar responses. MRI of her spine revealed a multifocal T2 hyperintensity
within the cervical and thoracic spine (FIGURE 3-3) predominantly involving
the gray matter and forming a sagittal line (FIGURE 3-3A) and H sign (FIGURES 3-3B
and 3-3F) with minimal enhancement (FIGURES 3-3C, 3-3D, 3-3G, and 3-3H). Brain
MRI revealed some mild hazy central brainstem T2 hyperintensity without
enhancement (not shown) and was otherwise normal. CSF analysis revealed
an elevated white blood cell count of 101 cells/mm3, elevated protein of
68 mg/dL, normal glucose, and negative oligoclonal bands. Serum
aquaporin-4 (AQP4)-IgG was negative, but serum myelin oligodendrocyte
glycoprotein (MOG)-IgG was positive at high titer of 1:1000 (normal <1:20).
She was diagnosed with MOG-IgG–associated disorder and treated with
1 g IV methylprednisolone once daily for 5 days followed by an oral
prednisone taper over 3 weeks. She had an excellent recovery over the
subsequent 2 months and returned to running, although she had mild
residual bladder dysfunction. A watchful waiting approach was taken
without empiric attack-prevention immunosuppressant treatment.
COMMENT In this patient, the subacute onset of myelopathy reaching its nadir
between 1 and 21 days is suggestive of transverse myelitis, and the positive
MOG-IgG confirmed MOG-IgG–associated disorder, which can follow
vaccination. The MRI findings were very suggestive of MOG-IgG–
associated disorder, with a longitudinally extensive T2 hyperintensity with
mild swelling (FIGURE 3-3A), multifocal T2 hyperintensity in the cord
(FIGURES 3-3A and 3-3E), conus involvement (FIGURE 3-3E), predominantly gray
matter T2 hyperintensity (FIGURES 3-3A, 3-3B, and 3-3F), and minimal
gadolinium enhancement (FIGURES 3-3C, 3-3D, 3-3G and 3-3H), compared to
AQP4-IgG–seropositive neuromyelitis optica spectrum disorder (NMOSD),
which usually has a solitary longitudinally extensive T2 hyperintensity, more
severe swelling, and more avid enhancement. The severity of the episode
at nadir (requiring a wheelchair), longitudinally extensive T2 hyperintensity,
absence of oligoclonal bands, and elevated white blood cell count
(>50 cells/mm3) favored MOG-IgG–associated disorder over multiple
sclerosis. The excellent recovery with acute treatment is typical of MOG-
IgG–associated disorder, which responds to treatment better than AQP4-
IgG–seropositive NMOSD. As the disease can be monophasic, empiric
attack-prevention immunosuppression is typically reserved for cases that
relapse.
76 FEBRUARY 2021
CONTINUUMJOURNAL.COM 77
FIGURE 3-4
MRI findings in paraneoplastic myelopathy. Sagittal T2-weighted thoracic spine image shows
longitudinally extensive T2 signal abnormality (A, arrows) extending over seven spinal
segments with associated gadolinium enhancement (B, arrows) on sagittal postcontrast
T1-weighted image. Axial T2-weighted image shows symmetric tract-specific T2 signal
abnormality (lateral columns) (C, arrows) that enhances after gadolinium administration on
axial post contrast T1-weighted image (D, arrows).
Modified with permission from Flanagan EP, et al, Neurology.9 © 2011 American Academy of Neurology.
78 FEBRUARY 2021
CONTINUUMJOURNAL.COM 79
CASE 3-2 A previously healthy 38-year-old man presented with numbness affecting
the trunk and painful dysesthesia involving both upper extremities, which
were followed by urinary retention, with symptoms worsening over the
course of 6 weeks. He had no other systemic symptoms.
Neurologic examination revealed a mild upper motor neuron pattern of
weakness affecting both upper extremities and abnormal proprioception
in the hands bilaterally but was otherwise normal. MRI of the cervical
spine showed a longitudinally extensive T2-hyperintense abnormality in
the cervical spine from C3 through T1 (FIGURES 3-5A and 3-5B), with dorsal
subpial (FIGURE 3-5C) and central canal (FIGURE 3-5C) gadolinium
enhancement forming a trident pattern on axial sequences, suggestive of
spinal cord sarcoidosis (FIGURE 3-5D). CSF analysis showed 67 total
nucleated cells/mm3 (normal 0 cells/mm3 to 5 cells/mm3) of which 89%
were lymphocytes, a mildly elevated protein at 50 mg/dL, a normal
glucose, and no oligoclonal bands. Testing for aquaporin-4 (AQP4)-IgG,
myelin oligodendrocyte glycoprotein (MOG)-IgG, antinuclear antibodies,
angiotensin-converting enzyme, vitamin B12, copper, and syphilis and
Lyme serologies were negative. CT of the chest was reported as negative
for malignancy or other abnormalities but fludeoxyglucose positron
emission tomography (FDG-PET) with CT showed increased glucose
uptake in the subcarinal, precarinal, and bilateral hilar nodes (FIGURE 3-5E),
and biopsy revealed non-necrotizing granulomatous inflammation.
Extensive testing for fungal and bacterial etiologies, including
tuberculosis, were negative.
The patient was treated with IV methylprednisolone (1 g/d for 5 days)
and transitioned to a prolonged oral steroid taper for 12 weeks. After
36 months of follow-up, no recurrence of enhancing lesions was seen and
the patient’s urinary retention had resolved, but he continued to have
residual allodynia in the upper limbs that responded poorly to multiple
neuropathic pain medications.
COMMENT The yield of PET-CT imaging may be higher than CT alone and should be
considered in the evaluation for neurosarcoidosis as it can help identify
potential sites for biopsy. The presence of gadolinium enhancement
involving the central canal and the dorsal subpial region forming a trident
pattern on axial images should raise suspicion for neurosarcoidosis.
Chronic neuropathic pain may be refractory to neuropathic medications
and is a common residuum of spinal cord sarcoidosis.
80 FEBRUARY 2021
CONTINUUMJOURNAL.COM 81
FIGURE 3-6
Comparison of brain MRI in multiple sclerosis (MS), aquaporin-4–IgG (AQP4-IgG)–seropositive
neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein
antibody (MOG-IgG)–associated disorder. Axial postcontrast T1-weighted MRIs show optic nerve
enhancement extending less than half the length of the nerve in a patient with MS (A, arrow),
whereas AQP4-IgG–seropositive NMOSD has a predilection for the optic chiasm (B, arrows) and
MOG-IgG–associated disorder is typically associated with bilateral anterior optic nerve pathway
enhancement extending more than half the length of the optic nerve (C, arrows). Axial
fluid-attenuated inversion recovery (FLAIR) images reveal peripheral small T2-hyperintense
lesions in the dorsal pons typical of MS (D, arrow); an additional characteristic inferior temporal
pole lesion of MS is also noted (D, arrowhead); a peri–fourth ventricle/area postrema
T2-hyperintense lesion is seen in the patient with AQP4-IgG–seropositive NMOSD (E, arrow),
whereas bilateral fluffy middle cerebellar peduncle T2-hyperintense lesions are typical of
MOG-IgG–associated disorder (F, arrows). Axial FLAIR MRIs reveal typical ovoid periventricular
lesions in MS (G, arrows), a peri–third ventricle hyperintense lesion in AQP4-IgG–seropositive
NMOSD (H, arrow), and characteristic deep gray matter (bithalamic) hyperintense lesions in
MOG-IgG–associated disorder (I, arrows). Axial postcontrast T1-weighted images show multiple
enhancing lesions typical of MS (J), linear ependymal enhancement occasionally encountered
with AQP4-IgG-seropositive NMOSD (K, arrow), and prominent enhancing vessels in MOG-
IgG–associated disorder (L, arrows).
82 FEBRUARY 2021
OTHER TESTING
In cases of suspected neurosarcoidosis, chest x-ray is insensitive and CT chest
is 73% sensitive; however, FDG-PET/CT has higher sensitivity (88%) and is
useful in selected cases (CASE 3-2; FIGURE 3-5E).1,8,19 CT body is considered
first line in assessing for malignancy accompanying a paraneoplastic
myelopathy, but PET-CT offers better sensitivity if suspicion is high;
mammogram is also useful.62 Searching for cancer is also recommended in older
patients (≥50 years) with AQP4-IgG–seropositive NMOSD as it is recognized to
occur occasionally in a paraneoplastic context.63 Somatosensory evoked
potentials may be helpful for patients who cannot undergo MRI. In patients with
clinical and radiologic progression despite immunotherapy, the diagnosis of an
autoimmune myelitis should be reconsidered. Spinal cord biopsy is considered a
last resort; however, in one study at a tertiary referral center it helped guide
specific treatment in 26% of patients with a morbidity of 21%, although
permanent deficits were rare (<5%).64
CONTINUUMJOURNAL.COM 83
FIGURE 3-7
Mimics of inflammatory/autoimmune myelitis. Sagittal T2-weighted cervical spine MRI shows
T2 hyperintensity extending from C5 through C7 in the anterior aspect of the cord (A, arrows);
axial T2-weighted MRI shows involvement of the anterior horn cells in a snake-eye pattern
(B, arrows), consistent with spinal cord infarct. Sagittal T2-weighted cervical spine MRI
shows T2 hyperintensity in the dorsal cord extending from C2 through C4 (C, arrows); axial
T2-weighted image shows involvement of the dorsal cord (D, arrow), consistent with
vitamin B12 deficiency. Sagittal T2-weighted thoracic spine MRI shows a longitudinally
extensive T2 hyperintensity extending from the upper thoracic cord to the conus (E, arrows);
axial T2-weighted image shows involvement of the central cord (F, arrow) that was
eventually confirmed to be a dural arteriovenous fistula despite the lack of evident flow
voids. Sagittal T2-weighted thoracic spine MRI shows a longitudinally extensive T2 hyperintensity
in the thoracic cord (G, arrows); axial T2-weighted image shows that the lesion is central
(H, arrow). Sagittal (I) and axial (J) postcontrast T1-weighted images show a rim of
enhancement (I, J, arrowheads) around a less enhancing center with a flame pattern at the
top and bottom of the lesion (I, arrow), a pattern that is highly characteristic of spinal
cord intramedullary metastasis.
Panels A and B modified with permission from Flanagan EP, Pittock SJ, Handb Clin Neurol.24 © 2017 Elsevier BV.
84 FEBRUARY 2021
CONTINUUMJOURNAL.COM 85
CASE 3-3 A 35-year-old man presented with subacute paresthesia initially affecting
the right arm, which had spread over the course of 5 weeks to include the
left arm symmetrically up to the midforearm. He had progressed despite
treatment for presumed bilateral carpal tunnel syndrome. Six months
later, he was involved in a motor vehicle accident and subsequently
developed a progressive gait disorder, with right leg weakness and
frequent falls. MRI of his cervical spine was abnormal, showing a
longitudinally extensive T2 hyperintensity (FIGURE 3-8A) centrally located
on axial imaging (FIGURE 3-8B), associated with a pancakelike transverse
band of enhancement in which the width was equal to the height at C5-C6
(FIGURE 3-8C). On axial images, the enhancement involved the white matter
and spared the gray matter (FIGURE 3-8D). Moderate to severe
degenerative disk disease was also noted. CSF showed a normal white
blood cell count, red blood cell count, and glucose; a mildly elevated
protein of 66 mg/dL; and negative oligoclonal bands and IgG index.
Extensive serologic testing for infectious and autoimmune causes of
myelopathy were negative, including aquaporin-4 (AQP4)–IgG and myelin
oligodendrocyte glycoprotein (MOG)–IgG. Brain MRI and optical
coherence tomography were normal. The patient was diagnosed with
seronegative neuromyelitis optica spectrum disorder (NMOSD) and
received treatment with IV methylprednisolone daily for 5 days, but his
sensory symptoms progressed, gait dysfunction worsened, and urinary
frequency and erectile dysfunction ensued.
A second neurologic opinion was sought. Neurologic examination
showed an upper motor neuron pattern of weakness affecting the right
upper extremity and diffuse hyperreflexia, a positive Hoffman sign on the
right, and bilateral extensor plantar responses. His gait was broad based,
and a positive Romberg sign was noted. A diagnosis of cervical
spondylotic myelopathy was established based on the characteristic
presentation and imaging findings. The patient underwent cervical
decompression surgery, after which his symptoms improved.
86 FEBRUARY 2021
CONTINUUMJOURNAL.COM 87
FIGURE 3-9
Distinctive imaging features and patterns of enhancement with myelopathies accompanied by
longitudinally extensive T2 lesions. The sagittal and axial images depict the typical lesion patterns
on T2-weighted images (shown in light red) and postcontrast T1-weighted images (enhancement
after contrast is shown in dark red). For each panel, the T2 sequences are shown on the left and
postcontrast T1 sequences are shown on the right. A, Aquaporin-4 (AQP4)-IgG–seropositive
neuromyelitis optica spectrum disorder (NMOSD) myelitis on sagittal cervical spine images typically
reveals a solitary T2-hyperintense lesion that is central on axial sequences and extends over three
or more vertebral segments, with contrast enhancement sometimes having a ringlike appearance.
B, Myelin oligodendrocyte glycoprotein (MOG)-IgG–associated disorder myelitis on cervicothoracic
cord images typically shows multifocal T2-hyperintense lesions with one or more longitudinally
extensive T2 lesions and a predilection for the conus. The T2 lesions are generally central on axial
sequences and in about one-third of patients will be restricted to the gray matter, forming an H
pattern. Contrast enhancement is infrequent; if present, it is usually faint. C, Neurosarcoidosis myelitis
in the cervical spine shows a typical nonspecific longitudinally extensive T2-hyperintense lesion that is
central on axial images. Postcontrast images show hallmark linear dorsal subpial enhancement with
some accompanying central canal enhancement, with the combination forming an axial trident sign.
D, Paraneoplastic myelopathy in the cervical spine shows the typical longitudinally extensive T2 signal
abnormality with a tractopathy on axial images confirmed by the presence of symmetric tract-specific
T2 hyperintensity and enhancement restricted to the dorsal columns or lateral columns, or both. E,
Spinal cord infarction in anterior spinal artery territory reveals the typical pencillike linear anterior cord
longitudinally extensive T2 hyperintensity with a partial linear strip of enhancement with contrast. On
axial T2 and postcontrast images, the anterior horn cells are preferentially affected in an owl-eye
or snake-eye pattern; occasionally (in approximately 10%), a vertebral body infarct can ensue, as
shown here. F, Cervical spondylotic myelopathy with sagittal imaging showing spondylosis and a
spindle-shaped T2 hyperintensity extending more than three vertebral segments, with a characteristic
flat pancakelike transverse band of enhancement just below the site of maximum stenosis on
postcontrast images. On axial images, the enhancement typically involves the white matter but spares
the gray matter. G, Intramedullary spinal cord metastasis reveals a longitudinally extensive T2
hyperintensity with an enhancing intramedullary mass with the hallmark thin rim of more intense
enhancement (the rim sign) accompanied by an ill-defined flame-shaped region of enhancement at its
superior and inferior margins with a central dot (the dot sign) occasionally noted on postcontrast
images, as shown here. H, Spinal dural arteriovenous fistula reveals the typical thoracic longitudinally
extensive T2 hyperintensity extending to the conus with prominent flow voids and contrast
enhancement and a characteristic “missing piece” of enhancement sometimes noted, as shown here.
88 FEBRUARY 2021
CONCLUSION
Autoimmune myelopathies are a heterogeneous group of spinal cord disorders
unified by their immune-mediated mechanism and potential for response to
immunotherapy. The time course of development of neurologic symptoms is
crucial in determining the likely etiology of a myelopathy, and autoimmune
myelopathies are usually subacute in onset. Immune-mediated myelopathies
may be monophasic or the initial manifestation of a relapsing disorder (eg, MS,
NMOSD); ancillary testing, particularly MRI, serologic antibody biomarkers, and
CSF analysis, can help determine a specific diagnosis and the correct treatment
approach and assist with prognosis. Idiopathic transverse myelitis should be
considered a diagnosis of exclusion and should only be assigned once a
comprehensive search for alternative etiologies has been completed. Timely
administration of acute treatment is critical to help stabilize and improve
symptoms while maintenance immunotherapy decisions are based on the
underlying etiology found.
CONTINUUMJOURNAL.COM 89
REFERENCES
1 Flanagan EP. Autoimmune myelopathies. Handb 14 Sechi E, Keegan BM, Kaufmann TJ, et al. Unilateral
Clin Neurol 2016;133:327-351. doi:10.1016/B978-0- motor progression in MS: association with a
444-63432-0.00019-0 critical corticospinal tract lesion. Neurology
2019;93(7):e628-e634. doi:10.1212/WNL.
2 Zalewski NL, Flanagan EP, Keegan BM. Evaluation
0000000000007944
of idiopathic transverse myelitis revealing
specific myelopathy diagnoses. Neurology 15 Flanagan EP, Hinson SR, Lennon VA, et al. Glial
2018;90(2):e96-e102. doi:10.1212/ fibrillary acidic protein immunoglobulin G as
WNL.0000000000004796 biomarker of autoimmune astrocytopathy:
analysis of 102 patients. Ann Neurol 2017;81(2):
3 Barreras P, Fitzgerald KC, Mealy MA, et al. Clinical
298-309. doi:10.1002/ana.24881
biomarkers differentiate myelitis from vascular
and other causes of myelopathy. Neurology 16 Lee CH, Bharwani L, Sullivan T. Paraneoplastic
2018;90(1):e12-e21. doi:10.1212/WNL. necrotizing myelopathy in a patient with newly
0000000000004765 diagnosed diffuse large B cell lymphoma. World J
4 Barnes G, Benjamin S, Bowen JD, et al. Proposed Oncol 2011;2:195-198. doi:10.4021/wjon279w
diagnostic criteria and nosology of acute 17 Flanagan EP. Neuromyelitis optica spectrum
transverse myelitis. Neurology 2002;59(4): disorder and other non–multiple sclerosis central
499-505. doi:10.1212/wnl.59.4.499 nervous system inflammatory diseases.
5 Sechi E, Shosha E, Williams JP, et al. Aquaporin-4 Continuum (Minneap Minn) 2019;25(3):815-844.
and MOG autoantibody discovery in idiopathic doi:10.1212/CON.0000000000000742
transverse myelitis epidemiology. Neurology 18 Flanagan EP, Keegan BM. Paraneoplastic
2019;93(4):e414-e420 doi:10.1212/WNL. myelopathy. Neurol Clin 2013;31(1):307-318.
0000000000007828 doi:10.1016/j.ncl.2012.09.001
6 Geraldes R, Ciccarelli O, Barkhof F, et al. The 19 Flanagan EP, Kaufmann TJ, Krecke KN, et al.
current role of MRI in differentiating multiple Discriminating long myelitis of neuromyelitis
sclerosis from its imaging mimics. Nat Rev Neurol optica from sarcoidosis. Ann Neurol 2016;79(3):
2018;14(4):199-213. doi:10.1038/nrneurol.2018.14 437-447. doi:10.1002/ana.24582
7 Reindl M, Waters P. Myelin oligodendrocyte 20 Salvarani C, Brown RD, Calamia KT, et al. Primary
glycoprotein antibodies in neurological disease. CNS vasculitis with spinal cord involvement.
Nat Rev Neurol 2019;15(2):89-102. doi:10.1038/ Neurology 2008;70(24 pt 2):2394-2400.
s41582-018-0112-x doi:10.1212/01.wnl.0000314687.69681.24
8 Zalewski NL, Flanagan EP. Autoimmune and 21 Dimberg EL. Rheumatology and neurology.
paraneoplastic myelopathies. Semin Neurol 2018; Continuum (Minneap Minn) 2017;23(3, Neurology
38:278-289. doi:10.1055/s-0038-1660856 of Systemic Disease):691-721. doi:10.1212/
9 Flanagan EP, McKeon A, Lennon VA, et al. CON.0000000000000474
Paraneoplastic isolated myelopathy: clinical course 22 Toledano M. Infectious myelopathies.
and neuroimaging clues. Neurology 2011;76(24): Continuum (Minneap Minn) 2021;27(1, Spinal Cord
2089-2095. doi:10.1212/WNL.0b013e31821f468f Disorders):93-120.
10 Murphy OC, Salazar-Camelo A, Jimenez JA, et al. 23 Zalewski NL. Vascular myelopathies. Continuum
Clinical and MRI phenotypes of sarcoidosis- (Minneap Minn) 2021;27(1, Spinal Cord Disorders):
associated myelopathy. Neurol Neuroimmunol 30-61.
Neuroinflamm 2020;7(4):e722. doi:10.1212/
NXI.0000000000000722 24 Flanagan EP, Pittock SJ. Diagnosis and
management of spinal cord emergencies. Handb
11 Flanagan EP, Cabre P, Weinshenker BG, et al. Clin Neurol 2017;140:319-335. doi:10.1016/B978-0-
Epidemiology of aquaporin-4 autoimmunity and 444-63600-3.00017-9
neuromyelitis optica spectrum. Ann Neurol 2016;
79(5):775-783. doi:10.1002/ana.24617 25 Savoldi F, Nasr Z, Hu W, et al. McArdle sign: a
specific sign of multiple sclerosis. Mayo Clin
12 Zalewski NL, Rabinstein AA, Krecke KN, et al. Proc 2019;94(8):1427-1435. doi:10.1016/j.
Characteristics of spontaneous spinal cord mayocp.2019.01.047
infarction and proposed diagnostic criteria.
JAMA Neurol 2019;76(1):56-63. doi:10.1001/ 26 Hardy TA. Spinal cord anatomy and localization.
jamaneurol.2018.2734 Continuum (Minneap Minn) 2021;27(1, Spinal Cord
Disorders):12-29.
13 Keegan BM, Kaufmann TJ, Weinshenker BG, et al.
Progressive solitary sclerosis: gradual motor 27 Sechi E, Krecke KN, Pittock SJ, et al. Frequency
impairment from a single CNS demyelinating and characteristics of MRI-negative myelitis
lesion. Neurology 2016;87(16):1713-1719. associated with MOG autoantibodies. Mult Scler
doi:10.1212/WNL.0000000000003235 2020;1352458520907900. doi:10.1177/
1352458520907900
90 FEBRUARY 2021
32 Asnafi S, Morris PP, Sechi E, et al. The frequency 45 Sechi E, Morris PP, McKeon A, et al. Glial fibrillary
of longitudinally extensive transverse myelitis in acidic protein IgG related myelitis:
MS: a population-based study. Mult Scler Relat characterisation and comparison with
Disord 2020;37:101487. doi:10.1016/j.msard. aquaporin-4-IgG myelitis. J Neurol Neurosurg
2019.101487 Psychiatry 2019;90(4):488-490. doi:10.1136/
jnnp-2018-318004
33 Flanagan EP, Weinshenker BG, Krecke KN, et al.
Short myelitis lesions in aquaporin-4-IgG– 46 Ogawa R, Nakashima I, Takahashi T, et al. MOG
positive neuromyelitis optica spectrum antibody-positive, benign, unilateral, cerebral
disorders. JAMA Neurol 2015;72(1):81-87. cortical encephalitis with epilepsy. Neurol
doi:10.1001/jamaneurol.2014.2137 Neuroimmunol NeuroInflamm 2017;4(2):e322.
doi:10.1212/NXI.0000000000000322
34 Ciron J, Cobo-Calvo A, Audoin B, et al. Frequency
and characteristics of short versus longitudinally 47 Budhram A, Mirian A, Le C, et al. Unilateral
extensive myelitis in adults with MOG antibodies: cortical FLAIR-hyperintense lesions in anti-MOG-
a retrospective multicentric study. Mult Scler associated encephalitis with seizures (FLAMES):
2019;1352458519849511. doi:10.1177/1352458519849511 characterization of a distinct clinico-radiographic
syndrome. J Neurol 2019;266(10):2481-2487.
35 Kumar N, Frohman EM. Spinal neurosarcoidosis doi:10.1007/s00415-019-09440-8
mimicking an idiopathic inflammatory
demyelinating syndrome. Arch Neurol 2004;61(4): 48 Dutra BG, José da Rocha A, Nunes RH, Martins
Maia Júnior C. Neuromyelitis optica spectrum
586-589. doi:10.1001/archneur.61.4.586
disorders: spectrum of MR imaging findings and
36 Jitprapaikulsan J, Lopez Chiriboga AS, Flanagan their differential diagnosis–erratum. Radiographics
EP, et al. Novel glial targets and recurrent 2018;38(2):662. doi:10.1148/rg.2018184002
longitudinally extensive transverse myelitis.
49 Mariotto S, Gajofatto A, Batzu L, et al. Relevance
JAMA Neurol 2018:e180805. doi:10.1001/
of antibodies to myelin oligodendrocyte
jamaneurol.2018.0805
glycoprotein in CSF of seronegative cases.
37 Zalewski NL, Morris PP, Weinshenker BG, et al. Neurology 2019;93(20):e1867-e1872. doi:10.1212/
Ring-enhancing spinal cord lesions in WNL.0000000000008479
neuromyelitis optica spectrum disorders.
50 Waters PJ, Komorowski L, Woodhall M, et al. A
J Neurol Neurosurg Psychiatry 2017;88(3):218-225.
multicenter comparison of MOG-IgG cell-based
doi:10.1136/jnnp-2016-314738
assays. Neurology 2019;92(11):e1250-e1255.
38 Jarius S, Paul F, Aktas O, et al. MOG doi:10.1212/WNL.0000000000007096
encephalomyelitis: international
51 Kunchok A, Chen JJ, McKeon A, et al.
recommendations on diagnosis and antibody Coexistence of myelin oligodendrocyte
testing. J Neuroinflammation 2018;15(1):134. glycoprotein and aquaporin-4 antibodies in adult
doi:10.1186/s12974-018-1144-2 and pediatric patients. JAMA Neurol 2019;77(2):
39 López-Chiriboga AS, Majed M, Fryer J, et al. 257-259. doi:10.1001/jamaneurol.2019.3656
Association of MOG-IgG serostatus with relapse 52 Faissner S, Lukas C, Reinacher-Schick A, et al.
after acute disseminated encephalomyelitis and Amphiphysin-positive paraneoplastic myelitis
proposed diagnostic criteria for MOG-IgG– and stiff-person syndrome. Neurol
associated disorders. JAMA Neurol 2018;75(11): Neuroimmunol Neuroinflamm 2016;3(6):e285.
1355-1363. doi:10.1001/jamaneurol.2018.1814 doi:10.1212/NXI.0000000000000285
40 Dubey D, Pittock SJ, Krecke KN, et al. Clinical, 53 Honorat JA, Sebastian Lopez-Chiriboga A, Kryzer
radiologic, and prognostic features of myelitis TJ, et al. Autoimmune gait disturbance
associated with myelin oligodendrocyte accompanying adaptor protein-3B2-IgG.
glycoprotein autoantibody. JAMA Neurol 2019; Neurology 2019;93(10):954-963. doi:10.1212/
76(3):301-309. doi:10.1001/jamaneurol.2018.4053 WNL.0000000000008061
CONTINUUMJOURNAL.COM 91
54 Hinson SR, Lopez-Chiriboga AS, Bower JH, et al. 67 Weinshenker BG, O'Brien PC, Petterson TM, et al.
Glycine receptor modulating antibody predicting A randomized trial of plasma exchange in acute
treatable stiff-person spectrum disorders. central nervous system inflammatory
Neurol Neuroimmunol Neuroinflamm 2018;5(2): demyelinating disease. Ann Neurol 1999;46(6):
e438. doi:10.1212/NXI.0000000000000438 878-886. doi:10.1002/1531-8249(199912)46:6<878::
aid-ana10>3.0.co;2-q
55 Shelly S, Kryzer TJ, Komorowski L, et al.
Neurochondrin neurological autoimmunity. 68 Abboud H, Petrak A, Mealy M, et al. Treatment of
Neurol Neuroimmunol Neuroinflamm 2019;6(6): acute relapses in neuromyelitis optica: steroids
e612. doi:10.1212/NXI.0000000000000612 alone versus steroids plus plasma exchange.
Mult Scler J 2016;22(2):185-192. doi:10.1177/
56 Alfugham N, Gadoth A, Lennon VA, et al. ITPR1
1352458515581438
autoimmunity: frequency, neurologic phenotype,
and cancer association. Neurol Neuroimmunol 69 Bonnan M, Valentino R, Debeugny S, et al. Short
Neuroinflamm 2018;5(1):e418. doi:10.1212/ delay to initiate plasma exchange is the strongest
NXI.0000000000000418 predictor of outcome in severe attacks of
NMO spectrum disorders. J Neurol Neurosurg
57 Basal E, Zalewski N, Kryzer TJ, et al.
Psychiatry 2018;89(4):346-351. doi:10.1136/
Paraneoplastic neuronal intermediate filament
jnnp-2017-316286
autoimmunity. Neurology 2018;91(18):e1677-e1689.
doi:10.1212/WNL.0000000000006435 70 Gross RH, Corboy JR. Monitoring, switching, and
stopping multiple sclerosis disease-modifying
58 Guerra H, Pittock SJ, Moder KG, et al. Frequency
therapies. Continuum (Minneap Minn) 2019;25(3):
of aquaporin-4 immunoglobulin g in longitudinally
715-735. doi:10.1212/CON.0000000000000738
extensive transverse myelitis with
antiphospholipid antibodies. Mayo Clin Proc 71 Pittock SJ, Berthele A, Fujihara K, et al.
2018;93(9):1299-1304. doi:10.1016/j.mayocp. Eculizumab in aquaporin-4-positive
2018.02.006 neuromyelitis optica spectrum disorder. N Engl J
Med 2019;381(7):614-625. doi:10.1056/
59 Takano R, Misu T, Takahashi T, et al. Astrocytic
NEJMoa1900866
damage is far more severe than demyelination in
NMO: a clinical CSF biomarker study. Neurology 72 Cree BAC, Bennett JL, Kim HJ, et al. Inebilizumab
2010;75(3):208-216. doi:10.1212/WNL. for the treatment of neuromyelitis optica
0b013e3181e2414b spectrum disorder (N-MOmentum): a
double-blind, randomised placebo-controlled
60 Ikeda K, Kiyota N, Kuroda H, et al. Severe
phase 2/3 trial. Lancet 2019;394(10206):1352-1363.
demyelination but no astrocytopathy in clinically
doi:10.1016/S0140-6736(19)31817-3
definite neuromyelitis optica with
anti-myelin-oligodendrocyte glycoprotein 73 Tahara M, Oeda T, Okada K, et al. Safety and
antibody. Mult Scler 2015;21(5):656-659. doi: efficacy of rituximab in neuromyelitis optica
10.1177/1352458514551455 spectrum disorders (RIN-1 study): a multicentre,
randomised, double-blind, placebo-controlled
61 Yu X, Li W, Deng Q, et al. MYD88 L265P mutation
trial. Lancet Neurol 2020;19:298-306. doi:10.1016/
in lymphoid malignancies. Cancer Res 2018;78(10):
S1474-4422(20)30066-1
2457-2462. doi:10.1158/0008-5472.CAN-18-0215
74 Yamamura T, Kleiter I, Fujihara K, et al. Trial of
62 McKeon A, Apiwattanakul M, Lachance DH, et al.
satralizumab in neuromyelitis optica spectrum
Positron emission tomography-computed
disorder. N Engl J Med 2019;381(22):2114-2124.
tomography in paraneoplastic neurologic
doi:10.1056/NEJMoa1901747
disorders: systematic analysis and review. Arch
Neurol 2010;67(3):322-329. doi:10.1001/ 75 Lopez-Chiriboga S, Sechi E, Buciuc M, et al.
archneurol.2009.336 Long-term outcomes in patients with myelin
oligodendrocyte glycoprotein immunoglobulin
63 Pittock SJ, Lennon VA. Aquaporin-4
G-associated disorder. JAMA Neurol 2020;31:
autoantibodies in a paraneoplastic context. Arch
e203115. doi:10.1001/jamaneurol.2020.3115
Neurol 2008;65(5):629-632. doi:10.1001/
archneur.65.5.629 76 Chen JJ, Flanagan EP, Bhatti MT, et al.
Steroid-sparing maintenance immunotherapy
64 Cohen-Gadol AA, Zikel OM, Miller GM, et al.
for MOG-IgG associated disorder. Neurology
Spinal cord biopsy: a review of 38 cases.
2020;95(2):e111-e120. doi:10.1212/
Neurosurgery 2003;52(4):806-815; discussion
WNL.0000000000009758
815-816. doi:10.1227/01.neu.0000053223.77641.5e
77 Gelfand JM, Bradshaw MJ, Stern BJ, et al.
65 Flanagan EP, Krecke KN, Marsh RW, et al. Specific
Infliximab for the treatment of CNS sarcoidosis:
pattern of gadolinium enhancement in
a multi-institutional series. Neurology 2017;
spondylotic myelopathy. Ann Neurol 2014;76(1):
89(20):2092-2100. doi:10.1212/
54-65. doi:10.1002/ana.24184
WNL.0000000000004644
66 Conway BL, Clarke MJ, Kaufmann TJ, Flanagan EP.
Utility of extension views in spondylotic
myelopathy mimicking transverse myelitis. Mult
Scler Relat Disord 2017;11:62-64. doi:10.1016/
j.msard.2016.12.004
92 FEBRUARY 2021
By Amy A. Pruitt, MD, FAAN C O N T I N U UM AUDIO
I NT E R V I E W A V A I L AB L E
ONLINE
Downloaded from http://journals.lww.com/continuum by wqLe/H3/oM2vx1Qs5A5qMemKKHLPqE4qkmGNpdheG3ikf1o85ttJSkFL2oTkgOkhMEmawHvsuTTE5xJG2ZjqccytIAhVn2qegy060KLcKJuPZsx5htaYiopRjp2zor2egUzWJAEWYNo/R1NuKT7SYsuBdzpo0ePV on 04/28/2022
ABSTRACT
PURPOSE OF REVIEW: This article reviews the current classification system of
primary spinal cord tumors and explores evolving diagnostic and
therapeutic strategies for both primary tumors and metastatic tumors to
various compartments of the spinal cord.
application of surgery, radiation, and targeted therapies can facilitate RELATIONSHIP DISCLOSURE:
diagnosis, minimize surgical morbidity, and prolong quality of life. Dr Pruitt serves on the editorial
boards of Neurology Clinical
Practice and Neurology Today.
A
PRODUCTS/INVESTIGATIONAL
lthough spinal cord tumors represent only 2% to 4% of all primary USE DISCLOSURE:
central nervous system (CNS) tumors, they cause significant Dr Pruitt reports no disclosure.
morbidity and are often confused clinically and radiographically
with non-neoplastic processes.1 Early identification of these © 2021 American Academy
neoplasms guides appropriate management and can minimize of Neurology.
CONTINUUMJOURNAL.COM 121
FIGURE 5-1
Algorithm for diagnosis and management of spinal mass on MRI.
a
Whole-neuraxis imaging usually indicated to delineate other levels of pathology.
b
Benign: bone cyst, angiolipoma, hemangioma, Langerhans cell histiocytosis, osteochondroma, osteoma.
Malignant: angiosarcoma, chondrosarcoma, chordoma, Ewing sarcoma, lymphoma, myeloma,
plasmacytoma.
CONTINUUMJOURNAL.COM 123
Intramedullary
◆ Ependymoma
◇ Ependymoma (World Health Organization [WHO] grade II)
◇ Anaplastic ependymoma (WHO grade III)
◇ Myxopapillary ependymoma (WHO grade I)
◇ Subependymoma (WHO grade I)
◆ Astrocytoma
◇ Pilocytic astrocytoma (WHO Grade I)
◇ Diffuse astrocytoma (WHO grade II)
◇ Anaplastic astrocytoma (WHO Grade III)
◇ Glioblastoma (WHO Grade IV)
→ Midline glioma (H3 K27M mutation)
◆ Oligodendroglioma
◇ Oligodendroglioma (WHO grade II)
◇ Anaplastic oligodendroglioma (WHO grade III)
◆ Atypical teratoid/rhabdoid tumors
◆ Mixed neuronal/glial tumors
◇ Ganglioglioma (WHO grade I)
◆ Mesenchymal tumors
◇ Hemangioblastoma (WHO grade I)
◇ Lipoma
◇ Melanocytoma
◆ Hematopoietic tumors
◇ Primary central nervous system lymphoma
◇ Leukemia (myelocytic sarcoma)
Astrocytoma
Intramedullary astrocytomas represent about 7% of all primary spinal cord
tumors.2 Most are low grade, but their location and infiltrative behavior preclude
effective resection. They are often lateralized to one side of the cord, and patients
may present with local pain or a Brown-Séquard syndrome. Many patients will
Intradural-extramedullary
◆ Meningioma
◆ Schwannoma
◆ Neurofibroma
◆ Hemangioblastoma
◆ Myxopapillary ependymoma
◆ Paraganglioma
◆ Lipoma
◆ Sarcoma
Extradural
◆ Meningioma
◆ En plaque meningioma
◆ Schwannoma
◆ Myxopapillary ependymoma
◆ Histiocytic tumors
◇ Erdheim-Chester disease
Primary brain tumors that disseminate to spinal canala
◆ Medulloblastoma
◆ Central nervous system neuroblastoma
◆ Ependymoma
◆ Primary central nervous system lymphoma
◆ High-grade gliomab
◆ Primary dural lymphoma (low-grade B-cell marginal zone lymphoma)
a
Drop metastases or leptomeningeal metastases.
b
These complications usually occur late in the disease course, after multiple surgical interventions.
CONTINUUMJOURNAL.COM 125
CASE 5-1 A 53-year-old man with type 2 diabetes developed right arm pain. A
cervical MRI with contrast was obtained, and he was found to have a
cervical spinal cord neoplasm (FIGURE 5-2). After being followed for 4
years, during which there was slow tumor growth with concomitant
increase in arm paresthesia, he underwent surgery with partial excision of
a World Health Organization grade II cellular ependymoma. He remained
numb from the cervical level down, with whole-body hyperalgesia “like a
tight wetsuit.” Proprioceptive problems produced balance difficulties
that were a limiting factor in his functional abilities such as driving. Three
years after the original surgery, he underwent radiation for a new tumor
2 cm caudal to the original side (3600 cGy in 20 fractions with an
additional radiation boost of 50.4 Gy to the area of greatest contrast
enhancement). Five years after radiation, he developed urinary retention,
left calf pain, and left footdrop and was found to have a conus
medullaris/cauda equina lesion.
FIGURE 5-2
Imaging of the patient in CASE 5-1 with ependymoma. Intramedullary tumor with cystic
component at first diagnosis of ependymoma on sagittal T2-weighted (A) and postcontrast
T1-weighted (B) MRIs. Sagittal T2-weighted (C) and postcontrast T1-weighted (D) MRIs
reveal tumor recurrence 7 years later and with progressive symptoms 2 years later not
attributable to tumor but to tethering of the atrophic cord at C5 on sagittal T2-weighted
MRI following radiation therapy (E).
COMMENT This case illustrates the typical MRI findings of cyst and syrinx in a spinal
cord ependymoma as well as the role of surgery at clinical progression and
the resultant considerable disability, in this case proprioceptive
dysfunction and pain. It also illustrates the propensity of ependymoma for
local recurrence and subsequent spread through the neuraxis. This patient
sustained surgical and radiation morbidities, with cord atrophy and a
tethered cord. Although the indolent behavior over more than a decade is
typical, recurrence is common both locally and through drop metastases.
Diabetes complicated this patient’s functional status as he likely had a
superimposed distal sensory neuropathy.
A 30-year-old woman first noted bandlike dysesthesia and occasional CASE 5-2
sharp neuralgic pains in the midthoracic region when she was 13 years of
age, and a nonenhancing intraaxial mass in the thoracic spinal cord was
first seen on imaging when she was 19 years of age. She was followed with
stable MRI scans for more than 10 years (FIGURE 5-3), and her examination
remained stable with mild hyperreflexia and allodynia over the T9
through T11 levels. In view of her clinicoradiographic stability, continued
annual imaging was elected. She had no family history of neurofibromatosis
type 1, neurofibromatosis type 2, or von Hippel-Lindau syndrome.
FIGURE 5-3
Imaging of the patient in CASE 5-2 with a nonenhancing intramedullary tumor. Sagittal
T2-weighted images of the same tumor with a 14-year interval between panel A and
panels B and C. Axial T2-weighted MRI shows the typical asymmetric location of this
slow-growing astrocytic neoplasm.
Low-grade intramedullary spinal tumors account for 10% to 20% of all spinal COMMENT
tumors.7 These tumors do not harbor the classic mutations associated with
their intracranial counterparts; thus, for this patient, targeted therapeutic
options are limited. Typical for astrocytomas, this tumor is nonenhancing
and appears as a T2 hyperintensity on sagittal views (FIGURES 5-3A and 5-3B)
that involve one-half of the cord (FIGURE 5-3C). MRI characteristically shows
no enhancement in over 50% of low-grade astrocytomas, in contrast to
high-grade glial neoplasms of the spine.8
CONTINUUMJOURNAL.COM 127
CASE 5-3 A 28-year-old man presented with shortness of breath and was found
to have a cardiac ejection fraction of 15%. Coronary angiography was
normal, but MRI done because of dysphagia and right facial numbness
showed a nonenhancing medullary lesion. Because of hemodynamic
instability and tumor location, no biopsy was done, and he was
treated empirically
with proton therapy. He
did well, with no dysphagia
or hemodynamic instability
for 9 months before
presenting again with
numbness below the
nipples, urinary retention,
and recurrent facial
numbness. Repeat MRI
showed a relatively stable
brainstem tumor but also a
T6 intramedullary lesion
(FIGURE 5-4A). Within a
month, dramatic spread FIGURE 5-4
of leptomeningeal Imaging of the patient in CASE 5-3 with H3
enhancement was seen K27M-mutant midline glioma presenting with
medullary symptoms. A, Axial fluid-attenuated
(FIGURE 5-4B). This area inversion recovery (FLAIR) MRI shows diffuse
was biopsied, and H3 K27M expansion of the right side of the medulla by a
astrocytoma was diagnosed. nonenhancing intramedullary lesion. One year
The patient’s disease later, the patient had developed paraparesis from
this aggressive tumor. B, Sagittal postcontrast
progressed too rapidly to T1-weighted MRI obtained 1 year after the initial
permit enrollment in a imaging shows diffuse contrast-enhancing
clinical trial. metastases throughout the thoracic spine.
CONTINUUMJOURNAL.COM 129
CASE 5-4 A 66-year-old man noted gradually progressive leg weakness over a
12-month period, during which he also experienced weight loss,
fevers, and night sweats. MRI showed a single enhancing expansile
abnormality in the cervical and thoracic cord (FIGURE 5-5), and brain MRI
showed worsening confluent
signal change in the corpus
callosum and brainstem.
Lumbar puncture showed
protein of 169 mg/dL and a
CD19-positive monoclonal
B-cell population consistent
with non-Hodgkin B-cell
lymphoma. He was human
immunodeficiency virus (HIV)
negative, and Epstein-Barr
virus was negative in the CSF.
His CD4+ count was 293.
He received rituximab,
methotrexate, and
temozolomide followed by
hematopoietic stem cell FIGURE 5-5
transplantation nearly 2 years Imaging of the patient in CASE 5-4 with
after onset of symptoms. intramedullary lymphoma. A, Sagittal T2-weighted
MRI shows an extensive area of intramedullary T2
Leg function returned, but signal abnormality. B, Sagittal postcontrast
he developed a persistent T1-weighted MRI shows diffuse homogeneous
need to self-catheterize. enhancement.
COMMENT This patient had primary central nervous system lymphoma involving both
brain and spinal cord, with the latter causing the predominant symptoms.
He also had B (systemic) symptoms, although this is not typical of primary
central nervous system lymphoma.
● Pilocytic astrocytomas of
Hemangioblastoma the spinal cord account for
Hemangioblastoma, a WHO grade I tumor, is rare except in von Hippel-Lindau about 11% of pediatric spinal
syndrome, an autosomal dominant disorder characterized by chromosome cord tumors. These often
3p deletion; von Hippel-Lindau syndrome accounts for up to 30% of cases are associated with
neurofibromatosis type 1.
of hemangioblastoma.33 Retinal hemangiomas, renal and pancreatic cysts, Most are well circumscribed
renal cell carcinoma, and pheochromocytoma are associated pathologies. and WHO grade I.
Hemangioblastomas have a male predominance. Clinically, hemangioblastomas
of the spinal cord are characterized by slowly progressive proprioceptive deficits. ● Hemangioblastoma, a
WHO grade I tumor, is rare
The location is more frequently cervical than thoracic, and neuroimaging shows
except in von Hippel-Lindau
a homogeneously enhancing mural nodule; cysts and a syrinx are additional syndrome, an autosomal
common features. Hemangioblastomas are more vascular than ependymomas, dominant disorder
and early draining veins may cause diagnostic confusion with a vascular characterized by
malformation. The presence of a syrinx, uncommon with vascular malformations, chromosome 3p deletion;
von Hippel-Lindau
is seen in up to one-half of hemangioblastomas.3 Surgical resection may be syndrome accounts for up to
curative. Tumor recurrence is common in patients with von Hippel-Lindau 30% of cases of
syndrome and case reports exist of tumor regression with treatment with hemangioblastoma.
bevacizumab, a vascular endothelial growth factor (VEGF) inhibitor.33,34
CONTINUUMJOURNAL.COM 131
Meningioma
Meningiomas are the most common primary spinal cord neoplasm in adults,
accounting for one-fourth of all primary spinal cord tumors. Eighty percent
of patients with spinal cord meningioma are female, and 80% of the cases in
females occur in the thoracic region, whereas spinal cord meningiomas in
males are equally distributed between the cervical and thoracic cord.36 The
majority of spinal cord meningiomas are WHO grade I slow-growing tumors.
Genetic predisposition (eg, in patients with NF2) and prior radiation are risk
factors. Over 90% of spinal cord meningiomas are located in the intradural-
extramedullary space, and only 6% are extradural.36 On T1-weighted MRI, the
tumors are isointense to hypointense and exhibit intense solid homogeneous
enhancement postgadolinium; an accompanying dural tail may be seen.
Radiosurgery is used for incomplete resection or recurrence, and protons are
gaining a larger role in the treatment of spinal cord meningioma. No role for
chemotherapy has been established, but intracranial meningiomas have been
reported to respond to everolimus (a mammalian target of rapamycin [mTOR]
inhibitor), sunitinib (a multi–tyrosine kinase inhibitor), and bevacizumab
(a VEGF inhibitor). By extension of this experience, although without evidence
from prospective trials, some of these agents may be considered for select
patients with refractory spinal cord meningiomas (CASE 5-5).36
Patients with asymptomatic spinal cord meningiomas can be followed with
serial MRIs. Surgery is the primary modality and can be curative. Conventional
fractionated radiation therapy or proton therapy is a consideration at progression.
Neurofibromatosis type 1 (NFI gene on Malignant nerve sheath tumors, optic gliomas, Neurofibroma, meningioma,
chromosome 17), autosomal dominant hamartomas schwannoma, ependymoma,
glioma
Von Hippel-Lindau syndrome (VHL gene Renal cell carcinomas, retinal angiomas, Hemangioblastoma
on chromosome 3) pheochromocytomas, hemangioblastomas of
the central nervous system, endolymphatic
sac tumors of middle ear, pancreatic tumors
a
Modified with permission from Wu J, Ranjan S, Continuum (Minneap Minn).4 © 2018 American Academy of Neurology.
TRENDS
A word about spinal cord tumors resulting from “stem cell tourism” is in order.
Berkowitz and colleagues38 reported a case of a mixed spinal cord tumor arising
This patient’s MRI looked considerably worse than the patient’s COMMENT
examination demonstrated, suggesting that the process had been slow.
She had a foramen magnum meningioma, which is often heralded by lower
cranial nerve findings. Her symptoms could not be improved, and some
hazard existed in surgery. Systemic therapy options for unresectable
meningioma are limited to investigational agents. For this older patient with
stable symptoms, no systemic therapy would be recommended.
CONTINUUMJOURNAL.COM 133
EXTRADURAL TUMORS
Numerically, extradural tumors represent the largest number of adult spinal cord
neoplasms and are usually metastases from a systemic neoplasm.
CASE 5-6 A 28-year old woman with neurofibromatosis type 1 (NF1) presented with
progressive neck pain, dysphagia, and evolving leg weakness. Multiple
surgeries and tipifarnib systemic therapy for NF1-associated
neurofibromas had failed. Cervical MRI was performed and showed
enlarging neurofibromas at multiple cervical levels (FIGURE 5-7).
She also had multiple neurofibromas caudal to the displayed level.
FIGURE 5-7
Imaging of the patient in CASE 5-6 with neurofibromatosis type 1. A, Sagittal postcontrast
T1-weighted MRI shows multiple lesions throughout the extramedullary cervical spine. B,
Axial postcontrast MRI shows the lesions more prominently. C, Sagittal postcontrast
T1-weighted MRI of the thoracic spine shows additional lesions.
COMMENT Surgery was not feasible for the patient in this case with multiple spinal
neurofibromas. If possible, she should be offered a trial of systemic
therapy. She is a candidate for selumetinib, which is a new development
for the treatment of plexiform neurofibromas that has shown significant
activity in large surgically hazardous tumors.37
CONTINUUMJOURNAL.COM 135
cancer and renal cell cancer, melanoma, and lymphoma. The cervical cord is the
most frequently involved region. Hematogenous spread or carcinomatous
meningitis can occur concurrently, possibly by direct extension through nerve
roots. Two radiographic signs of intramedullary spinal cord metastases may be
seen: rim and flame. A thin rim of peripheral enhancement and a flame-shaped
appearance in the region of enhancement at the superior and inferior margins
should suggest a non-CNS metastatic intramedullary tumor rather than one of
primary spinal cord origin.45,46 The flame-shaped ovoid lesion is hypointense on
T2-weighted sequences with a hyperintense rim with enhancement (FIGURE 5-8).
RADIATION-RELATED MYELOPATHY
Despite careful attention to dosimetry, the risk of permanent myelopathy
from radiation remains possible and frequently is devastating. Early
symptoms of radiation toxicity include paresthesia with the Lhermitte sign
occurring 2 to 4 months after treatment, which may respond to a brief
corticosteroid course. Less readily reversible signs and symptoms, such as
paresthesia, pain, sphincter dysfunction, and weakness, can develop later.
MRI shows hyperintensity on T2-weighted sequences with or without
enhancement. At later stages, spinal cord atrophy predominates. Many
treatment interventions have been attempted for these disabling symptoms,
including high-dose corticosteroids, hyperbaric oxygen, anticoagulation, and
bevacizumab (CASE 5-7).47 Another
complication of radiation therapy,
cavernous malformations (which have
been well described intracranially) can
also be found in the spinal cord and may
cause sudden paraplegia due to
hemorrhage.
CHEMOTHERAPY-RELATED
MYELOPATHY
Both intrathecally and systemically
administered cytotoxic agents can
infrequently result in a longitudinally
devastating myelopathy. The most
frequently implicated agents are
methotrexate and cytarabine. The onset is
often rapid; sometimes after a first dose,
recovery is possible, although it is often
incomplete (CASE 5-8).
CONTINUUMJOURNAL.COM 137
CASE 5-7 A 62-year-old woman with kappa light chain multiple myeloma
developed back pain and was treated with local radiation to lytic lesions
at T5 and T7 in 10 daily fractions to 3000 cGy. She received multiple other
chemotherapy regimens but had progressive plasmacytomas in many
bony sites. Nine months after the radiation, she developed progressive
back pain and left leg weakness along with new lytic fractures at T12, L2
through L4, and S1 that were treated with vertebroplasty. Her gait was
further impaired by significant peripheral neuropathy from bortezomib
and pomalidomide as well as proximal weakness from multiple extended
corticosteroid courses. MRI showed enhancement of the spinal cord
from T7 through T10 without mass lesion (FIGURE 5-9) and was felt to be
most consistent with radiation myelitis. She also had chronic
compression fractures at multiple levels.
FIGURE 5-9
Imaging of the patient in CASE 5-7 with myeloma and multiple bone lesions presenting with
rapidly progressive leg weakness. The T2 signal abnormality extends beyond the radiation
fields on sagittal T2-weighted cervical (A) and thoracic (B) spine images, but the area
receiving the largest dose of radiation shows an expansile enhancing lesion on sagittal
postcontrast T1-weighted image (C, arrow).
COMMENT This case illustrates the spread of bone tumor to the spinal canal,
causing weakness and pain and complicated by radiation myelitis,
chemotherapy-associated peripheral neuropathy, and
corticosteroid-related myopathy. Multiple comorbidities must be
considered when a patient has been treated with radiation and neurotoxic
chemotherapy but also has evidence of advancing disease. Vertebroplasty
can be an effective palliative maneuver.
A 47-year old woman had stage IV breast cancer, diagnosed when she CASE 5-8
was found to have thoracic compression fractures in the course of a
back-pain evaluation. She was treated systemically with denosumab,
letrozole, and palbociclib. Initial CSF cytology was positive, and she
received seven intrathecal methotrexate treatments. She continued to
have increasing back pain, which was treated with spinal radiation and
fusion. Nine months later, she had progressive leg spasms and
progressive right footdrop as well as urinary retention and within 48 hours
developed paraplegia. MRI showed extensive posterior fossa and spinal
cord leptomeningeal enhancement as well as developing hydrocephalus.
Repeat CSF cytology was again positive.
FIGURE 5-10
Imaging of the patient in CASE 5-8. Axial fluid-attenuated inversion recovery (FLAIR) MRI (A)
and axial FLAIR MRI 1 month later (B) reflect a rapid rise in intracranial pressure and
transependymal flow of CSF, with impaired CSF resorption and development of
hydrocephalus. The posterior fossa and cervical spine leptomeningeal enhancement are
visible on sagittal postcontrast T1-weighted MRI (C), consistent with carcinomatous
meningitis.
CONTINUUMJOURNAL.COM 139
CONCLUSION
Early recognition of signs and symptoms of spinal cord tumors leads to
expeditious neuroimaging that can define the compartment involved and focus
the differential diagnosis with excellent accuracy among different histologies.
Pain is the predominant symptom of spinal cord tumors and may not be
alleviated with surgical resection. Surgery is the first-line treatment of
symptomatic primary spinal cord tumors and is more effective for control of
ependymomas than for astrocytomas. The histologic grade of the tumor and
extent of resection are important determinants of outcome. Newer techniques,
including separation surgery and stereotactic radiosurgery, offer better chances
of quality survival in patients with spinal cord metastasis from systemic
malignancies. The H3 K27M mutant diffuse midline glioma has been recently
recognized, and some targeted therapies may have efficacy. Experience with
chemotherapy for recurrent spinal cord tumors is limited, although successes
with intracranial counterparts of similar histology may suggest potentially
helpful agents.
REFERENCES
1 Chamberlain MC, Tredway TL. Adult primary 5 Parks NE, Goyal G, Go RS, et al. Neuroradiologic
intradural spinal cord tumors: a review. Curr manifestations of Erdheim-Chester disease.
Neuro Neurosci Rep 2011;11(3):320-328. Neurol Clin Pract 2018;8(1):15-20. doi:10.1212/
doi:10.1007/s11910-011-0190-2 CPJ.0000000000000422
2 Ostrom QT, Cioffi G, Gittleman H, et al. CBTRUS 6 Chiapparini L, Cavalla G, Langella T, et al. Adult
Statistical Report: primary brain and other central leukoencephalopathies with prominent
nervous system tumors diagnosed in the United infratentorial involvement can be caused by
States in 2012-2016. Neuro Oncol 2019;21(suppl 5): Erdheim-Chester disease. J Neurol 2018;265(2):
v1-v100. doi:10.1093/neuonc/noz150 273-284. doi:10.1007/s00415-017-8692-8
3 Mechtler LL, Nandigam K. Spinal cord tumors: 7 Zhang M, Iyer RR, Azad TD, et al. Genomic
new views and future directions. Neurol Clin landscape of intramedullary spinal cord gliomas.
2013;31(1):241-268. doi:10.1016/j.ncl.2012.09.011 Sci Rep 2019;9(1):18722. doi:10.1038/s41598-019-
54286-9
4 Wu J, Ranjan S. Neoplastic myelopathies.
Continuum (Minneap Minn) 2018;24(2, Spinal 8 Muccilli A, Cavrol R, Kvam KA. A case of
Cord Disorders):474-496. doi:10.1212/ progressive myelopathy in a middle-aged
CON.0000000000000585 woman. JAMA Neurol 2019;76(10):1253-1254.
doi:10.1001/jamaneurol.2019.2806
CONTINUUMJOURNAL.COM 141
Cord and Cauda Equina CONTINUUM AUDIO
INTERVIEW AVAILABLE
ONLINE
Disorders
Downloaded from http://journals.lww.com/continuum by wqLe/H3/oM2vx1Qs5A5qMemKKHLPqE4qkmGNpdheG3ikf1o85ttJSkFL2oTkgOkhMEmawHvsuTTE5xJG2ZjqccytIAhVn2qegy060KLcKJuPZsx5htaYiopRjp2zor2egUzWJAEWYNrC3bBuCzr1RdmqNUpjE4IY on 04/28/2022
ABSTRACT
PURPOSE OF REVIEW: This article reviews the neuroimaging of disorders of the
spinal cord and cauda equina, with a focus on MRI. An anatomic approach
is used; diseases of the extradural, intradural-extramedullary, and
intramedullary (parenchymal) compartments are considered, and both
neoplastic and non-neoplastic conditions are covered. Differentiating
imaging features are highlighted.
CONTINUUMJOURNAL.COM 225
INTRODUCTION
I
n patients with myelopathy, spinal cord signal abnormality on MRI,
particularly increased T2 signal, can occur with a wide variety of diseases
intrinsic and extrinsic to the spinal cord. To arrive at a specific diagnosis for
such myelopathic signal abnormality or a limited imaging differential
diagnosis, additional clinical and imaging features must be evaluated. The
preceding articles in this issue detail many of the clinical considerations and
therefore these are not further discussed here. Such additional imaging features
include, but are not limited to, the cross-sectional pattern of involvement, the
longitudinal extent, cord expansion, associated findings in the spinal cord,
enhancement, any extrinsic compressive/adhesive cause of myelopathic signal,
and findings outside the spinal canal. A complete workup that includes MRI can
more often than not provide a specific diagnosis for a patient’s myelopathy.1 The
wastebasket term idiopathic transverse myelitis, which is a diagnosis of exclusion,
should generally not be used in MRI interpretations at primary presentation.2
This article focuses on causes of myelopathy for which advanced imaging
(particularly MRI but also CT or CT myelography) can provide specific
diagnoses or short lists of differential considerations.
Select extrinsic causes of myelopathy are discussed first, since compression of
the cord/cauda equina is more common than intrinsic myelopathy and the
imaging findings can often specifically identify the disease process. This is
followed by a discussion of intrinsic cord diseases. Because of space constraints,
acute traumatic myelopathy (eg, fractures, traumatic malalignment, traumatic
disk herniations, cord contusion/hemorrhage) is not considered specifically
herein, nor are neurodegenerative/hereditary myelopathies. The brain MRI
findings that can help diagnose diseases such as multiple sclerosis (MS) are also
not included.
MRI First line for any suspected nontraumatic For initial complete evaluation of a myelopathy
myelopathy; follow-up of most or suspected/known infection/active
myelopathies; in acute traumatic inflammation/neoplasm/vascular cause,
myelopathy after initial evaluation with CT should be performed without and with IV
to assist in spinal canal evaluation and gadolinium; include segments of spine
potential operative planning clinically affected; protocol used depends on
indication (refer to TABLE 10-2)
Magnetic resonance Suspected or known vascular myelopathy; Typically performed with IV gadolinium; not a
angiography (MRA) workup of myelopathy demonstrated on substitute for conventional angiography but
MRI of unknown cause; arterial dissection can help guide spinal angiography if suggests
(including vertebral artery) level of dural arteriovenous fistula; CT
angiography is an infrequently used
alternative, especially if patient not an MRI
candidate or MRI is not available; CT
angiography is first line for acute arterial injury
CT Acute trauma; assess for degree of Soft tissue attenuation lesions in the canal may
calcification/ossification of a compressive be difficult/impossible to discriminate from
lesion, degree of osseous stenosis; CSF/cord
reasonable first-line examination (over CT
myelography) if patient not an MRI
candidate or MRI is not available; assess
margins/nature of osseous lesions causing
compressive myelopathy seen on MRI
Conventional myelography Patient not an MRI candidate or MRI is not Minimally invasive; dynamic capabilities
and postmyelography CT available (including when CT has not (temporal: initial contrast flow at level of a
diagnosed the cause of a myelopathy); space-occupying lesion; positional: lateral
surgical planning or problem solving; decubitus, prone); other uses include
differentiation of arachnoid cyst, arachnoid evaluation of spontaneous intracranial
web, and spinal cord herniation; assess hypotension/CSF leak (usually not in a setting
dynamic nature of lumbar spinal stenosis of myelopathy)
with standing cone-beam technique
Conventional angiography Dural arteriovenous fistula (localizing level Minimally invasive; MRA can inform search for
and, in appropriate cases, treatment); other fistula and decrease time/radiation dose;
spinal vascular malformation, including complete examination is from vertebral to
arteriovenous malformation; spinal internal iliac arteries; CT angiography is an
vasculitis; localize artery of Adamkiewicz alternative for artery of Adamkiewicz
localization
Fludeoxyglucose positron Not typically used primarily for myelopathy Spinal canal a relative blind spot; normal
emission tomography but most commonly for metastatic workup variant increased uptake of conus; both
(FDG-PET) CT of many suspected/known malignancies neoplastic and, less commonly, inflammatory
causes may show increased uptake3
CSF = cerebrospinal fluid; CT = computed tomography; IV = intravenous; MRI = magnetic resonance imaging.
CONTINUUMJOURNAL.COM 227
approximately 150 ms to 170 ms). Axial plane imaging of cord and canal is most
effective using T2-weighted techniques. Cord gray-white differentiation is best
appreciated on axial images, with the gray matter expected to be slightly more
hyperintense than the white matter. An axial gradient recalled echo (GRE)
sequence can demonstrate the gray-white differentiation to better advantage
than T2-weighted images; the inherently normal gray matter hyperintensity on
this sequence relative to white matter should not be mistaken for abnormal. GRE
sequences also have fewer CSF flow artifacts. Together and in conjunction with
sagittal sequences, the two axial sequences can be complementary in evaluating
intradural anatomy and pathology. IV administration of gadolinium with
postcontrast T1-weighted imaging performed in at least the sagittal plane, if not also
the axial plane, is recommended for complete evaluation of suspected intrinsic
myelopathy with blood–spinal cord barrier breakdown (eg, infectious, active
inflammatory, vascular, or neoplastic causes). Inclusion of diffusion-weighted
imaging (DWI) in the MRI protocol is suggested for any hyperacute or acute
myelopathy, particularly to help assess for infarct.4
CT myelography involves percutaneous intrathecal access and injection of
iodinated contrast material, typically via lumbar puncture with fluoroscopic
Neoplasm, infection, active Basic protocol as above, including gadolinium; sagittal with or without axial
inflammation T2-weighted fat-suppressed sequence (STIR or fat saturation)a; include fat saturation
on postgadolinium T1-weighted images in at least one plane (sagittal or axial);
consider diffusion-weighted imaginga if abscess suspected
Spinal cord herniation, arachnoid Basic protocol as above; consider thin-section heavily T2-weighted three-
cyst, arachnoid web dimensional GRE steady state sequencesb
Scoliosis Basic protocol as above; consider coronal plane (T2-weighted with or without
T1-weighted)
CONTINUUMJOURNAL.COM 229
FIGURE 10-2
Normal variant and artifacts of the spinal cord. The central canal of the spinal cord is an
ependyma-lined CSF space that can be mildly prominent as an anatomic variant (A through
E); this is not a pathologic syrinx. Artifactual spinal cord signal abnormality (F through K) can
occur for a variety of reasons, such as patient motion (eg, respiration, swallowing); it is
usually more apparent on short tau inversion recovery (STIR) (H, I) than on conventional
T2-weighted images (F, G). Evaluation of the spinal cord in two planes is essential; axial
images (J, K) in this patient do not confirm the apparent T2 hyperintensity seen on sagittal
images. Artifactual cord enhancement (L through N) can occur for similar reasons. Often, it is
seen only in one of the two planes (seen sagittally in L and M but not axially in N, and no
corresponding cord T2 hyperintensity is seen [O, P]). CSF flow artifact (Q, R) can simulate
intrathecal pathology to the uninitiated; it is most apparent on conventional T2-weighted
images (Q, R, arrows), and in this patient was misconstrued as nodular drop metastases. Note
that it is not evident on the T1-weighted image (S) and does not enhance (T). In patients
with chronic repetitive subarachnoid hemorrhage resulting in superficial siderosis, the
low-signal-intensity hemosiderin that coats the pial surface of the spinal cord and conus
(U through W, white arrows) can cause an artifact of pseudoparenchymal T2 hyperintensity
(blue arrows, V, W).
Pitfalls
A few pitfalls regarding the use of MRI for myelopathy deserve specific mention.
The normal gray matter is slightly more hyperintense than the white matter,
which may simulate abnormal T2 hyperintensity anteriorly and centrally on
sagittal T2-weighted images (FIGURE 10-1). Second, patient motion can cause
apparent but artifactual signal abnormality, including false-positive T2
hyperintensity in the cord (FIGURE 10-2). Third, adjacent to the cord, CSF flow
artifact can confound; it can be particularly prominent on conventional
T2-weighted images (FIGURE 10-2). Especially on axial images, this artifactual T2
hypointensity can simulate extradural or intradural lesions such as disk
herniations, osteophytes, or nerve sheath tumors. As artifact, it often cannot be
confirmed as truly lesional on sagittal images or other sequences. Axial GRE
images are less susceptible to such motion artifact and can help problem solve.
Fourth, chronic repetitive subarachnoid hemorrhage can result in superficial
siderosis. In this condition, the T2-hypointense hemosiderin that coats the spinal
cord can cause the parenchyma to appear relatively T2 hyperintense
CONTINUUMJOURNAL.COM 231
Extradural Compartment
A wide variety of spinal or paraspinal lesions, both benign and malignant, may
cause myelopathy or cauda equina symptoms by compression of neural tissue.
Selected causes that are important to recognize are discussed here.
DISK HERNIATIONS. The most common mass in the epidural space is a disk
herniation. Most disk herniations are located in the ventral/ventrolateral epidural
space and remain in anatomic continuity with their parent disk, a key clue to
the diagnosis. The disk herniation, especially when acute/subacute, may not
have the same signal characteristics as the parent disk, which can cause
confusion. Less commonly encountered locations for disk herniations that can
compress neural tissue include the lateral/dorsal epidural space and the
intradural compartment (FIGURE 10-4).6 A highly prevalent finding for dorsal
disk herniations is that the abnormal epidural soft tissue still typically maintains
continuity with the parent disk in the ventrolateral epidural space, wrapping
around the thecal sac dorsally.7 Because of a lack of familiarity with this less
commonly encountered location of disk herniation and given the often-acute
clinical presentation with cauda equina syndrome, such dorsal herniations are
frequently initially misdiagnosed as epidural hematomas, epidural abscesses, or
synovial cysts. Misdiagnosis occurs in part because any of these lesions, including
disk herniations, can and often do demonstrate peripheral enhancement.
Peripheral enhancement is expected for disk herniations because of the
surrounding inflammatory/fibrotic reaction. It is also the rule for synovial cysts
and epidural abscesses (FIGURE 10-4). An additional uncommon location for disk
herniations is the intradural compartment (FIGURE 10-4). In the lumbar spine,
occasionally the dorsal edge of an intradural disk herniation may demonstrate a
sharp posterior edge, the so-called hawk-beak sign.8 Although disk herniations in
the thoracic spine are commonly asymptomatic, they have a propensity to
calcify, especially when giant. Such giant calcified disk herniations have a
tendency to erode the dura and be intradural.6 The calcified nature of a disk
herniation is most easily appreciated on CT; on MRI, this often manifests as very
low signal on T1-weighted and T2-weighted images. A clue to the diagnosis of
any disk herniation is air within the lesion (ie, the vacuum phenomenon) due to
accumulation of nitrogen gas.
EXTRADURAL HEMATOMAS AND ABSCESSES. Extradural hematomas and abscesses ● The heterogeneous
internal signal
are more commonly epidural than subdural. A history of trauma, spinal
characteristics of synovial
procedure/surgery, or anticoagulated/coagulopathic state can be a helpful clue to cysts are wide-ranging and
the diagnosis of extradural hematoma. The signal characteristics of spinal include T1 and T2
hematomas can be quite variable because of the inherently complex signal of hypointensity or
blood products and the varying possible and potentially mixed age contents of hyperintensity or a
combination.
such collections.10
Confident diagnosis of an extradural abscess can be aided by symptoms, signs, ● MRI of extradural
and laboratory markers of infection. MRI of extradural abscesses may show abscesses may show
associated adjacent inflammatory changes, including in the paraspinal soft associated adjacent
inflammatory changes,
tissues and bones, or frank findings of spondylodiskitis (FIGURE 10-4).11 The including in the paraspinal
inflammatory changes, phlegmon, or abscess are often best visualized on images soft tissues and bones, or
with fat suppression, which are critical sequences in this setting. On T2-weighted frank findings of
fat-suppressed images, hyperintensity is expected, and on postgadolinium spondylodiskitis.
T1-weighted fat-suppressed images, enhancement will be present. Extradural
● On CT, ossification of the
abscesses should enhance peripherally, with central fluidlike T2-hyperintense posterior longitudinal
and T1-hypointense contents (FIGURE 10-4). ligament is readily
identifiable as flowing
ossification along the
OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT. Ossification of the
expected course of the
posterior longitudinal ligament may cause compression of the spinal cord, alone posterior longitudinal
or in combination with spondylotic changes (FIGURE 10-5). It is implicated in up ligament in and along the
to one-fourth of cases of cervical myelopathy and is most common in the cervical midline at the ventral aspect
spine.12 On CT, ossification of the posterior longitudinal ligament is readily of the spinal canal.
CONTINUUMJOURNAL.COM 233
Enhancement findings
Disease postgadolinium Other key helpful MRI findings
Extradural
Cervical spondylotic (compressive) Pancakelike on sagittal, at/just Spondylotic changes causing cord
(FIGURES 10-5G through 10-5R) below maximal stenosis, within compression, which may be
larger region of increased T2 greatest in extension
signal; often peripheral on axial,
sparing gray matter
Disk herniation (FIGURES 10-4A through 10-4Q); Peripheral enhancement Disk herniation: usually ventral
synovial cyst (FIGURES 10-4R through 10-4W); expected for these lesions (acute epidural but can be lateral/dorsal,
epidural or subdural hematoma hematoma usually does not rarely intradural
or abscess (FIGURES 10-4X through 10-4AA) enhance)
Synovial cyst: may have complex
internal signal with or without
T2-hypointense rim
Abscess: usually has associated
inflammatory changes elsewhere,
such as in bone/disks
(osteomyelitis-diskitis) and
paraspinal regions
Hirayama disease (FIGURES 10-7G through 10-7R) Robust enhancement of the Loss of cervical kyphosis, loss of
enlarged dorsal epidural space on dural attachment, asymmetric
flexion cord atrophy/flattening, focal
myelomalacia
Intrinsic: neoplastic-primary
Ependymoma (FIGURES 10-11A through 10-11I) Typically present, well-defined Central location, relatively well
defined, cystic change, cap sign
(polar hemorrhage)
Astrocytoma (FIGURES 10-11J through 10-11P) Usually present but may not be; Eccentric location, relatively
may be patchy/ill-defined/subtle poorly defined, can be holocord
Hemangioblastoma (FIGURES 10-11Q through 10-11V) Avidly enhancing nodule on cord With or without cyst, with
surface, often dorsally significant cord edema/syrinx for
lesion size; if von Hippel-Lindau
disease, often multiple, with or
without lesions in posterior
fossa, with or without cysts/
neoplasms in pancreas, kidneys,
adrenal glands
Intrinsic: neoplastic-secondary
Metastasis (FIGURES 10-11W through 10-11BB) Rim, flame, and/or central Significant cord edema for lesion
dot signs size, evidence for other metastatic
disease with or without
primary tumor
Enhancement findings
Disease postgadolinium Other key helpful MRI findings
Intrinsic: demyelinating/immune-mediated/
inflammatory
Multiple sclerosis Enhancing lesion(s) when acute/ Small, peripheral, multiple; usually
active; ill-defined, solid/nodular, no cord enlargement
ring, or partial ring
Neurosarcoidosis (FIGURES 10-12U through 10-12EE) Along dorsal subpial/pial aspect With or without hilar/mediastinal
of a long-segment myelopathy; adenopathy; with or without
with or without extension into meningeal more than osseous
central canal (trident sign); may lesions
persist over months
Paraneoplastic (FIGURES 10-13I through 10-13N) Tract-specific when present Long segment; evidence for
primary tumor with or without
metastatic disease
Intrinsic: vascular
Infarct (FIGURES 10-14A through 10-14L) Anterior cord/central gray if Restricted diffusion when acute
anterior spinal artery infarct;
associated bone infarcts typically
enhance, and cauda equina may
enhance (both usually in subacute
phase)
Dural arteriovenous fistula Vascular-type along conus/cord T2-hypointense flow voids along
(FIGURES 10-14M through 10-14V) surface (serpiginous, conus/cord surface; parenchymal
corresponding to T2-hypointense T2-hyperintense signal sparing
flow voids); parenchyma may periphery
enhance, including missing
piece sign
IgG = immunoglobulin G.
a
Many other causes of myelopathy can enhance, especially if in an acute/active phase, but variably so and without such relatively specific patterns.
CONTINUUMJOURNAL.COM 235
FIGURE 10-3
Causes of nontraumatic myelopathy identifiable on imaging, based on location and category.
ADEM = acute disseminated encephalomyelitis; AIDP = acute inflammatory demyelinating
polyradiculoneuropathy; ALS = amyotrophic lateral sclerosis; AQP4 = aquaporin-4; AVF = arteriovenous
fistula; AVM = arteriovenous malformation; CIDP = chronic inflammatory demyelinating
polyradiculoneuropathy; CSF = cerebrospinal fluid; MOG = myelin oligodendrocyte glycoprotein;
MRI = magnetic resonance imaging; NMOSD = neuromyelitis optica spectrum disorder; OPLL = ossification
of the posterior longitudinal ligament.
a
Discussed in detail and/or illustrated specifically in this article.
CONTINUUMJOURNAL.COM 237
FIGURE 10-5
Extradural benign compressive cervical and thoracic myelopathy. Ossification of the
posterior longitudinal ligament (A through F) can cause significant spinal cord compression
even in the absence of appreciable spinal cord T2 hyperintensity (A, C, D). It can have
variable signal characteristics, but most commonly mature bone signals hypointense on
T2-weighted and T1-weighted images (A and C; B, respectively). Because of the osseous
nature, the ossified ligament often appears more prominent on gradient recalled echo (GRE)
imaging (D). CT can more definitely characterize this entity (E, F). The ossification involves not
only disk space but also vertebral body levels, a finding that distinguishes it from
disk-osteophyte complexes at interspace levels. Cervical spondylotic (compressive)
myelopathy (G through J, K through N, O through R, three different MRI dates in the same
patient) can present with characteristic imaging findings but may be confused with
inflammatory/neoplastic myelopathy. On the initial sagittal T2-weighted image of this
patient, the spinal cord compression is related to both anterior (G, blue arrow) and posterior
(G, white arrow) spondylotic changes (ie, a disk osteophyte complex and ligamentum flavum
redundancy, respectively). T2 hyperintensity of the spinal cord is longitudinal, spindle-shaped,
and mildly expansile (G, H). A characteristic enhancement pattern features peripheral
distribution (white matter involvement, sparing gray matter) in the axial plane (I) and
pancakelike morphology at/just caudal to the cord compression in the sagittal plane (J, white
arrow). After an anterior decompressive surgery, the findings persisted (K through N), as they
may for months to even years, with the spinal cord mildly expanding into the more
capacious canal. The patient underwent posterior decompressive surgery, and the characteristic
findings again persisted (O through R), which is common. Thoracic spondylotic (compressive)
myelopathy (S through V) occurs with lower frequency than its cervical counterpart; most
spondylotic changes encountered in the thoracic spinal canal are asymptomatic. Findings can be
similar, including cord compression from anteriorly or posteriorly (S, blue arrow; S, U, V, white
arrows, respectively) and focal enhancement (T, white arrow).
CONTINUUMJOURNAL.COM 239
FIGURE 10-6
Lumbar spinal stenosis. Multilevel multifactorial lumbar spinal stenosis (A through N, Q
through V, W through DD, three different patients) is common in patients who present with
neurogenic intermittent claudication. In the first patient (A through N), unenhanced CT (A
through D) demonstrates spinal stenosis, although MRI (E through N) displays the contributing
findings and degree of narrowing to better advantage. In this patient, multifactorial spinal
canal narrowing is mild at L2-L3 (B, H), moderate at L3-L4 (C, J), and advanced at L4-L5
(D through G, K through M). The stenosis has both ventral (A through F, K, white arrows) and
dorsal components (A, C through E, black arrows; J through K, blue arrows). Ventrally, disk
bulges contribute at L2-L3 through L4-L5, and at the latter, low-grade anterolisthesis also
contributes. At the advanced L4-L5 stenosis, the CSF is nearly completely effaced (D, K,
arrowheads) and the cauda equina focally enhances (G, M, white arrows). Because of the
high-grade stenosis, the cauda equina nerve roots are redundant/tortuous in the sagittal
plane (E, blue arrows) and abnormally ventrally located at several levels in the axial plane
(sedimentation sign; I at L3, N at L5, blue arrows); a normal comparison at these levels is
provided (O, P), demonstrating normally posteriorly dependently layering nerve roots. A
companion case of multilevel, multifactorial lumbar stenosis (Q through V) demonstrates
moderate spinal stenosis at L2-L3 and advanced stenosis at L3-L4 (Q, white arrows). At L2-L3,
L3, and L4-L5, the nerve roots are located more ventrally than normal (S, T, V, blue arrows,
respectively). At the high-grade L3-L4 stenosis (U), one cannot evaluate for the
sedimentation sign. A second companion case of multilevel, multifactorial lumbar spinal
stenosis (W through DD) also demonstrates cauda equina redundancy/tortuosity (W, blue
arrows) and cauda equina enhancement greatest at the highest degree of narrowing (CC, DD,
blue arrows). A developmentally narrow spinal canal contributes to the spinal stenosis.
Superimposed spondylotic changes result in spinal stenosis that is moderate at L2-L3 (Y, blue
arrow) and advanced at L3-L4 and L4 vertebral body levels (Z, AA, blue arrows, respectively).
A large disk extrusion posterior to the L4 vertebral body primarily contributes to the spinal
stenosis (W, AA through DD, white arrows); this peripherally enhances as can be expected
(refer to FIGURE 10-4). Neoplastic spinal stenosis (EE through II) can also occur, especially with
neoplastic involvement of the ventral epidural space (FF through II, white arrows), which in
this patient contributes to relatively advanced spinal canal narrowing (EE, blue arrow). On
axial images, the bilateral ventral epidural involvement with preservation of the midline septum
(draped curtain sign, GG through II, white arrows) suggests an indolent process such as
malignancy over a more rapidly aggressive process such as infection. In this patient, enhancing
tumor involves the basivertebral vein (FF, II, blue arrows) and paraspinal metastatic disease is
evident in the right retroperitoneal musculature (GG through II, black arrows).
CONTINUUMJOURNAL.COM 241
FIGURE 10-7
Dynamic lumbar and cervical spinal stenosis. Dynamic lumbar spinal stenosis (A through F) is
not optimally imaged in routine supine MRI or CT/CT myelography. In this patient, such
standard recumbent imaging demonstrates, at most, moderate spinal stenosis at L4-L5
(A, B, white arrows, MRI; C, D, CT myelography). A small right synovial cyst (B) contributes to
the spinal canal narrowing. When the patient is imaged in the standing position of axial
loading using cone-beam CT myelography, the degree of stenosis changes to advanced (E, F,
white arrows) and the cauda equina becomes redundant/tortuous (F, blue arrow). Hirayama
disease (G through K; L, M; N through R, three different patients) is a dynamic flexion
myelopathy. On neutral images, loss of normal cervical lordosis (G) and loss of attachment of
the dura to the lamina can be present; the latter best seen on axial images (H through I, white
arrows). This loss of dural attachment on axial images may become more prominent in flexion
(J, white arrow), and the dorsal epidural space can be seen to expand, especially on sagittal
images in flexion (K, R) compared to neutral positioning (G, white arrow). This results in
dynamic spinal canal narrowing and mass effect on the cord. In the first companion case
(Patient 2) (L, M), the dorsal epidural space becomes prominent in flexion (L, white arrow;
neutral not shown) and accompanying bilateral myelomalacia of the cord is seen (M, white
arrows). A second companion case (Patient 3) (N through R) again demonstrates loss of
cervical lordosis (N, O) and loss of dural attachment to the lamina axially (P, white arrow).
Postcontrast and in flexion, compared to images in neutral positioning (N through P), the
dorsal epidural space significantly enlarges, acts with mass effect on the spinal cord, and
enhances robustly (Q, R, white arrows).
Intradural-Extramedullary Compartment
A multitude of disease processes can occur in the intradural-extramedullary
compartment of the spinal canal.
MENINGIOMAS. Spinal meningiomas are most common in the thoracic spine and
most often lateral to the cord.27 Characteristic, although not entirely specific,
CONTINUUMJOURNAL.COM 243
FIGURE 10-8
Intradural-extramedullary disease. Meningiomas (A through F) may be relatively T2
hypointense (B, E) because of their high cellularity or calcification. They tend to enhance
avidly postcontrast (C, F) and may have adjacent enhancing dural tails (C, white arrows). Axial
images demonstrate the characteristic features of intradural-extramedullary masses; the
ipsilateral subarachnoid space is expanded immediately above and below the lesion (D, F,
white arrows, respectively), with displacement of the spinal cord contralaterally (D through
F, blue arrows). At the level of the lesion, the spinal cord is significantly compressed (E, blue
arrow), whereas the T2-hypointense lesion fills the adjacent subarachnoid space. Benign
nerve sheath tumors (schwannomas [G through I] and neurofibromas [J through M]) can be
difficult to differentiate. This cervical schwannoma enhances avidly (G, H), extends through
and expands the neural foramen, fills the subarachnoid space, and displaces the spinal cord
contralaterally (I). Neurofibromas may similarly extend through and expand neural foramina,
as is true for many lesions in this patient with neurofibromatosis type 1 (eg, J, white arrow).
These tumors may characteristically be centrally relatively T2 hypointense and peripherally
relatively T2 hyperintense (target sign; L, white arrow). Myxopapillary ependymomas (N, O)
classically present as well-defined, avidly enhancing oval masses of the tip of the conus,
proximal cauda equina, or filum terminale. Although focal intradural-extramedullary lesions
are typically benign, low grade, or slow growing (such as meningiomas, nerve sheath tumors,
and myxopapillary ependymomas), intradural-extramedullary metastases (P through R) can
occur in this compartment. The metastasis in this patient causes extensive T2 hyperintensity
in the spinal cord (P, Q; Q, blue arrow), with associated focal cord enhancement (R, blue arrow).
The lesion is heterogeneously signaling and enhancing and occupies the subarachnoid space
and neural foramen (Q, R, white arrows). Multifocal leptomeningeal disease (S through U)
presenting as multifocal smooth or nodular enhancement is not diagnostically specific and
can be benign or malignant. Among benign causes, neurosarcoidosis is in the differential
diagnosis. This patient with neurosarcoidosis has both smooth pial enhancement along the
conus and multifocal nodular enhancement along the cauda equina (S through U, white arrows).
NERVE SHEATH TUMORS. Benign nerve sheath tumors (schwannomas and ● Myxopapillary
ependymomas are usually
neurofibromas) are well-circumscribed neoplasms that can be difficult to relatively large, oval or
differentiate by imaging. Schwannomas are more prevalent than neurofibromas. sausage shaped, well
When located at least partially in the neural foramen, dumbbell morphology is a circumscribed, T2
characteristic feature (FIGURE 10-8). Schwannomas have a higher propensity to hyperintense, and avidly
enhancing.
demonstrate cystic change or intratumoral hemorrhage than either
neurofibromas or meningiomas. A classic appearance of a neurofibroma is a
peripherally T2-hyperintense lesion that is relatively T2 hypointense centrally,
the so-called target sign (FIGURE 10-8). Multiple schwannomas can be seen in
neurofibromatosis type 2 or, less commonly, schwannomatosis, whereas
multiple neurofibromas can occur in neurofibromatosis type 1. When an
isolated, incidental, small enhancing nodule of the cauda equina nerve roots is
encountered, the most likely consideration is a nerve sheath tumor. Malignant
peripheral nerve sheath tumors are rare. Although these tumors often have a
heterogeneous appearance, they may mimic the appearance of their benign
counterparts, particularly since they too are usually well-circumscribed.27
CONTINUUMJOURNAL.COM 245
FIGURE 10-9
Arachnoiditis and inflammatory demyelinating polyneuropathies. Arachnoiditis (A through P,
three different patients) can have varying imaging findings and causes. It is often idiopathic
(A through D) or can result from specific irritants within the thecal sac, such as stem cells
(E through J) or infections (K through P). Thickening or nodularity of cauda equina nerve roots
may be evident, best seen on T2-weighted images (A, B, E, H, white arrows). The nerve roots
are commonly nonanatomically distributed (B through D, H) and may be centrally clumped
(C, H) or dispersed peripherally (empty thecal sac sign, D, white arrows). Abnormal
enhancement is often only mild if present (F, J, white arrows). Adhesive arachnoiditis
(K through P) such as that caused by infections (including tuberculosis) may cause bizarre
appearances related to adhesions and loculations in the thecal sac, altered CSF dynamics,
and effects on the spinal cord. The spinal cord may be displaced (M, N, blue arrows) and may
contain T2 hyperintensity or a syrinx (K, O, white arrows). Thickening and enhancement of the
meninges, including the dura, may be observed (L, P, white arrows). Acute inflammatory
demyelinating polyradiculoneuropathy (AIDP) (Q through S) and chronic inflammatory
demyelinating polyradiculoneuropathy (CIDP) (T through V) are considerations when
thickened (Q, U, white arrows) or enhancing (R through T, V, white arrows) nerve roots are
encountered but the distribution is anatomic. AIDP has a predilection to involve the ventral
nerve roots (Q through S, white arrows).
Arachnoid cysts. Arachnoid cysts can occur in other compartments of the spinal
canal but are usually intradural-extramedullary. The most common location for
an arachnoid cyst is dorsal to the thoracic cord; although these lesions tend to be
well circumscribed, their wall is often imperceptible, especially on MRI
(FIGURE 10-10). As a result, and since their signal characteristics are generally
isointense to CSF (fluid-type high T2 signal, low T1 signal), they may be difficult
CONTINUUMJOURNAL.COM 247
FIGURE 10-10
Dorsal cord flattening: spectrum of disease. Arachnoid cysts (A through H), arachnoid webs
(I through N), and idiopathic spinal cord herniation (O through Q, R through W, two different
patients) can all cause flattening of the dorsal aspect of the spinal cord and apparent
expansion of the dorsal subarachnoid space. Spinal cord T2 hyperintensity or syrinx
formation can be present with any of these entities, such as the syrinx seen in the case of
arachnoid cyst (A, B, blue arrows). On MRI, expansion of the dorsal subarachnoid space
(A through C, white arrows) is associated with ventral displacement and dorsal flattening of
the cord, well seen axially (C). On fluoroscopic myelographic visualization before CT
myelography, a filling defect is observed (D, white arrows) consistent with an arachnoid cyst;
by the time the patient has been transferred to CT, the arachnoid cyst has filled with contrast
(E through G, white arrows). The walls of the cyst are not visualized on either MRI or CT
myelography. Spinal cord compression can be observed, just as on MRI (G, blue arrow).
Above this level of maximal mass effect, the spinal cord is ventrally displaced and atrophic
(F, blue arrow), whereas below it the caliber is normal (H). Arachnoid webs classically present
with a sharply marginated dorsal cord contour irregularity; this is sometimes better seen on CT
myelography than MRI (scalpel sign; M, N, compared to J, white arrows). As with other causes
of myelopathic signal abnormality, spinal cord T2 hyperintensity (J through L, blue arrows) is
seen to slightly better advantage on short tau inversion recovery (STIR) than conventional
T2-weighted images (K compared to J, blue arrows). The arachnoid web itself is not visualized.
Idiopathic spinal cord herniation has similar imaging findings to arachnoid cysts and webs,
including dorsal cord contour irregularity and expansion of the dorsal subarachnoid space
(O through Q, R through W, white arrows, two different patients) as well as spinal cord T2
hyperintensity (O, blue arrow). Extreme ventral cord positioning on sagittal images with loss of
subarachnoid space between the cord and posterior aspect of the vertebral bodies/disk can
be a clue (O, R) and is best evaluated on axial images, which can better show the herniation of
the spinal cord through the dura (P through Q; S). Prominent ventral extradural fluid is an
additional clue (P, blue arrows; Q, black arrow; S, U, W, blue arrows). Thin-section heavily
T2-weighted three-dimensional steady state sequences can be useful to depict the focal
ventral transdural cord herniation in high resolution (S).
Idiopathic spinal cord herniation. The spinal cord may herniate through a defect in
the dura into the extradural compartment (FIGURE 10-10).32 Such herniation
typically occurs ventrally in the thoracic spine (usually T4 through T7) and in
many, but not all, cases at a disk space level.33 In some cases, diskal calcification
or osteophytes at the disk space level probably erode the dura and result in the
cord herniation. Making the diagnosis is important because surgical treatment
may allow reversal or at least stabilization of neurologic deficits. On MRI or CT
myelography, the characteristic findings of idiopathic spinal cord herniation
include ventral displacement of a short segment of cord that is focally
distorted/kinked, with the subarachnoid space being lost ventrally and expanded
dorsally (FIGURE 10-10). A ventral extradural CSF collection (leak) may be
present. An arachnoid cyst may also be coexistent. Differentiating between a
dorsal arachnoid cyst that displaces the cord ventrally and ventral cord
herniation with or without an arachnoid cyst can be challenging. Just as is the
case for diagnosis of arachnoid cysts and webs, thin-section heavily T2-weighted
images on MRI can be helpful (FIGURE 10-10). CT myelography is often
required, but in subtle/challenging cases, especially when an arachnoid cyst is
coexistent, confident and correct diagnosis may be elusive until surgery.
CONTINUUMJOURNAL.COM 249
FIGURE 10-11
Intramedullary neoplastic myelopathy. Ependymomas (A through I) are expansile neoplasms
that may demonstrate blood products, including as T1- and T2-hypointense regions at the
margin of the tumor (cap sign; A, C, F, white arrows); this is related to hemosiderin content,
which blooms or becomes more pronounced on gradient recalled echo (GRE) images
(B, white arrow). Blood products may also layer dependently as blood-fluid levels (A, E, blue
arrows). One clue for ependymoma over astrocytoma is the centrally located nature of the
tumor (D). Ependymomas tend to enhance (H, I, white arrows). Astrocytomas (J through P)
tend to be eccentrically located, which may be most evident at the margins of the expansile
neoplasm (L, N, white arrows, at slices along the superior and inferior aspects of the
tumor, compared to M at a slice in the midportion). Enhancement may be absent or minimal
(O, P). Hemangioblastomas (Q through T, U and V, two different patients) typically have a
markedly different appearance compared to ependymomas and astrocytomas. The lesions
are often located on the dorsal cord surface, avidly enhancing, and small (R through T, white
arrows), especially with regard to the extensive spinal cord T2 hyperintensity, syrinx, or cysts
they produce (Q, R). Lesions can be multiple (V, white arrows) and may have significant
associated vascularity, well seen as hypointense flow voids in the CSF on T2-weighted
images (U, white arrows). Like hemangioblastomas, intramedullary spinal cord metastases
(W through BB) can produce significant cord T2 hyperintensity for neoplasm size
(W compared to Y). The lesions may demonstrate one or more of three characteristic
enhancement features: a rim of more intense enhancement around the enhancing mass (rim
sign; Y, BB, blue arrows); ill-defined flame-shaped enhancement at the superior or inferior, or
both, margins of the lesion (flame sign; Y, white arrows); and a punctate focus of
enhancement in/near the center of the lesion (central dot sign; BB, arrowhead). On
fludeoxyglucose positron emission tomography (FDG-PET), spinal cord metastases are
typically FDG avid (Z, AA); just as on MRI, other evidence for metastatic disease may be
present (Z, white arrow, a metastatic paratracheal lymph node from a lung carcinoma).
CONTINUUMJOURNAL.COM 251
FIGURE 10-12
Longitudinally extensive intramedullary inflammatory/demyelinating myelitis. Long-segment
multiple sclerosis is not common, but confluent multiple sclerosis may result from
innumerable adjacent T2-hyperintense lesions (A, B, D through G), best seen sagittally on
short tau inversion recovery (STIR) (B) and axially on gradient recalled echo images (GRE) (F)
compared to traditional T2-weighted images (A, E). In the chronic phase, the lesions do not
enhance (C) and atrophy may be evident (A, G, white arrows). Aquaporin-4-IgG neuromyelitis
optica spectrum disorder (NMOSD) (H through M; N through R; S and T, three different
patients) characteristically presents as a longitudinally extensive myelitis (H, N, S). Imaging
features with relative specificity include small foci on axial images that are at least as T2
hyperintense as CSF (bright spotty lesions; J through M, white arrows) and ring/partial ring
enhancement on sagittal or axial images (I, Q, R, white arrows). Any myelopathy can cause
atrophy in the chronic phase, which can be short or long segment (S, T). Neurosarcoidosis
(U through AA, BB through EE, two different patients) is also usually long segment (U, BB). A
characteristic enhancement pattern is broad-based involvement of the dorsal subpial/pial
aspect of the cord (W, X, Z, AA, CC through EE, white arrows), which may also involve the
central canal of the cord (DD, EE, blue arrows) as best seen on axial images; this concomitant
dorsal subpial/pial and central canal enhancement of the cord on axial images is termed the
trident sign. When the thoracic spine is imaged, cord T2 hyperintensity/enhancement (V,
white arrow) may not be the only critical observation; mediastinal/hilar adenopathy can be
a clue to the diagnosis (V, blue arrow). The spinal cord findings typically are responsive to
steroids, but even when improving they can persist for months after treatment has been
initiated (Z, AA compared to W, X, white arrows). Myelin oligodendrocyte glycoprotein
(MOG)-IgG myelitis (FF through KK) similarly tends to be long segment and commonly involves
the thoracolumbar region (FF), often with central/gray matter selective involvement (HH, II,
white arrows). Enhancement may be absent (JJ) or minimal (KK, white arrow), a clue to the
diagnosis.
CONTINUUMJOURNAL.COM 253
FIGURE 10-13
Intramedullary nontumoral inflammatory myelopathies. Viral myelitis (A through G) may
result in long-segment T2 hyperintensity of the central gray matter (A through E), which can
enhance in the acute phase (G, H, arrows). Paraneoplastic myelopathy (I through N) may
cause long-segment T2 hyperintensity (I, J) and enhancement (L through N, arrows). A clue
can be the tract-specific nature of the signal abnormality or of the enhancement, as is
evident in this case of lateral column enhancement bilaterally (L, M, arrows). Subacute
combined degeneration (O through T) characteristically causes T2 hyperintensity of the
dorsal columns (O through Q, arrows). The morphology on axial images may be that of an
inverted V or inverted rabbit ears (P, arrows). If acute-subacute, the process may be mildly
expansile (O), and enhancement can occur (S, T, arrows). Radiation-induced myelopathy
(U through X) can present with nonspecific spinal cord T2 hyperintensity (U, V), which can be
confluent or patchy (U), may involve the central cord (V), and may enhance (X, Y, arrows).
A key clue is the radiation-induced inherent (precontrast) marrow T1 hyperintensity of the
regional spinal column (eg, W, arrow). This manifests as very hypointense signal on
fat-suppressed T2-weighted (U) or T1-weighted postcontrast (X) images. The patient shown
also has multifocal T1-hypointense enhancing osseous metastases.
CONTINUUMJOURNAL.COM 255
CONTINUUMJOURNAL.COM 257
FIGURE 10-14
Vascular myelopathies. Spinal cord infarct (A through G, I through L, two different patients)
may be MRI negative, especially on conventional T2-weighted images shortly after symptom
onset (A). In the later acute and early subacute phase, involvement of the thoracic cord/
conus by T2 hyperintensity is most common (B through D, I, white arrows). An anterior spinal
artery infarct commonly affects the gray matter preferentially, with an H-shaped or
butterfly-shaped pattern on axial images (C, white arrows). Markedly hyperintense signal on
diffusion-weighted imaging matched by hypointense signal on apparent diffusion
coefficient (restricted diffusion, E, F, white arrows) is a key clue for an acute infarct. The
infarct may also demonstrate gray matter enhancement in the acute-subacute phase (G, H, J,
white arrows). Two helpful ancillary findings that may be present, especially in the subacute
phase, are vertebral body infarcts (I, J, blue arrows) and cauda equina enhancement (J, K,
arrowheads). Spinal dural arteriovenous fistula (M through V) is an often-missed diagnosis.
Key clues are parenchymal T2 hyperintensity, especially of the distal cord/conus sagittally
on lumbar spine MRI (M, P, blue arrows) and T2-hypointense flow voids (M, white arrows) or
vascular enhancement (R, white arrows) along the cord/conus, related to increased pial
vascularity. These subtle findings were not detected on this MRI, with the spinal stenosis at
L4-L5 (M through O) being a major distracting feature. Six months after presentation, with the
patient now having undergone an L4-L5 laminectomy (Q), a lumbar spine and myelopathy
protocol thoracic spine MRI were performed. The spinal cord T2 hyperintensity (P, blue
arrow), surface flow voids (P, white arrows), and vascular enhancement (R, white arrows)
were identified. The parenchymal T2 hyperintensity is well seen on sagittal short tau
inversion recovery (STIR) images (T, blue arrow) and involves the central aspects of the cord
on axial images (S, blue arrow). Magnetic resonance angiography (MRA) shows the abnormal
vascularity (U, white arrows) and suggests an origin for the arteriovenous malformation at L4
(U, blue arrow), confirmed on conventional angiography upon injection of a common L4
segmental arterial trunk (V, blue arrow). Cavernous malformations (cavernomas)
(W through CC) usually have heterogeneous signal intensity on both T2-weighted (W, X) and
T1-weighted images (BB). This heterogeneity can include inherent T1 hyperintensity due to
subacute blood products (BB). The lesions may present with partial or complete
T2-hypointense rims (W, X, blue arrows). Even more prevalent is relatively linear extension of
typically T2-hypointense and often also T1-hypointense blood products in the spinal cord
cranially or caudally away from the lesion (W, Y through AA, white arrows). Enhancement of
cavernous malformations is usually either lacking (CC) or minimal, when allowing for inherent
T1 hyperintensity.
CONTINUUMJOURNAL.COM 259
KEY POINT popcorn-type morphology, with well-circumscribed but lobulated margins and
a reticulated core of heterogeneous T1 and T2 signal abnormality. If subacute
● Adjacent hemorrhage in
the spinal cord extending
hemorrhage is present, T1 hyperintensity is expected (FIGURE 10-14). Classically,
craniocaudally away from a a T2-hypointense rim representing hemosiderin may surround the lesion
cavernous malformation is (FIGURE 10-14). Sequences sensitive to hemosiderin, such as GRE, will
relatively prevalent; a 2020 demonstrate pronounced hypointensity (blooming) of the lesion. Spinal cord
retrospective series
edema may accompany a cavernous malformation if it has recently bled.
demonstrated that this
finding is more common than Adjacent hemorrhage in the spinal cord extending craniocaudally away from a
some classic features of cavernous malformation is relatively prevalent; a 2020 retrospective series
these lesions, such as demonstrated that this finding is more common than some of the
popcorn morphology and
aforementioned classic features of these lesions, such as popcorn morphology
T2-hypointense rim.
and T2-hypointense rim (FIGURE 10-14).77 Lesional enhancement is typically
either not present or only minimal in degree. The differential diagnosis for a
hemorrhagic cord lesion also includes a neoplasm (especially hemangioblastoma
or ependymoma) and posttraumatic contusion/hematoma.
CONCLUSION
A rational imaging approach to myelopathy should be employed. MRI is typically
first line, and a protocol tailored to the indication is advised. Abnormal T2
hyperintensity of the spinal cord has a broad differential diagnosis. Imaging
features should be sought that can help arrive at specific diagnoses or a narrowed
list of differential considerations. The process of narrowing the differential
diagnosis starts with placing the lesion into one of three compartments:
extradural, intradural-extramedullary, and intramedullary. Imaging features of
the lesion itself and of the adjacent spinal column, paraspinal soft tissues, and
visualized nonspinal regions must be evaluated. Both precontrast and
postcontrast MRI can hold clues to the diagnosis. Specific contrast enhancement
patterns can be helpful in correctly identifying individual disease processes. CT
myelography can help evaluate lesions of the arachnoid and dura, particularly the
spectrum of disease that includes arachnoid cyst, arachnoid web, and idiopathic
cord herniation. For some conditions that have a dynamic positional component,
flexion MRI or upright MRI/CT myelography can be helpful.
REFERENCES
1 Zalewski NL, Flanagan EP, Keegan BM. Evaluation 4 Vargas MI, Gariani J, Sztajzel R, et al. Spinal cord
of idiopathic transverse myelitis revealing ischemia: practical imaging tips, pearls, and
specific myelopathy diagnoses. Neurology 2018; pitfalls. AJNR Am J Neuroradiol 2015;36(5):
90(2):e96-e102. doi:10.1212/ 825-830. doi:10.3174/ajnr.A4118
WNL.0000000000004796
5 Hardy TA. Spinal cord anatomy and localization.
2 Lee MJ, Aronberg R, Manganaro MS, et al. Continuum (Minneap Minn) 2021;27(1, Spinal Cord
Diagnostic approach to intrinsic abnormality of Disorders):12-29.
spinal cord signal intensity. Radiographics 2019;
6 Diehn FE, Maus TP, Morris JM, et al. Uncommon
39(6):1824-1839. doi:10.1148/rg.2019190021
manifestations of intervertebral disk pathologic
3 Flanagan EP, Hunt CH, Lowe V, et al. conditions. Radiographics 2016;36(3):801-823.
[(18)F]-fluorodeoxyglucose-positron emission doi:10.1148/rg.2016150223
tomography in patients with active myelopathy.
Mayo Clin Proc 2013;88(11):1204-1212. doi:10.1016/j.
mayocp.2013.07.019
CONTINUUMJOURNAL.COM 261
67 Laur O, Nandu H, Titelbaum DS, et al. 76 Goyal A, Rinaldo L, Alkhataybeh R, et al. Clinical
Nontraumatic spinal cord compression: MRI presentation, natural history and outcomes of
primer for emergency department radiologists. intramedullary spinal cord cavernous
Radiographics 2019;39(6):1862-1880. malformations. J Neurol Neurosurg Psychiatry
doi:10.1148/rg.2019190024 2019;90(6):695-703. doi:10.1136/jnnp-2018-319553
68 Diehn FE, Hunt CH, Lehman VT, et al. Vertebral 77 Panda A, Diehn FE, Kim DK, et al. Spinal cord
body infarct and ventral cauda equina cavernous malformations: MRI commonly shows
enhancement: two confirmatory findings of adjacent intramedullary hemorrhage.
acute spinal cord infarct. J Neuroimaging 2015; J Neuroimaging 2020;30(5):690-696.
25(1):133-135. doi:10.1111/jon.12058 doi:10.1111/jon.12738
CONTINUUMJOURNAL.COM 263
Spinal Cord Anatomy
C O N T I N UU M AUDIO
I NT E R V I E W A V AI L A B L E
ONLINE
and Localization
By Todd A. Hardy, PhD, MBBS, FRACP
Downloaded from http://journals.lww.com/continuum by wqLe/H3/oM2vx1Qs5A5qMemKKHLPqE4qkmGNpdheG3ikf1o85ttJSkFL2oTkgOkhMEmawHvsuTTE5xJG2ZjqccytIAhVn2qegy060KLcKJuPZsx5htaYiopRjp2zor2egUzWJAEWYNrC3bBuCzr1RdmqNUpjE4IY on 04/28/2022
ABSTRACT
PURPOSE OF REVIEW: This
article focuses on clinically relevant teaching points
in spinal anatomy and localizing the lesion in myelopathy.
A
todd.hardy@sydney.edu.au. thorough understanding of the anatomy of the spinal cord is of
value to the neurologist because patients can present with an array
RELATIONSHIP DISCLOSURE:
Dr Hardy serves as coeditor of
of symptoms and signs referable to the spinal cord, and the capacity
Advances in Clinical to distinguish cord pathology from brain or peripheral nerve
Neuroscience and Rehabilitation pathology facilitates early diagnosis and avoids unnecessary
and on an advisory board for
Merck & Co, Inc. Dr Hardy has
investigations. Early diagnosis is particularly important because the consequences
received personal compensation of delayed diagnosis of spinal cord pathology can be devastating, with the
for speaking engagements from potential for permanent disability.
Biogen; Merck & Co, Inc; Novartis
AG; Sanofi Genzyme; and Teva The neuroanatomy of the spinal cord is somatotopically and segmentally
Pharmaceutical Industries Ltd organized, with tracts and pathways that transmit sensory information from
and research/grant support from
organs and peripheral receptors to the brain and motor information from the
Novartis AG.
brain to internal and peripheral effector organs. This means that sensory or
UNLABELED USE OF motor deficits in one area of the body can often be deduced to be due to damage
PRODUCTS/INVESTIGATIONAL
USE DISCLOSURE:
in a specific area of the spinal cord.
Dr Hardy reports no disclosure. The localization of lesional pathology is an essential skill for the neurologist
and helps with differential diagnosis and targeted investigation. For the most
© 2021 American Academy part, spinal cord lesions are associated with upper motor neuron signs. The
of Neurology. approach to a patient with a suspected myelopathy involves ascertaining the
12 FEBRUARY 2021
CONTINUUMJOURNAL.COM 13
FIGURE 1-1
The gross anatomy of the spinal cord and adjacent spinal nerve roots.
Reprinted with permission from Moore KL, et al, Wolters Kluwer/Lippincott Williams & Wilkins.1
© 2014 Lippincott Williams & Wilkins.
14 FEBRUARY 2021
● The butterfly-shaped
area of the spinal cord in
cross section is known as
the central gray matter.
FIGURE 1-2
Cross-sectional anatomy of the gray and white matter tracts of the spinal cord.
Reprinted with permission from Cho TA, Continuum (Minneap Minn).3 © 2015 American
Academy of Neurology.
layer between the ventral and dorsal horns is where autonomic preganglionic
cells lie, divided into intermediolateral and intermediomedial groups; the
preganglionic sympathetic neurons are located from C8 through L1. The
preganglionic parasympathetic neurons are located from S2 through S4.
The white matter of the spinal cord surrounds the gray matter and is
composed of myelinated axons. Principal white matter tracts of clinical
significance include the descending motor pathways of the corticospinal
(pyramidal) tract, which run laterally and anteriorly (ventrally) in the cord
throughout its length (FIGURE 1-3).5 These convey somatic motor information
arising from the contralateral cerebral cortex, which decussates in the anterior
medulla just before entering the cervical spinal cord. The descending motor
pathways of the corticospinal tract synapse with the anterior horns cells that
convey motor information via the motor nerve roots and then via somatic
(peripheral) motor neurons to a target muscle. The descending motor pathways
in the cord before the anterior horns are called upper motor neurons, and those of
the anterior horns and somatic motor nerves are called lower motor neurons.
Additional descending motor pathways referred to as extrapyramidal tracts
arise from the brainstem and convey involuntary information important in
different aspects of motor control (FIGURE 1-3).5 Important extrapyramidal tracts
include the rubrospinal tract, which transmits information to the spinal
interneurons to maintain balance; the reticulospinal tract, which transmits
motor information from the reticular formation in the brainstem; the tectospinal
tract, which assists in coordinating head and eye movements; and the
vestibulospinal tract, which transmits balance information to the extremities
from the vestibular system.
Somatosensory information in the form of temperature, pinprick sensation,
and touch is carried anterolaterally in the cord via the spinothalamic (also known
CONTINUUMJOURNAL.COM 15
FIGURE 1-3
Cross-sectional anatomy of the principal white matter tracts of the spinal cord.
Reprinted with permission from Cho TA, Continuum (Minneap Minn).3 © 2015 American
Academy of Neurology.
16 FEBRUARY 2021
FIGURE 1-4
The arterial supply of the spinal cord.
Reprinted with permission from Martirosyan NL, et al, J Neurosurg Spine.7 © 2011 Nicholas Theodore, MD.
CONTINUUMJOURNAL.COM 17
General symptoms
◆ Bilateral greater than unilateral sensory and/or motor symptoms
◆ Bladder, bowel, and/or sexual dysfunction
◆ Stiffness in the legs
◆ Neck and/or back pain in association with neurologic symptoms, particularly if the patient
had preceding trauma or if pain is exacerbated by neck flexion or extension
◆ Lhermitte or Uhthoff phenomenon
◆ Sensory level across the trunk (often more reliable as a symptom than a sign)
◆ Tight band around the trunk or torso
◆ Neurogenic claudication (suggests cauda equina pathology rather than a lower cord lesion)
◆ Sensory ataxia (can also occur with peripheral nervous system disorders)
◆ Dyspnea when lying flat (C3-C5 lesion)
Time course of symptoms
◆ Acute
◇ Trauma
◇ Vascular (infarction, hemorrhage)
◆ Subacute
◇ Demyelination
◇ Space-occupying lesion (eg, epidural abscess)
◆ Chronic or progressive
◇ Primary or secondary progressive multiple sclerosis
◇ Hereditary spastic paraparesis
◇ Motor neuron disease (amyotrophic lateral sclerosis, primary lateral sclerosis)
18 FEBRUARY 2021
CONTINUUMJOURNAL.COM 19
20 FEBRUARY 2021
CONTINUUMJOURNAL.COM 21
(C5, C6) occurs when an attempt to elicit the biceps jerk leads to flexion of the
fingers rather than elbow flexion because of a lesion at the C5 and/or C6 level.
Injury to the C5 and/or C6 nerve root leads to an absent brachioradialis jerk
(ie, no elbow flexion or supination), and spinal cord damage below that level leads
to hyperactivity of the finger flexor (C8) jerks and finger flexion from spread
when the adjacent brachioradialis tendon is struck.19 An inverted biceps reflex can
similarly occur from a lesion at this location when loss of the biceps jerk is
associated with spread to the hyperactive triceps, causing elbow extension rather
than the expected flexion. Cervical spondylosis is the most common etiology of
these inverted reflexes in the upper limb. The presence of a crossed adductor reflex
(contraction of both hip adductors when testing a reflex at the ipsilateral knee)
from either or both lower limbs is considered an upper motor neuron sign.
Superficial abdominal reflexes are cutaneous reflexes that can be tested in
the four quadrants of the abdomen by stroking the skin (eg, with an orange stick)
in the direction of the umbilicus, which causes reflex contractions of the
abdominal wall. The upper abdominal reflexes are supplied by T9 through T11
and the lower reflexes by T11 and T12. The superficial abdominal reflexes are
absent when a spinal cord lesion above the segmental level is present, but their
clinical relevance is limited as it can be difficult to elicit abdominal reflexes in
patients who are obese, have undergone abdominal surgery, are pregnant, or are
elderly, and they may be absent in 15% of healthy individuals.20 The Beevor sign,
which is also nonspecific, refers to upward displacement of the umbilicus when
the neck is flexed on getting up from a reclining position; it occurs because of
relative weakness of the lower abdominal muscles compared to the upper
abdominal muscles.21 The Beevor sign can indicate a thoracic cord lesion between
T10 and T12 but is also seen in fascioscapulohumeral muscular dystrophy.
An extensor plantar response (positive Babinski reflex) is a major clue,
particularly if bilateral, as it suggests involvement of the corticospinal tracts in
the spinal cord, whereas an isolated unilateral extensor plantar response could be
caused by either ipsilateral cord or contralateral brain pathology. The plantar
response is elicited by gently scraping along the lateral border of the foot and
then across the ball of the foot to the middle metatarsophalangeal joint; it is
considered abnormal in adult patients when extension (rather than flexion) of
the great toe is seen, with or without fanning of the other toes.22 It is worth
mentioning that spinal cord pathology can still be present even with a flexor
plantar response, so the sign is more helpful in localizing cord pathology when
extensor rather than when flexor.
A dermatome is the area of skin supplied by the sensory nerve root of a single
spinal segment (FIGURE 1-5).23 Knowledge of the dermatomes can help the
clinician establish the level of a lesion involving sensation in the nervous system.
If a spinal cord lesion is suspected, a dedicated search to try to determine the
spinal sensory level of the lesion should be conducted, including over the anterior
and posterior trunk.10 Anatomic landmarks, such as the position of the nipples
(which correspond to approximately the T4 dermatomal level) and the umbilicus
(which corresponds to the T10 level), can greatly assist the clinician. Light touch,
pinprick, and temperature sensation can all be tested over the trunk anteriorly or
posteriorly. It is worth remembering that the C4 dermatome abuts the T2
dermatome on the chest. A spinal cord lesion affecting the spinothalamic tract(s)
may cause anesthesia below the lesion. The most caudal dermatome of normal
pain and temperature sensation on the trunk (truncal sensory level) occurs two
22 FEBRUARY 2021
CONTINUUMJOURNAL.COM 23
AUTONOMIC DYSREFLEXIA
Autonomic dysreflexia occurs when patients have injury above T6, leading to an
exaggerated sympathetic nervous system response to sensory stimuli (eg, urinary
retention, urinary tract infection, or constipation) below the level of injury. A
reflex response causes a strong sympathetic response, leading to constriction of
splanchnic blood vessels and arterial hypertension. Carotid baroreceptors
trigger descending inhibitory signals to reduce sympathetic tone via the spinal
cord, but a signal cannot reach most sympathetic outflow levels because of the
cord lesion at or above T6. A further compensatory parasympathetic vagal
response tries to reduce blood pressure by lowering the heart rate. In addition to
hypertension and bradycardia, the excessive sympathetic tone below the lesion
results in pale cool extremities with piloerection. Above the lesion, the
parasympathetic activity results in pupil constriction, flushing, and sweating.
Autonomic dysreflexia is managed by treating the offending stimulus.
24 FEBRUARY 2021
CONTINUUMJOURNAL.COM 25
deficiencies and nitrous oxide use, refer to the article “Metabolic and Toxic
Myelopathies” by Natalie Elizabeth Parks, MD,28 in this issue of Continuum.
Brown-Séquard Syndrome
Brown-Séquard syndrome refers to ipsilateral upper motor neuron motor
weakness in one lower limb (and rarely proprioceptive loss) with spinothalamic
pain and temperature loss in the contralateral lower limb. It is caused by a lesion
that involves the lateral half of the cord, affecting the corticospinal,
spinothalamic, and, sometimes, proprioceptive tracts on that side. Patients will
have a truncal sensory level to pain and temperature on the contralateral side of
the lesion two or three segments below the level of the lesion. Causes include MS,
unilateral cord compression due to spinal degenerative disease, or
hemitransection of the cord due to a knife injury or other trauma.
26 FEBRUARY 2021
FIGURE 1-7
Imaging of the patient in CASE 1-1, who presented with a central cord syndrome due to
cervical syringomyelia. A, Sagittal T2-weighted MRI of the cervical spine shows cerebellar
ectopia at the level of the foramen magnum (arrowhead ) with a T2-hyperintense lesion of
similar signal intensity to CSF in the central cord from C4 to T2 (arrows), consistent with a
syrinx. B, Axial T2-weighted MRI confirms that the syrinx involves the central cord. C,
Sagittal T2-weighted MRI of the cervical spine after foramen magnum decompression
shows significant improvement in the caliber of the syrinx.
CONTINUUMJOURNAL.COM 27
KEY POINTS than three vertebral segments in length) on sagittal images, which is typical of
MS, or may be longitudinally extensive (extending three or more vertebral
● A partial transverse
myelitis refers to spinal cord
segments in length), which is characteristic of aquaporin-4 IgG–seropositive
inflammation in which NMOSD.13,15 A variety of causes of transverse myelitis exist. Some have argued
symptoms and signs occur for a new classification of spinal cord inflammatory disorders that removes the
that are attributable to only term transverse from its definition as a large proportion of inflammatory
a portion of the spinal cord
myelopathies do not involve the entire transverse dimension of the spinal cord.
in cross section rather than
involving the entire For more information on transverse myelitis, refer to the article “Myelitis and
transverse diameter. A Other Autoimmune Myelopathies” by Sebastian Lopez Chiriboga, MD, and
complete transverse Eoin P. Flanagan, MBBCh,29 in this issue of Continuum.
myelitis is attributable to
spinal cord inflammation Cauda Equina Syndrome
involving its entire cross
section. Cauda equina syndrome refers to distal greater than proximal weakness and
sensory disturbance in the lower limbs accompanied by impairment of sphincter
● Patients with a control, including weakness of the anal sphincter, with areflexia of the ankle
longitudinally extensive jerks but preserved knee jerks. Patients may report saddle anesthesia. The most
transverse myelitis should
be tested for aquaporin-4
common cause is compression of the cauda equina by a structural lesion, such as
IgG and myelin a prolapsed lumbosacral disk or tumor, but the syndrome can occur due to
oligodendrocyte infiltration of the cauda equina by neoplasm or involvement by infection or
glycoprotein IgG. granulomatous disease. For more information on cauda equina syndrome, refer
to the article “Disorders of the Cauda Equina” by Samantha LoRusso, MD,30 in
this issue of Continuum.
CONCLUSION
When a patient reports neurologic symptoms that are potentially attributable
to the spinal cord or cauda equina, a careful history and examination may
provide numerous clinical clues that, together with a thorough knowledge
of spinal neuroanatomy, can assist with lesion localization and suggest a
differential diagnosis.
REFERENCES
1 Moore KL, Dalley AF, Agur AMR. Clinically 3 Cho TA. Spinal cord functional anatomy.
oriented anatomy. 7th ed. Wolters Kluwer/ Continuum (Minneap Minn) 2015;21(1 Spinal Cord
Lippincott Williams & Wilkins Health, 2014: xxviii:1134. Disorders):13-35. doi:10.1212/01.
CON.0000461082.25876.4a
2 Bican O, Minagar A, Pruitt AA. The spinal cord: a
review of functional neuroanatomy. Neurol Clin
2013;31(1):1-18. doi:10.1016/j.ncl.2012.09.009
28 FEBRUARY 2021
CONTINUUMJOURNAL.COM 29
Structural Myelopathies C O N T I N U UM AUDIO
INTERVIEW AVAILABLE
ONLINE
By Shamik Bhattacharyya, MD, MS
Downloaded from http://journals.lww.com/continuum by wqLe/H3/oM2vx1Qs5A5qMemKKHLPqE4qkmGNpdheG3ikf1o85ttJSkFL2oTkgOkhMEmawHvsuTTE5xJG2ZjqccytIAhVn2qegy060KLcKJuPZsx5htaYiopRjp2zor2egUzWJAEWYNo65TEub0G9tZtPaMachiqn on 04/28/2022
ABSTRACT
PURPOSE OF REVIEW: This article highlights both common structural causes of
myelopathy, such as spondylotic disease, and infrequent but treatable
causes, such as syringomyelia, spinal cord herniation, arachnoid cyst,
arachnoid band and web, epidural lipomatosis, Hirayama disease, and
arachnoiditis.
Address correspondence to
Dr Shamik Bhattacharyya,
INTRODUCTION Brigham and Women’s Hospital,
S
tructural causes of myelopathy are important to diagnose early and Department of Neurology,
75 Francis Rd, Boston, MA 02115,
accurately because symptoms can often be improved or at least sbhattacharyya3@bwh.harvard.
arrested with timely intervention. Despite the widespread availability edu.
of imaging, structural etiologies are the leading source of nontraumatic RELATIONSHIP DISCLOSURE:
spinal cord injury.1 On the other hand, most practicing neurologists Dr Bhattacharyya has served as
know of patients who have undergone spinal surgeries with little benefit or were a consultant for Alexion
Pharmaceuticals, Inc and has
worse off after the surgery. Accurate estimates of “unnecessary surgeries” are received personal
hard to come by, but a single-center study showed about 17% of patients compensation for providing
recommended to undergo spinal surgeries were unlikely to benefit from them.2 second opinion service for
Teladoc Health, Inc. Dr
The neurologist has a critical role in assessing the cause of neurologic symptoms, Bhattacharyya receives
prognosis, and risks and benefits of intervention in structural causes of myelopathy. publishing royalties from
Springer and UpToDate, Inc.
CONTINUUMJOURNAL.COM 163
Pathogenesis
As with many other slowly progressive diseases, the final clinical development of
cervical spondylotic myelopathy is frequently preceded by years of subclinical
changes. Susceptibility factors for clinical disease are congenital spinal stenosis,
osteoarthritis, ossification of the ligamentum flavum and posterior longitudinal
ligament, inflammatory arthritides such as rheumatoid arthritis or ankylosing
spondylitis, Down syndrome, and Klippel-Feil syndrome. In congenital stenosis
of the cervical spine, patients developmentally have a narrow cervical spinal
canal and are predisposed to get cervical spondylotic myelopathy from relatively
minor spinal degenerative disease. Based on large series of cadaveric
measurements, an anterior-posterior cervical spinal canal measurement of 13 mm
or less may define congenital narrowing of the cervical canal (FIGURE 7-1).4
Others have countered that absolute measurement of the spinal canal width is
less important than the relative fraction of space occupied by the spinal cord
compared to the width of the canal itself. This parameter is known as the spinal
cord occupancy ratio, and values greater than 70% may more accurately capture
the concept of a congenitally narrow canal.5 Among different inflammatory
arthritis syndromes, rheumatoid arthritis frequently affects the cervical spine;
MRI of the cervical spine shows
evidence of degenerative disease
in more than 70% of patients
with chronic rheumatoid
arthritis.6 The cause of this
tropism is unclear but may have
to do with the exclusively
synovial joints in the upper
cervical spine.
Klippel-Feil syndrome is
characterized by congenital
fusion of multiple cervical
vertebral bodies, resulting in
spinal instability and propensity
FIGURE 7-1 for injury. Clinically, patients
Congenital spinal stenosis. A, Sagittal
T2-weighted MRI of the cervical spine showing
with Klippel-Feil syndrome have
congenital stenosis. The anterior-posterior decreased neck mobility, a low
distance of the thecal sac averages about 10 mm, posterior hairline, and a short
putting the patient at risk for spondylotic neck. Most patients with
myelopathy from mild degenerative disease. B,
For comparison, sagittal T2-weighted MRI of the
Klippel-Feil syndrome do not
cervical spine of a patient without congenital have all these features, and no
spinal stenosis. single unifying genetic basis for
CONTINUUMJOURNAL.COM 165
after prior instrumentation, to assess for displacement of the hardware ● Lack of neck pain does
(FIGURE 7-3). Another use of x-ray imaging is in flexion/extension images. In this not exclude cervical
procedure, an x-ray image is first spondylotic myelopathy.
taken with the neck flexed, and
● Bladder and bowel
then the image is repeated with
sphincter dysfunction are
the neck extended. If significant atypical in chronic
change in the alignment of the progressive cervical
bones is seen, dynamic spondylotic myelopathy.
instability is present; static
● The Babinski sign is not
images obtained in a flat position very sensitive for cervical
may underestimate the degree of spondylotic myelopathy and
dynamic stenosis. In some may be absent in early
centers, flexion and extension disease. The Hoffman sign
may be positive more often.
views of the cervical spine can
also be obtained by MRI and ● MRI of the cervical spine
show ligamentous and bony without contrast is the
instability better than x-ray.16 preferred study to evaluate
for cervical degenerative
When examining an MRI of a
disease.
patient with suspected cervical
spondylotic myelopathy, the ● X-ray of the cervical spine
most important parameters are is useful to evaluate
the degree of stenosis, the nature instrumentation and for
FIGURE 7-3 dynamic instability of bony
of bony or soft tissue changes, structures with flexion and
Sagittal x-ray of the cervical spine showing C4-C5
anterior cervical diskectomy with intervertebral
and cord signal intensity. Having extension of the neck.
disk graft placement and fusion. X-ray imaging can no cervical spinal stenosis
show hardware without significant artifact. essentially excludes the
CONTINUUMJOURNAL.COM 167
The optimal management strategy in this case is unclear. The patient had COMMENT
signs of mild myelopathy from cervical spondylotic disease that could
stabilize or progress with time. After discussing different options, he
elected to continue conservative management with physical therapy and
sequential neurologic examinations. Five years later, he continued to be
stable with minimal myelopathic signs. Another observation is that
although the patient had more significant right-sided spinal cord
compression, he was symptomatic on the left side of the body. This
mismatch between the side of the compression and side with more
symptoms is a known phenomenon and does not exculpate the
compressive lesion.
CONTINUUMJOURNAL.COM 169
FIGURE 7-6
Severe multilevel degenerative disease. A, Sagittal T2-weighted MRI shows severe multilevel
degenerative disease of the cervical spine with abnormal focal T2 hyperintensity of the cord
at C5-C6 just caudal to the level of the greatest stenosis at C5-C6 (arrow). B, Axial
T2-weighted MRI at C5-C6 (level of arrow in panel A) shows bilateral anterior cord T2
hyperintensity that is more hyperintense on the right compared to the left.
Treatment
How best to treat cervical spondylotic myelopathy is controversial, and
significant regional and practitioner variation exists. This variability originates
from a lack of understanding of the natural history of untreated disease and lack
of robust trials comparing conservative and interventional methods. To begin
with, patients with severe cervical spinal stenosis on imaging without
myelopathic symptoms likely do not all need surgery. The natural history of
cervical spondylotic myelopathy was evaluated in a cohort of 199 patients with
asymptomatic severe cervical spinal stenosis followed for a median of 44 months.
Although about 22% developed symptoms of myelopathy during follow-up, no
CONTINUUMJOURNAL.COM 171
treatment and followed them for 2 years.26 In this trial also, no clear differences
were seen in myelopathy rating scores or in electrophysiologic measures between
the two groups after 2 years.
These small randomized trials contrast with usual clinical practice at many
centers. Prospective clinical series demonstrate neurologic and pain
improvement with surgery, although any surgical intervention necessarily has a
large placebo effect.27,28 More patients likely have surgery for mild myelopathy
than benefit in the long term. On the other hand, cervical spondylotic
myelopathy continues to be a major cause of morbidity and neurologic injury.
The clinical trials are small and underpowered, and the clinical scales used in the
trials may not be sensitive to small improvements in spinal cord function. In
clinical practice, the author of this article generally recommends conservative
therapy for signs or symptoms of mild myelopathy present for many months or
years (CASE 7-2) and recommends intervention for significant disability or
progressive neurologic injury in sequential clinical examinations.
CASE 7-2 A 50-year-old man with prior spinal cord trauma and residual mild
left-sided weakness experienced increasing difficulty walking and loss of
dexterity with fine finger movements. On examination, he had moderate
weakness in the flexor muscles
of his legs, spasticity in his
left arm and both legs, and
diminished sensation to
vibration in both legs.
MRI of his cervical spine
showed disk protrusion at the
C6-C7 level causing severe
stenosis of the cervical spine
in addition to prior cord
trauma at C4-C5 (FIGURE 7-8A).
Surgery was recommended,
but the patient did not
follow up. He returned FIGURE 7-8
3 years later and was walker Imaging of the patient in CASE 7-2. A, Sagittal
dependent with persistent T2-weighted MRI shows an area of T2 cord
spasticity in the legs. Repeat hyperintensity at C4-C5 and disk protrusion
causing severe canal stenosis at C6-C7 (arrow). B,
MRI showed resolution of
Repeat sagittal T2-weighted MRI obtained 3 years
the disk protrusion at later shows resolution of the prior disk protrusion
C6-C7 (FIGURE 7-8B). at C6-C7 (arrow) without surgery.
COMMENT This case illustrates that if the spinal cord is compressed for long enough,
irreversible injury to the spinal cord can occur. In this case, the disk
reabsorbed back without any intervention, but the patient’s neurologic
signs did not improve. His disability may have been preventable if he had
gotten surgical decompression.
CONTINUUMJOURNAL.COM 173
SYRINGOMYELIA
Syringomyelia refers to the presence of a syrinx, a fluid-filled, glial-lined cavity,
within the parenchyma of the spinal cord. This entity must be distinguished from
an enlarged central canal (hydromyelia), which is an ependymal-lined enlargement
of the normally obliterated central canal. This is an important distinction that is
sometimes not recognized and can lead to inappropriate diagnosis and therapies.
The central canal is a circular midline structure located at the junction of the ventral
one-third and dorsal two-thirds of the spinal cord. The central canal is an
embryologic remnant that progressively becomes obliterated during adulthood.
However, not uncommonly, some portions of the central canal can remain visible
on imaging and are often found incidentally (FIGURE 7-9). In an MRI spine series of
794 patients, the central canal was enlarged in 12, corresponding to a rate of 1.5%.32
In none of the patients was the central canal enlargement pathogenic or related to
the clinical syndrome leading to the imaging study. When enlargement of the
central canal is visible, the contours are generally smooth and without nodularity.
Most instances of incidental enlarged central canal are in the thoracic spinal cord,
although cervical spinal cord enlarged central canals are also seen.32
By contrast, syringomyelia can occur in the cervical or thoracic segments and
has variable appearance. The prevalence of syringomyelia is estimated to be 3.3
per 100,000 to 8.5 per 100,000, with variation in different ethnic groups.33
Epidemiologically, syringomyelia can be primary or associated with other
predisposing conditions. The most common predisposing condition is Chiari type
I malformation, which can be clinically silent but seen on imaging as herniation
of the cerebellar tonsils into the foramen magnum. About a 65% to 80% incidence
of syringomyelia is seen with Chiari type I malformation (FIGURE 7-10).34 More
uncommonly, patients with syringomyelia may have Chiari type II malformations,
in which both the cerebellum and brainstem herniate into the foramen magnum,
often accompanied by myelomeningocele in the lumbar spine. Acquired spinal
FIGURE 7-9
Enlarged central canal. A, Sagittal fat-suppressed short tau inversion recovery (STIR)
MRI shows a dilated cystic region at the C6 level. B, Axial T2-weighted image shows a
rounded central structure without myelomalacia that is most consistent with an enlarged
central canal.
FIGURE 7-10
Syringomyelia with Chiari type I malformation. A, Sagittal T2-weighted MRI shows
syringomyelia at the C6-C7 level. B, Concurrent T1-weighted sagittal brain MRI shows a mild
Chiari type I malformation with herniation of the cerebellar tonsils (arrow) into the foramen
magnum. These findings were incidental for the patient.
cord injury can also lead to syrinx formation. Traumatic spinal cord injury can
predispose to late development of a syrinx. In one study, the mean interval
between spinal cord injury and syrinx development was 8.6 years.35
Other causes of spinal cord injury, such as spinal cord infarction or myelitis from
multiple sclerosis or neuromyelitis optica (NMO), may also infrequently lead to
syringomyelia in a delayed fashion. Neoplasms are an important secondary cause of
acquired syringomyelia. Midline neoplasms in the spinal cord, such as ependymoma
or hemangioblastoma, are primarily associated with syringomyelia. Interestingly,
the syrinx is most frequently located above the tumor, followed by both above and
below the level of the tumor. It is infrequent to have a syrinx located solely below the
level of the tumor. The chances of developing a syrinx are generally higher with a
more rostral tumor in the spinal cord.36 Familial syringomyelia has also been
described in small clusters, pointing to as-yet undiscovered genetic causes.
Pathogenesis
Many different theories exist to explain the development and progression of
syringomyelia. An early theory hypothesized that syringomyelia represents the
cavitation of a glial tumor that became necrotic from insufficient blood supply.37
However, histopathology did not show tumor cells in most syringes, and
tumor-directed treatment with radiation therapy did not resolve the syringes.
Others observed that in the nervous system, vascular injury evolved to
cavitation. They hypothesized that either ischemic or hemorrhagic injury to the
spinal cord evolved with time to have the final appearance of a syrinx. However,
these theories do not explain the progressive nature of a syrinx, which often
expands with time and causes increasing spinal cord dysfunction. Many patients
did not have signs or symptoms of vascular injury to the spinal cord before the
development of myelopathy from the syrinx.
Over time, hydrodynamic theories have gained favor as the cause of
syringomyelia. Simple occlusion of the central canal and impairment of bulk flow of
CONTINUUMJOURNAL.COM 175
CSF are not fully explanatory since most healthy adults have an occluded central
canal and do not develop a syrinx. The English neurosurgeon Bernard Williams
developed one of the first widely accepted hydrodynamic theories seeking to
explain why syringomyelia is more common in Chiari malformations. He
hypothesized that activities such as coughing or sneezing transiently displace CSF
from the head into the spinal canal. In patients with Chiari malformation and a
crowded foramen magnum with impaired circulation of CSF, a longer time passes
before pressure in the head and spinal canal equilibrate. During this vulnerable time,
CSF is postulated to be sucked into the spinal cord either through the central canal or
potentially through the spinal cord itself, causing a cystic cavitation.37 Although the
theory has empirical support in cases of Chiari malformation, the theory does not
explain other causes of syringomyelia in which no crowding of the foramen
magnum is present. An alternative theory postulates that with interference of CSF
circulation in the spinal subarachnoid space, the velocity of CSF in the subarachnoid
space increases. Following the Bernoulli law, the increased velocity of the fluid
results in lower net subarachnoid pressure, which causes a distending force on the
spinal cord. Over time, this gradually results in a cavitary expansion of the spinal
cord, causing a syrinx.38 Many other theories have been postulated to explain the
buildup of fluid in the spinal cord. Although we do not yet have a definitive answer,
a unifying theme appears to be impairment of free CSF flow in the spinal
subarachnoid space. Understanding the mechanism will be important in the future
because treatment directed at improving the flow of CSF, such as by lysis of
adhesions in arachnoiditis or decompression of the foramen magnum, may be
sufficient to prevent the progression of syringomyelia.
Clinical Features
Classically, slow expansion of a syrinx in the central cord causes interruption of the
crossing spinothalamic tracts via the anterior commissure. Hence, early on,
patients develop a band of numbness limited to pain and temperature sensation in
the affected dermatomes with preserved vibration and joint position sense
(dissociated sensory loss). This pattern of sensory loss has been called a capelike
distribution of sensory loss as the cervical and upper thoracic dermatomes are
often affected by syringomyelia. Over time, as the syrinx expands and causes
further spinal cord destruction, descending tracts (such as the corticospinal tract)
are affected, causing weakness and spasticity in the legs. In clinical practice,
many types of syrinx are not located exactly in the midline but are eccentric
to one side. Hence, many patients do not have the classic progression from
the capelike bilateral sensory loss pattern to weakness. Wide variability can
exist in the clinical syndrome, such as starting with a slowly progressive
hemicord syndrome.
Because of the interruption of the spinothalamic tracts, neuropathic pain that is
often poorly localized is an important early feature. For example, in a case series of
midline cord ependymomas, neuropathic pain with sensory loss was the earliest
feature, present for a median of 13 months before diagnosis of the tumor.39 Other
important clinical clues are lower motor neuron features that gradually become
apparent as the anterior horn cells become injured. This can cause muscle atrophy
in the arms with a cervical spinal cord syrinx. When the paraspinal muscles
become weak, progressive scoliosis is common as well. Since autonomic fibers
descend in the midline, slow expansion of midline lesions as in syringomyelia can
cause early autonomic dysfunction. This can take the form of bowel and urinary
CONTINUUMJOURNAL.COM 177
Arachnoid Cyst
Spinal arachnoid cysts are intradural-extramedullary cystic structures in the
subarachnoid space. In many cases, arachnoid cysts are found incidentally on
routine imaging of the spine and are clinically asymptomatic. The etiology of the
cysts is unclear; many are idiopathic, whereas others are associated with
congenital spinal deformities in children or with spinal trauma in adults, such as
after epidural hematoma or lumbar myelography. The latter etiologies suggest
impairment of subarachnoid fluid flow or arachnoiditis as possible contributors
to cyst formation. Overall, spinal arachnoid cysts are located primarily in the
thoracic spine dorsal to the spinal cord, although anterior thoracic arachnoid
cysts and cervical arachnoid cysts have also been rarely described. MRI is the
preferred imaging modality to diagnose arachnoid cysts. Arachnoid cysts have
the same signal intensity as CSF, with generally visible boundaries and
displacement of the spinal cord (FIGURE 7-12). The boundaries of the cysts do not
Epidural Lipomatosis
Spinal epidural lipomatosis refers to the accumulation of fat in the epidural space.
When enough fat is present to encroach on the spinal canal or foramina,
patients can have symptoms of myelopathy, neurogenic claudication, or
radiculopathy. Spinal epidural lipomatosis can be idiopathic or secondary to
other conditions, such as exogenous steroids, hypercortisolism, or obesity.
Epidural corticosteroid injections are strongly associated with epidural fat
CONTINUUMJOURNAL.COM 179
Hirayama Disease
Initially described in Japan and other Asian countries, the characteristic feature
of this eponymous disease is insidious onset of weakness and atrophy of the
hand and forearm, predominantly in young males in their teens or twenties
without other cranial or pyramidal signs. The weakness is typically asymmetric
or unilateral. After progression for several years, the disease stops with static
weakness. When initially described, the proposed mechanism was thought to be
motor neuron disease of a restricted spinal segment, which the authors called
monomelic amyotrophy.52 Subsequently, Hirayama and colleagues53 established
that in patients who are symptomatic and in whom the disease is progressive,
movement of the dural sac occurs in flexion and extension postures. When
imaged with the neck extended and flexed, the diameter of the dural sac
decreases during flexion, with corresponding stenosis and pressure on the
spinal cord. Typically, no movement is seen in the bony elements. The
hypothesis is that with repeated neck flexion and extension movements,
the anterior horn of the lower cervical spinal cord is injured, accounting
for the forearm and hand weakness. Recognition of the clinical syndrome
is important because the dynamic movement of the dural sac can be missed
entirely on static MRI with the neck extended. How best to manage the
disease is unclear. In most patients, conservative therapy with avoidance
of neck flexion can stabilize the disease. The natural history of the disease
is generally of progression initially with long periods of stability. If patients
have progressive disability, cervical decompression and fusion can be performed.
FIGURE 7-13
Arachnoiditis with spinal cord tethering. A, Axial T2-weighted MRI of the cervical spine
shows tethering of the cervical spinal cord (arrow) from arachnoiditis. B, Sagittal
T2-weighted MRI also shows tethering of the cord (arrow) through the arachnoid space.
CONTINUUMJOURNAL.COM 181
REFERENCES
1 New PW, Reeves RK, Smith É, et al. International 12 Sadasivan KK, Reddy RP, Albright JA. The natural
retrospective comparison of inpatient history of cervical spondylotic myelopathy.
rehabilitation for patients with spinal cord Yale J Biol Med 1993;66(3):235-242.
dysfunction epidemiology and clinical outcomes.
13 Wang Z, Sakakibara T, Kasai Y. Overactive bladder
Arch Phys Med Rehabil 2015;96(6):1080-1087.
in cervical spondylotic myelopathy. J Orthop Sci
doi:10.1016/j.apmr.2015.02.016
2014;19(1):22-25. doi:10.1007/s00776-013-0491-1
2 Epstein NE, Hood DC. “Unnecessary” spinal
14 Estanol BV, Marin OS. Mechanism of the
surgery: a prospective 1-year study of one
inverted supinator reflex. A clinical and
surgeon’s experience. Surg Neurol Int 2011;2:83.
neurophysiological study. J Neurol Neurosurg
doi:10.4103/2152-7806.82249
Psychiatry 1976;39(9):905-908. doi:10.1136/
3 Nouri A, Tetreault L, Singh A, et al. Degenerative jnnp.39.9.905
cervical myelopathy: epidemiology, genetics,
15 Houten JK, Noce LA. Clinical correlations of
and pathogenesis. Spine (Phila Pa 1976)
cervical myelopathy and the Hoffmann sign.
2015;40(12):E675-E693. doi:10.1097/
J Neurosurg Spine 2008;9(3):237-242. doi:10.3171/
BRS.0000000000000913
SPI/2008/9/9/237
4 Bajwa NS, Toy JO, Young EY, Ahn NU.
16 Conway BL, Clarke MJ, Kaufmann TJ, Flanagan EP.
Establishment of parameters for congenital
Utility of extension views in spondylotic
stenosis of the cervical spine: an anatomic
myelopathy mimicking transverse myelitis. Mult
descriptive analysis of 1,066 cadaveric
Scler Relat Disord 2017;11:62-64. doi:10.1016/j.
specimens. Eur Spine J 2012;21(12):2467-2474.
msard.2016.12.004
doi:10.1007/s00586-012-2437-2
17 Matsumoto M, Fujimura Y, Suzuki N, et al. MRI of
5 Nouri A, Tetreault L, Nori S, et al. Congenital
cervical intervertebral discs in asymptomatic
cervical spine stenosis in a multicenter global
subjects. J Bone Joint Surg Br 1998;80(1):19-24.
cohort of patients with degenerative cervical
doi:10.1302/0301-620x.80b1.7929
myelopathy: an ambispective report based on a
magnetic resonance imaging diagnostic criterion. 18 Nouri A, Martin AR, Mikulis D, Fehlings MG.
Neurosurgery 2018;83(3):521-528. doi:10.1093/ Magnetic resonance imaging assessment of
neuros/nyx521 degenerative cervical myelopathy: a review of
structural changes and measurement
6 Younes M, Belghali S, Kriâa S, et al. Compared
techniques. Neurosurg Focus 2016;40(6):E5.
imaging of the rheumatoid cervical spine:
doi:10.3171/2016.3.FOCUS1667
prevalence study and associated factors. Joint
Bone Spine 2009;76(4):361-368. doi:10.1016/j. 19 Matsumoto M, Toyama Y, Ishikawa M, et al.
jbspin.2008.10.010 Increased signal intensity of the spinal cord on
magnetic resonance images in cervical
7 Abiola R, Rubery P, Mesfin A. Ossification of the
compressive myelopathy. Does it predict the
posterior longitudinal ligament: etiology,
outcome of conservative treatment?
diagnosis, and outcomes of nonoperative and
Spine (Phila Pa 1976) 2000;25(6):677-682.
operative management. Global Spine J 2016;6(2):
doi:10.1097/00007632-200003150-00005
195-204. doi:10.1055/s-0035-1556580
20 Vedantam A, Rajshekhar V. Does the type of
8 Takamiya Y, Nagata K, Fukuda K, et al.
T2-weighted hyperintensity influence surgical
Cervical spine disorders in farm workers
outcome in patients with cervical spondylotic
requiring neck extension actions. J Orthop Sci
myelopathy? A review. Eur Spine J 2013;22(1):
2006;11(3):235-240. doi:10.1007/
96-106. doi:10.1007/s00586-012-2483-9
s00776-006-1005-1
21 Flanagan EP. Autoimmune myelopathies. Handb
9 Kato F, Yukawa Y, Suda K, et al. Normal
Clin Neurol 2016;133:327-351. doi:10.1016/
morphology, age-related changes and
B978-0-444-63432-0.00019-0
abnormal findings of the cervical spine.
Part II: magnetic resonance imaging of 22 Flanagan EP, Krecke KN, Marsh RW, et al. Specific
over 1,200 asymptomatic subjects. pattern of gadolinium enhancement in
Eur Spine J 2012;21(8):1499-1507. spondylotic myelopathy. Ann Neurol 2014;76(1):
doi:10.1007/s00586-012-2176-4 54-65. doi:10.1002/ana.24184
10 al-Mefty O, Harkey HL, Marawi I, et al. 23 Bednařík J, Sládková D, Kadaňka Z, et al. Are
Experimental chronic compressive cervical subjects with spondylotic cervical cord
myelopathy. J Neurosurg 1993;79(4):550-561. encroachment at increased risk of cervical spinal
doi:10.3171/jns.1993.79.4.0550 cord injury after minor trauma? J Neurol
Neurosurg Psychiatry 2011;82(7):779-781.
11 Hashmi SZ, Marra A, Jenis LG, Patel AA. Current
doi:10.1136/jnnp.2009.198945
concepts: central cord syndrome. Clin Spine
Surg 2018;31(10):407-412. doi:10.1097/
BSD.0000000000000731
CONTINUUMJOURNAL.COM 183
49 Sridharan A, Heilman CB. Transverse dorsal 53 Hirayama K, Tokumaru Y. Cervical dural sac and
arachnoid web and syringomyelia: case report. spinal cord in juvenile muscular atrophy of distal
Neurosurgery 2009;65(1):E216-E217; discussion upper extremity. Neurology 2000;54(10):
E217. doi:10.1227/01.NEU.0000348007.84175.FA 1922-1926. doi:10.1212/wnl.54.10.1922
50 Theyskens NC, Paulino Pereira NR, Janssen SJ, 54 Killeen T, Kamat A, Walsh D, et al. Severe
et al. The prevalence of spinal epidural adhesive arachnoiditis resulting in progressive
lipomatosis on magnetic resonance imaging. paraplegia following obstetric spinal
Spine J 2017;17(7):969-976. doi:10.1016/j. anaesthesia: a case report and review.
spinee.2017.02.010 Anaesthesia 2012;67(12):1386-1394.
doi:10.1111/anae.12017
51 Kellett CG, Siva V, Norman ICF, et al.
Symptomatic idiopathic spinal epidural 55 Anderson TL, Morris JM, Wald JT, Kotsenas AL.
lipomatosis in 9 patients: clinical, radiologic, and Imaging appearance of advanced chronic
pathogenetic features. World Neurosurg 2019; adhesive arachnoiditis: a retrospective review.
126:e33-e40. doi:10.1016/j.wneu.2019.01.098 AJR Am J Roentgenol 2017;209(3):648-655.
doi:10.2214/AJR.16.16704
52 Gourie-Devi M, Suresh TG, Shankar SK.
Monomelic amyotrophy. Arch Neurol
1984;41(4):388-394. doi:10.1001/
archneur.1984.04050160050015
Vascular Myelopathies
C O N T I N UU M A UD I O By Nicholas L. Zalewski, MD
I NT E R V I E W A V AI L A B L E
ONLINE
Downloaded from http://journals.lww.com/continuum by wqLe/H3/oM2vx1Qs5A5qMemKKHLPqE4qkmGNpdheG3ikf1o85ttJSkFL2oTkgOkhMEmawHvsuTTE5xJG2ZjqccytIAhVn2qegy060KLcKJuPZsx5htaYiopRjp2zor2egUzWJAEWYNrC3bBuCzr1RdmqNUpjE4IY on 04/28/2022
ABSTRACT
PURPOSE OF REVIEW: Neurologists should be able to identify clinical and
neuroimaging features that distinguish vascular disorders from other
causes of myelopathy.
INTRODUCTION
T
wo large retrospective studies recently showed that patients initially
CITE AS: diagnosed with idiopathic transverse myelitis frequently had
CONTINUUM (MINNEAP MINN) alternative myelopathy diagnoses, with vascular etiologies among the
2020;27(1, SPINAL CORD DISORDERS):
30–61.
most common.1,2 Vascular disorders of the spinal cord have important
time-to-treatment considerations as delays in diagnosis can be
Address correspondence to associated with worse outcomes,3 highlighting the importance of considering
Dr Nicholas L. Zalewski,
vascular causes early. Physicians should also be aware that treatments used for
Department of Neurology, Mayo
Clinic, Mayo Clinic Building, inflammatory disorders can potentially worsen symptoms and outcomes in
13400 E Shea Blvd, Scottsdale, vascular myelopathies.4-7 Although certain features strongly suggest a vascular
AZ 85259, zalewski.nicholas@
mayo.edu.
myelopathy in acute (severe deficits developing within ≤12 hours with pain) and
chronic (exertional/Valsalva worsening) settings, accurate MRI interpretation
RELATIONSHIP DISCLOSURE: within the clinical context is most critical. Many different vascular mechanisms
Dr Zalewski reports no
disclosure. exist; to simplify organization, this article divides vascular myelopathies into the
categories of arterial ischemia, venous congestion/ischemia, hematomyelia, and
UNLABELED USE OF
extraparenchymal hemorrhage.
PRODUCTS/INVESTIGATIONAL
USE DISCLOSURE: Myelopathy should be presumed as acute and a potential neurologic
Dr Zalewski discusses the emergency at initial presentation until proven otherwise. Practically speaking, if
unlabeled/investigational use of
IV alteplase for the treatment of
a patient presents with rapid accumulation of deficits within approximately
spinal cord infarction. 24 hours or the acuity is indeterminate, a time-sensitive five-step, five-category
approach is recommended (TABLE 2-1). This approach provides an important
© 2021 American Academy
framework for compressive and noncompressive diagnoses and management
of Neurology. considerations in the acute setting.
30 FEBRUARY 2021
CONTINUUMJOURNAL.COM 31
32 FEBRUARY 2021
CONTINUUMJOURNAL.COM 33
CASE 2-1 A 66-year-old man was lifting heavy equipment when he acutely
developed severe neck pain and a sense of general weakness. The
following day, he suddenly developed worsening leg weakness and
urinary retention. He took a brief nap and awoke developing rapid
paraplegia within minutes. He was taken to the emergency department,
nearly quadriplegic and in respiratory distress. He was intubated and
transferred for further care.
Examination demonstrated skew deviation, severe asymmetric
quadriparesis in proximal and distal muscles, and a truncal sensory level
to temperature and pain on the left at C4 and the right at T4. Dorsal
column function was preserved. Resting tone was flaccid with areflexia.
Emergent MRI revealed
T2-hyperintense signal in the
upper cervical spinal cord,
predominantly in the ventral
gray matter (FIGURE 2-3A).
Characteristic owl eyes were
observed on axial cuts,
typical of spinal cord
infarction (FIGURE 2-3B).
CT angiography of the
head and neck identified
a left vertebral artery
dissection as the etiology.
Brain MRI confirmed
multifocal strokes
in the cerebellum contributing
to skew deviation (FIGURE 2-3C).
The patient was treated with
mean arterial blood pressure FIGURE 2-3
Imaging of the patient in CASE 2-1. A, Sagittal
augmentation and a lumbar T2-weighted MRI shows T2-hyperintense signal in
drain for 48 hours, then the upper cervical spinal cord, predominantly in
placed on aspirin for the ventral gray matter (arrow). B, Axial
long-term treatment. T2-weighted MRI shows characteristic owl eyes
(arrow), typical of spinal cord infarction. C, Axial
Follow-up several months
brain diffusion-weighted MRI confirms multifocal
later revealed subtle residual strokes in the cerebellum contributing to
motor and sensory deficits. skew deviation.
COMMENT This case highlights several points. Despite the patient’s reported earlier
symptoms of pain and generalized weakness, the sudden change with
rapid severe myelopathy was an essential clue to suspect spinal cord
infarction; examination suggesting deficits in the anterior spinal artery
territory raised additional suspicion for spinal cord infarction. Typical
imaging findings were seen on T2-weighted imaging, with owl eyes and
severe deficits out of proportion to a smaller lesion, and specific findings
confirmed spinal cord infarction (dissection, concurrent cerebral stroke).
Treatment was pursued, and the patient had an excellent outcome.
34 FEBRUARY 2021
CONTINUUMJOURNAL.COM 35
into the mechanism (eg, dissection, fibrocartilaginous embolism), given its higher
frequency in spontaneous spinal cord infarction than periprocedural cases.19 A
truncal sensory level or localized pain, or both, is helpful in localization of spinal cord
infarction; clinicians should consider alternative localizations if these features are
absent (bilateral anterior cerebral artery territory, rapid peripheral disorder). Strictly
unilateral presentations can occur but are rare and raise suspicion for cerebral
localization (eg, contralateral anterior cerebral artery territory with leg weakness). A
physical maneuver (eg, lifting, back hyperextension, neck movement, Valsalva) is
frequently reported at or before onset. This serves as a clue to the diagnosis and
potential mechanism (eg, arterial dissection, fibrocartilaginous embolism, radicular
artery compression from disk, or other mechanical mechanism).
ACUTE. Refer to TABLE 2-1 for the emergent protocol for acute myelopathy. A low
threshold for MRI of the entire spine should exist, unless the localization is clear
(eg, cervical spinal cord in quadriplegia). Diffusion-weighted imaging (DWI)/
apparent diffusion coefficient (ADC) should be performed, but the sensitivity
is incomplete (50% to 70%),7,19 and sometimes takes days to evolve.25 In the
initial hours of symptoms, imaging is likely normal or equivocal.7 Early
FIGURE 2-4
MRI findings in spinal cord infarctions. Typical patterns of T2-hyperintense signal seen
in spinal cord infarction include owl eyes (A), associated with noncontiguous anterior
pencillike hyperintensity (B); anteromedial spot (C), confirmed with short anterior pencillike
hyperintensity on sagittal view (D); residual cystic myelomalacia with very bright T2
hyperintensity (E, F) and associated T1 hypointensity (G, H), seen more than 1 month after
spinal cord infarction; anteromedial T2 hyperintensity (I) with associated anterior pencillike
hyperintensity (J); anterior U or V shape (K) with associated anterior pencillike hyperintensity
on sagittal view (L); hologray (entire gray matter) pattern (M) with associated edematous T2
hyperintensity on sagittal view (N); and holocord (entire spinal cord) pattern (O) with
associated edematous T2 hyperintensity extending through the conus on sagittal view (P).
Modified with permission from Zalewski NL, et al, JAMA Neurol.7 © 2019 American Medical Association.
36 FEBRUARY 2021
ADDITIONAL TESTS. Many patients with spinal cord infarction are initially
suspected to have Guillain-Barré syndrome. When nerve conduction studies/EMG
and CSF evaluation are obtained, it is important to recognize frequent abnormalities
attributable to spinal cord infarction. In one series, 13 of 19 patients with spinal
cord infarction had EMG abnormalities corresponding to the area of infarction.7,28
CONTINUUMJOURNAL.COM 37
FIGURE 2-5
Axial MRI findings of spinal cord infarctions. A variety of axial T2-hyperintense MRI patterns can
be seen in spinal cord infarctions, which are often incomplete, asymmetric, or noncontiguous,
including owl eyes (large [A] or small [B]), hologray (entire gray matter) (C), anteromedial spot
(D), and anterior U or V (E). Infarcts often involve territories other than the typical anterior
two-thirds of the spinal cord, including holocord (entire spinal cord), dorsomedial (F), and
lateral (G). A small focus of bright T2-hyperintense signal (F) accompanied by focal T1
hypointensity (not shown) represents residual cystic myelomalacia as a chronic finding after
infarction. Anterior spinal artery T2 hyperintensity (H) (demonstrated ventral to an anteromedial
spot) is observed in some cases, supporting the presence of a thrombus or slow flow
contributing to ischemia. T1-weighted contrast enhancement highlights the predominant area of
ischemia, which is often an owl-eye pattern (I), and in this example demonstrates associated
ventral root enhancement.
Reprinted with permission from Zalewski NL, et al, J Neurol Sci.19 © 2018 Elsevier BV.
CSF often shows mild to moderate protein elevation, frequently confused for the
albuminocytologic dissociation seen in Guillain-Barré syndrome. In some cases
(<10%),7 mild elevation in inflammatory markers is seen, raising caution for
alternatives, but it is important to note that mild abnormalities can still be
consistent with spinal cord infarction; significant elevations of greater than
25 cells/mm3 would be unlikely.
DIAGNOSIS. Spinal cord infarction diagnostic criteria are outlined in TABLE 2-2.7
Clinicians should err on the side of using a working diagnosis of “possible spinal
cord infarction” acutely, as criterion 4 highlights a workup ensuring alternative
diagnoses are not likely.
38 FEBRUARY 2021
● It is reasonable to discuss
risks and benefits of IV
recombinant tissue
plasminogen activator
within the first 4.5 hours
after onset if suspicion of
spinal cord infarction is high
and the patient understands
the limited evidence.
FIGURE 2-6
Confirmatory MRI findings and typical gadolinium enhancement pattern in spinal cord
infarctions. Vertebral body infarction is seen on short tau inversion recovery (STIR) images (A)
with associated gadolinium enhancement (B) of the vertebral body infarct, spinal cord
infarction (C), and anterior cauda equina (D); T1-weighted fat-suppressed images show
cervical artery dissection with significantly decreased left vertebral flow (E, F), with
confirmed intramural hematoma (G) adjacent to spinal cord infarction. Diffusion-weighted
image shows diffusion restriction (H) with correlation on apparent diffusion coefficient (I)
image. Gadolinium enhancement of spinal cord infarction demonstrated with a typical
craniocaudal linear strip on sagittal views (J, K) and corresponding anterior predominant gray
matter (L) and anteromedial spot (M) patterns on axial views, highlighting the predominant
areas of ischemia.
Reprinted with permission from Zalewski NL, et al, JAMA Neurol.7 © 2019 American Medical Association.
CONTINUUMJOURNAL.COM 39
Criteria
1 Acute nontraumatic myelopathy (no preceding progressive myelopathy)
Onset to nadir of severe deficitsb 12 hours or less
If stuttering course is more than 12 hours, severe deficits rapidly develop over 12 hours or less
2 MRI
A No spinal cord compression
B Supportive: intramedullary T2-hyperintense spinal cord lesion
C Specific (one of ): diffusion-weighted imaging/apparent diffusion coefficient restriction,
associated vertebral body infarction, arterial dissection/occlusion adjacent to lesion
3 CSF
Noninflammatory (normal cell count and IgG index and no oligoclonal bands)
4 Alternative diagnoses
Alternative diagnosis is not more likely
Type and diagnostic certainty of spinal cord infarction
◆ Definite spontaneous spinal cord infarction (requires all of the following: 1, 2A, 2B, 2C, 4)
◆ Probable spontaneous spinal cord infarction (requires all of the following: 1, 2A, 2B, 3, 4)
◆ Possible spontaneous spinal cord infarction (requires all of the following: 1, 4)
◆ Definite periprocedural spinal cord infarction (requires all of the following: 1, 2A, 2B, 4)
◆ Probable periprocedural spinal cord infarction (requires all of the following: 1, 4)
40 FEBRUARY 2021
Atherosclerosis
Dissection
◆ Aortic dissection
◆ Vertebral artery dissection
◆ Subclavian artery dissection
Mechanical
◆ Fibrocartilaginous embolism
◆ Surfer’s myelopathy
◆ Arterial compression (disk, other)
Embolic
◆ Fibrocartilaginous embolism
◆ Aortic embolism (eg, atheroma, calcium)
◆ Cardioembolic (eg, atrial fibrillation, endocarditis, myxoma, fat, paradoxical)
◆ Fungal embolus
Vasculitis
◆ Primary angiitis of the central nervous system
◆ Systemic vasculitis (eg, giant cell arteritis)
◆ Infectious (eg, varicella-zoster virus, syphilis, fungal, schistosomiasis, Lyme disease,
tuberculous meningitis, hepatitis)
Hypotension
Hypercoagulability
◆ Lupus anticoagulant/antiphospholipid antibody syndrome
◆ Malignancy
◆ Sickle cell disease, hereditary spherocytosis, polycythemia vera
◆ Disseminated intravascular coagulation
Pharmacologic
◆ Medications (sildenafil, oral contraceptives, phentermine, others)
◆ Drugs of abuse (eg, cocaine, cannabis)
a
Modified with permission from English SW, Zalewski NL, Semin Neurol.9 © 2021 Thieme Medical Publishers, Inc.
CONTINUUMJOURNAL.COM 41
Standard evaluation
◆ Imaging
◇ MRI cervical/thoracic spine (with diffusion-weighted imaging/apparent diffusion
coefficient and gadolinium, with or without brain MRI)
◇ Magnetic resonance angiography (MRA) cervical (if cervical level affected, with T1 fat
saturation for dissection)
◆ Blood tests
◇ Hemoglobin A1c, fasting lipids, glucose
◇ Complete blood cell count, prothrombin time/activated partial thromboplastin time
◆ CSF (can consider deferring if clear diagnosis)
◇ Cell count, glucose, protein, IgG index, oligoclonal bands
Additional testing to consider
◆ Imaging
◇ MRI brain (evaluate for concurrent stroke, alternative lesions)
◇ MRA spinal canal or angiogram (clinical/radiographic concern for spinal dural
arteriovenous fistula/arteriovenous malformation, or vasculitis)
◇ CT chest/abdomen/pelvis (malignancy concern)
◆ Blood
◇ Aquaporin-4-IgG, myelin oligodendrocyte glycoprotein (MOG)-IgG
◇ Syphilis and Lyme serology
◇ Hypercoagulable profile
◇ Erythrocyte sedimentation rate, C-reactive protein
◇ Antinuclear antibody, extractable nuclear antigen, antineutrophil cytoplasmic antibody
panel, dsDNA
◇ Paraneoplastic autoantibody evaluation
◇ Toxicology screen (with urine)
◆ CSF
◇ Varicella-zoster virus polymerase chain reaction (PCR)
◇ Venereal Disease Research Laboratory test
◇ Lyme serology/PCR
◇ Cryptococcus antigen
◆ Cardiac evaluation
◇ Transesophageal echocardiogram
◇ Holter monitoring
◆ Other
◇ EMG (suspicion of Guillain-Barré syndrome)
◇ Temporal artery biopsy (concern of giant cell arteritis)
42 FEBRUARY 2021
CONTINUUMJOURNAL.COM 43
CASE 2-2 A 62-year-old man was referred for evaluation of “transverse myelitis.”
He reported 9 months of progressive weakness and sensory loss of the
right more than left leg. Walking resulted in dramatic worsening of
weakness. His past medical history included hypertension,
hyperlipidemia, and lumbar spine surgery 5 years earlier.
Examination demonstrated moderate asymmetric right more than left
leg weakness, with severe sensory loss to all modalities in the lower
extremities and no truncal sensory level. Reflexes were reduced, and
plantar responses were mute. Nerve conduction studies and EMG were
performed, revealing a lumbosacral polyradiculopathy; however, MRI of
the lumbar spine revealed T2-hyperintense signal extending into the
conus, with further imaging demonstrating T2-hyperintense signal
throughout the lower thoracic cord (FIGURE 2-7A). Multiple small
T2-hypointense flow voids were seen surrounding the cord (FIGURES 2-7A
and 2-7B), and T1-weighted imaging with gadolinium demonstrated abrupt
missing pieces within a confluent area of enhancement (FIGURES 2-7C
and 2-7D); these findings were suspicious for spinal dural arteriovenous
fistula. Digital subtraction angiography demonstrated a fistula at the right
T10 intercostal artery. Surgical obliteration was successful, and the
patient had clinical stabilization.
44 FEBRUARY 2021
FIGURE 2-7
Imaging of the patient in CASE 2-2. Sagittal (A)
and axial (B) T2-weighted MRIs show
T2-hyperintense signal and edema throughout the
lower thoracic cord. Multiple small T2-hypointense
flow voids are seen surrounding the cord (A, blue arrow;
B, arrows). Sagittal (C) and axial (D) T1-weighted
images with gadolinium show abrupt missing
pieces (C, arrows) within a confluent area of
enhancement. These findings are suspicious for
spinal dural arteriovenous fistula.
CONTINUUMJOURNAL.COM 45
FIGURE 2-8
MRI findings in spinal dural arteriovenous fistula. Sagittal (A) and axial (B) T2-weighted thoracic
spine images reveal longitudinally extensive holocord (entire spinal cord) T2 hyperintensity (A,
B, arrows) extending to the conus with associated flow voids along the ventral and dorsal cord
surface (A, B, arrowheads). Sagittal (C) and axial (D) postcontrast T1-weighted images show
the missing piece sign (C, D, arrowheads), with a well-defined abrupt segment of gadolinium
enhancement missing amid an otherwise homogenous, avid enhancing area (C, D, arrows)
Sagittal postcontrast T1-weighted image (E) reveals another frequent enhancement pattern
with hazy enhancement (arrow) and central canal predominance (arrowhead).
Reprinted with permission from English SW, Zalewski NL, Semin Neurol.9 © 2021 Thieme Medical Publishers, Inc.
46 FEBRUARY 2021
CONTINUUMJOURNAL.COM 47
HEMATOMYELIA
Intraparenchymal spinal cord hemorrhage (hematomyelia) is very rare. Trauma
is the most common cause,83 followed by intramedullary spinal cord cavernous
malformation and AVMs; many additional causes are also been reported.
Hematomyelia presents similarly to spinal cord infarction, frequently with
severe back pain at onset (localizing the hemorrhage) followed by rapid severe
myelopathy deficits; however, deficits can often progress over days instead of
hours. Recognition of blood products within the spinal cord on MRI (T1
hyperintensity, dark T2 hypointensity, gradient recalled echo [GRE]
hypointensity) is critical as it significantly shifts the differential diagnosis and
acute management toward a focus on hematomyelia.
Cavernous Malformation
Intramedullary spinal cord cavernous malformations are likely the most common
etiology of nontraumatic hematomyelia. Cerebral cavernous malformations are
nonshunting vascular malformations found in about 0.5% of the general
population,84-86 whereas intramedullary spinal cord cavernous malformations
represent approximately 5% of all cavernous malformations in the CNS.87 Only
5% of patients with an intracranial cavernous malformation have an
intramedullary spinal cord cavernous malformation, whereas approximately 25%
of patients with intramedullary spinal cord cavernous malformations have an
intracranial cavernous malformation.86 A cavernous malformation is a cluster of
tightly packed dilated sinusoidal veins with no intervening parenchyma and no
feeding artery or draining vein. Lesions occur not only in the spinal cord but also
48 FEBRUARY 2021
CONTINUUMJOURNAL.COM 49
surgical benefit include surgery less than 3 months after symptom onset,88
cavernous malformation size greater than 1 cm, and predominantly motor
symptoms, which along with gross total resection via hemilaminectomy can be
predictive of improved neurologic outcome. Preoperative sensory symptoms and
pain may be predictive of poor postoperative improvement. Various data have
been reported on radiosurgery in cerebral cavernous malformations, yet it
remains unclear whether it has any demonstrable benefit in the management of
intramedullary spinal cord cavernous malformations.90
Arteriovenous Malformation
An arteriovenous shunt comprises a direct connection between feeding arteries
and vein(s) without an intervening capillary network. When an arteriolovenular
network (nidus) transitions between feeding artery(s) and vein(s), it is referred
to as an AVM. When a direct connection exists between the main arterial feeder(s)
and a single vein, it is termed an arteriovenous fistula. Although spinal dural
arteriovenous fistula (type I) comprises 70% of spinal arteriovenous shunts, 30%
of cases are secondary to types II through V: intramedullary glomus AVM (type
CASE 2-3 A 50-year-old woman presented with abrupt-onset neck pain and upper
extremity weakness. Her pain became progressively more severe over
days, extending into her shoulders. Within a few more days, the pain
extended into her left arm and was accompanied by a loss of strength.
She also developed left-sided ptosis. An MRI of the cervical spine was
obtained and revealed blood in the left anterior spinal cord between C6
and C8. Symptoms were observed over several weeks, and her ptosis
resolved and left arm strength returned to normal.
Over the next few years of observation, she developed many episodes
of recurrent neck and upper extremity pain lasting hours to weeks, with
altered dysesthetic sensation and contact allodynia. Neuroimaging
findings were consistent with a cavernous malformation (FIGURE 2-9).
Surgical resection was performed, and the patient had a good outcome,
with improvement in symptoms.
50 FEBRUARY 2021
FIGURE 2-9
Imaging of the patient in CASE 2-3. Sagittal T2-weighted (A) and T1-weighted (B) MRI of the
cervical spine shows hematomyelia with mixed T2 hypointensity (A, arrow) and T1
hyperintensity (B, arrow). Corresponding axial T2-weighted images (C, D) show a
well-demarcated T2-hypointense rim (C, arrow; D, arrow) around the masslike lesion,
typical of intramedullary spinal cord cavernous malformation.
CONTINUUMJOURNAL.COM 51
FIGURE 2-10
MRI findings in hematomyelia and extraparenchymal hemorrhage. Sagittal (A) and axial (B)
T2-weighted cervical spine MRIs show intramedullary and extramedullary flow voids consistent
with spinal arteriovenous malformation. Sagittal (C) and axial (D) T2-weighted thoracic spine
images reveal a mixed-signal central lesion with surrounding dark T2-hypointense rim
(C, D, arrows) typical of a cavernous malformation. Sagittal (E, G) and axial (F, H) T2-weighted
MRIs of the cervical spine reveal an extramedullary mixed T2-hyperintense and T2-hypointense
signal dorsal to the cord (E, F, arrows) representative of anticoagulation-associated
subdural hematoma, with concurrent subarachnoid hemorrhage best appreciated on axial
view (H, arrow) and associated cord edema with T2-hyperintense signal on sagittal views (G).
Reprinted with permission from English SW, Zalewski NL, Semin Neurol.9 © 2021 Thieme Medical Publishers, Inc.
52 FEBRUARY 2021
CONTINUUMJOURNAL.COM 53
Epidural Hematoma
Spinal epidural hematoma is most commonly encountered in trauma or after
surgery, epidural catheterization, or lumbar puncture. Epidural hematoma is
estimated to be approximately 4 times more common than subdural hematoma.8
In the postsurgical setting, deficits may be present immediately after surgery or
develop in the subsequent hours to days. Symptomatic postsurgical epidural
hematoma involves significant motor deficits in 80% of patients or isolated
intractable pain in 20% of patients.112 Other diagnostic possibilities should also be
considered, with new severe myelopathy immediately post–spinal surgery
occurring in approximately 0.2% of patients,113 including inadequate
decompression, spinal cord ischemia, graft/cage dislodgement, or presumed
direct surgical trauma. A prospective study routinely evaluating for the
radiographic presence of spinal epidural hematoma within 2 to 5 days of lumbar
decompression demonstrated spinal epidural hematoma with thecal sac
compression in 58% of patients; none had new deficits, highlighting that spinal
epidural hematoma can be an asymptomatic finding.114
The incidence of spontaneous spinal epidural hematoma is much rarer than
postsurgical spinal epidural hematoma, estimated at 0.1 per 100,000
person-years.115 Notably, radicular pain is common at onset.8 Attributable causes
are usually secondary to coagulopathy (eg, anticoagulation, liver disease, or
portal hypertension). Epidural hematomas have been described after
exertion/straining and venous thoracic outlet syndrome116 and as a rare
phenomenon of dural and epidural arteriovenous malformations.117,118
Bleeding diatheses and medications Prior history of bleeds; family history; contributing
medications or supplements
54 FEBRUARY 2021
Subdural Hematoma
Spinal subdural hematoma is much less common than spinal epidural hematoma
but can present similarly with acute back pain, myelopathy, or radicular
symptoms. Nontraumatic causes are generally iatrogenic from procedures and
use of anticoagulation/antiplatelet agents.83 Chronic spinal subdural hematomas
are rare, reported with antiplatelet treatment and anticoagulation,121,122 but also
may be related to prior trauma or small bleeds. In the setting of recent spine
surgery, radiographic evidence of spinal subdural hematoma is not
uncommon.123 Management considerations for symptomatic spinal subdural
hematoma are similar to spinal epidural hematoma.
Subarachnoid Hemorrhage
Spontaneous spinal SAH is rare, accounting for 1% of all SAHs, and is the initial
presenting symptom in 10% of spinal AVMs.124 Symptoms typically include the
sudden onset of severe neck or back pain, and patients also frequently have
headache, meningismus, and hyponatremia. Depending on the extent of
hemorrhage and etiology, a variable severity in myelopathy deficits can be seen.
Redistribution of blood products throughout the CNS and typical complications
of SAH may occur (eg, vasospasm). Management is generally conservative,
addressing the underlying mechanism, and treating complications similar to
cerebral aneurysmal SAH. Etiologies and risk factors include hypertension
(common), spinal AVM, aneurysm, vascular neoplasm, intramedullary spinal
cord cavernous malformation, spinal dural arteriovenous fistula, vasculitis,125
blood dyscrasia, collagen vascular disease, anticoagulation, coarctation of the
aorta, and acute aortic dissection.126,127 Of note, spinal aneurysms rarely
rupture.8 Also, the accumulation of subarachnoid blood products in the thecal sac
can occur over time from prior lumbar punctures or spinal anesthesia with
CONTINUUMJOURNAL.COM 55
anticoagulation and compress the spinal cord and roots, termed subarachnoid
space hematoma.
CONCLUSION
Vascular myelopathies represent uncommon but frequently underrecognized
neurologic disorders. Clinicians need to carry a high index of clinical suspicion
for a possible vascular etiology in patients presenting with myelopathy or the
correct diagnosis will often be missed or delayed because of the overlapping
clinical and imaging features that may mimic other causes of myelopathy.
Providing patients with the proper medical management while avoiding
potentially harmful and unnecessary treatments may help improve outcomes.
REFERENCES
1 Zalewski NL, Flanagan EP, Keegan BM. Evaluation 9 English SW, Zalewski NL. Vascular disorders of
of idiopathic transverse myelitis revealing the spinal cord. Semin Neurol 2021;41(1).
specific myelopathy diagnoses. Neurology
10 Colman MW, Hornicek FJ, Schwab JH. Spinal cord
2018;90(2):e96-e102. doi:10.1212/WNL.
blood supply and its surgical implications. J Am
0000000000004796
Acad Orthop Surg 2015;23(10):581-591.
2 Barreras P, Fitzgerald KC, Mealy MA, et al. Clinical doi:10.5435/JAAOS-D-14-00219
biomarkers differentiate myelitis from vascular
11 Martirosyan NL, Feuerstein JS, Theodore N, et al.
and other causes of myelopathy. Neurology
Blood supply and vascular reactivity of the spinal
2018;90(1):e12-e21. doi:10.1212/WNL.
cord under normal and pathological conditions.
0000000000004765
J Neurosurg Spine 2011;15(3):238-251.
3 Brinjikji W, Nasr DM, Morris JM, et al. Clinical doi:10.3171/2011.4.SPINE10543
outcomes of patients with delayed diagnosis of
12 Perez VH, Hernesniemi J, Small JE. Anatomy of
spinal dural arteriovenous fistulas. AJNR Am J
the great posterior radiculomedullary artery.
Neuroradiol 2016;37(2):380-386. doi:10.3174/
AJNR Am J Neuroradiol 2019;40(12):2010-2015.
ajnr.A4504
doi:10.3174/ajnr.A6304
4 Nasr DM, Brinjikji W, Rabinstein AA, Lanzino G.
13 Etz CD, Kari FA, Mueller CS, et al. The collateral
Clinical outcomes following corticosteroid
network concept: a reassessment of the
administration in patients with delayed diagnosis
anatomy of spinal cord perfusion. J Thorac
of spinal arteriovenous fistulas. J Neurointerv
Cardiovasc Surg 2011;141(4):1020-1028. doi:10.1016/
Surg 2017;9(6):607-610. doi:10.1136/neurintsurg-
j.jtcvs.2010.06.023
2016-012430
14 Vuong SM, Jeong WJ, Morales H, Abruzzo TA.
5 Cordoba JP, Larrarte C, Medina MC. Experience
Vascular diseases of the spinal cord: infarction,
in therapeutic plasma exchange by membrane
hemorrhage, and venous congestive
filtration at an academic center in Colombia:
myelopathy. Semin Ultrasound CT MR 2016;37(5):
registry of the first 500 sessions. J Clin Apher
466-481. doi:10.1053/j.sult.2016.05.008
2015;30(6):347-352. doi:10.1002/jca.21391
15 Hughes JT. Pathology of the spinal cord. Major
6 Benadiba J, Robitaille N, Lambert G, et al.
Probl Pathol 1978;6:1-257.
Intravenous immunoglobulin-associated
thrombosis: is it such a rare event? Report of a 16 Sandson TA, Friedman JH. Spinal cord infarction.
pediatric case and of the Quebec Hemovigilance Report of 8 cases and review of the literature.
System. Transfusion 2015;55(3):571-575. Medicine (Baltimore) 1989;68(5):282292.
doi:10.1111/trf.12897
17 Petterson CA, Olsson Y. Blood supply of spinal
7 Zalewski NL, Rabinstein AA, Krecke KN, et al. nerve roots. An experimental study in the rat.
Characteristics of spontaneous spinal cord Acta Neuropathol 1989;78(5):455-461.
infarction and proposed diagnostic criteria. doi:10.1007/BF00687706
JAMA Neurol 2019;76(1):56-63. doi:10.1001/
18 Miyasaka K, Asano T, Ushikoshi S, et al. Vascular
jamaneurol.2018.2734
anatomy of the spinal cord and classification of
8 Caplan L, Massaro A. Spinal cord vascular spinal arteriovenous malformations. Interv
disease. In: Caplan LR, editor. Caplan's stroke: a Neuroradiol 2000;6 suppl 1(suppl 1):195-198.
clinical approach. Cambridge University Press, doi:10.1177/15910199000060S131
2016:534-543.
56 FEBRUARY 2021
CONTINUUMJOURNAL.COM 57
47 Lee CS, Pyun HW, Chae EY, et al. Reversible 60 Wrobel CJ, Oldfield EH, Di Chiro G, et al.
aggravation of neurological deficits after steroid Myelopathy due to intracranial dural
medication in patients with venous congestive arteriovenous fistulas draining intrathecally into
myelopathy caused by spinal arteriovenous spinal medullary veins. Report of three cases.
malformation. Interv Neuroradiol 2009;15(3): J Neurosurg 1988;69(6):934-939. doi:10.3171/
325-329. doi:10.1177/159101990901500310 jns.1988.69.6.0934
48 McKeon A, Lindell EP, Atkinson JL, et al. Pearls & 61 Kalamangalam GP, Bhattacharya J, Teasdale E,
oy-sters: clues for spinal dural arteriovenous Thomas M. Myelopathy from intracranial dural
fistulae. Neurology 2011;76(3):e10-e12. arteriovenous fistula. J Neurol Neurosurg
Psychiatry 2002;72(6):816-818. doi:10.1136/
49 Lee J, Lim YM, Suh DC, et al. Clinical presentation,
jnnp.72.6.816
imaging findings, and prognosis of spinal dural
arteriovenous fistula. J Clin Neurosci 2016;26: 62 Manners J, Jadhav AP, Xia Z. Mystery case: a
105-109. doi:10.1016/j.jocn.2015.06.030 61-year-old woman with lower extremity
paralysis and sensory loss. Neurology 2017;
50 Sato K, Terbrugge KG, Krings T. Asymptomatic
89(22):e257-e263. doi:10.1212/
spinal dural arteriovenous fistulas:
WNL.0000000000004684
pathomechanical considerations. J Neurosurg
Spine 2012;16(5):441-446. doi:10.3171/2012.2. 63 Shin MJ, Kim W, Baik SK, et al. Cauda equina
SPINE11500 syndrome caused by spinal dural arteriovenous
fistula. Ann Rehabil Med 2011;35(6):928-933. doi:
51 Shimizu K, Takeda M, Mitsuhara T, et al.
10.5535/arm.2011.35.6.928
Asymptomatic spinal dural arteriovenous fistula:
case series and systematic review. J Neurosurg 64 Steinmetz MP, Chow MM, Krishnaney AA, et al.
Spine 2019:1-9. doi:10.3171/2019.5.SPINE181513 Outcome after the treatment of spinal dural
arteriovenous fistulae: a contemporary
52 Toossi S, Josephson SA, Hetts SW, et al. Utility of
single-institution series and meta-analysis.
MRI in spinal arteriovenous fistula. Neurology
Neurosurgery 2004;55(1):77-87; discussion 87-78.
2012;79(1):25-30. doi:10.1212/WNL.
doi:10.1227/01.neu.0000126878.95006.0f
0b013e3182582f07
65 Narvid J, Hetts SW, Larsen D, et al. Spinal dural
53 Krings T, Geibprasert S. Spinal dural
arteriovenous fistulae: clinical features and
arteriovenous fistulas. AJNR Am J Neuroradiol
long-term results. Neurosurgery 2008;62(1):
2009;30(4):639-648. doi:10.3174/ajnr.A1485
159-166; discussion 166-157. doi:10.1227/01.NEU.
54 Gilbertson JR, Miller GM, Goldman MS, Marsh 0000311073.71733.C4
WR. Spinal dural arteriovenous fistulas: MR and
66 Open and endovascular treatment of spinal dural
myelographic findings. AJNR Am J Neuroradiol
arteriovenous fistulas: a 10-year experience.
1995;16(10):2049-2057.
J Neurosurg Spine 2017;26(4):519-523. doi:10.3171/
55 Zalewski NL, Rabinstein AA, Brinjikji W, et al. 2016.9.SPINE16394
Unique gadolinium enhancement pattern in
67 Muralidharan R, Mandrekar J, Lanzino G, et al.
spinal dural arteriovenous fistulas. JAMA Neurol
Prognostic value of clinical and radiological signs
2018;75(12):1542-1545. doi:10.1001/
in the postoperative outcome of spinal dural
jamaneurol.2018.2605
arteriovenous fistula. Spine (Phila Pa 1976) 2013;
56 Saraf-Lavi E, Bowen BC, Quencer RM, et al. 38(14):1188-1193. doi:10.1097/BRS.0b013e31828b2e10
Detection of spinal dural arteriovenous fistulae
68 Brinjikji W, Yin R, Nasr DM, Lanzino G. Spinal
with MR imaging and contrast-enhanced MR
epidural arteriovenous fistulas. J Neurointerv
angiography: sensitivity, specificity, and
Surg 2016;8(12):1305-1310. doi:10.1136/neurintsurg-
prediction of vertebral level. AJNR Am J
2015-012181
Neuroradiol 2002;23(5):858-867.
69 Song Y, Cho SH, Lee DW, et al. Osseous versus
57 Luetmer PH, Lane JI, Gilbertson JR, et al.
nonosseous spinal epidural arteriovenous
Preangiographic evaluation of spinal dural
fistulas: experiences of 13 patients. AJNR Am J
arteriovenous fistulas with elliptic centric
Neuroradiol 2019;40(1):129-134. doi:10.3174/
contrast-enhanced MR Angiography and effect
ajnr.A5904
on radiation dose and volume of iodinated
contrast material. AJNR Am J Neuroradiol 2005; 70 Lenck S, Nicholson P, Tymianski R, et al. Spinal
26(4):711-718. and paraspinal arteriovenous lesions. Stroke
2019;50(8):2259-2269. doi:10.1161/STROKEAHA.
58 Bowen BC, Fraser K, Kochan JP, et al. Spinal dural
118.012783
arteriovenous fistulas: evaluation with MR
angiography. AJNR Am J Neuroradiol 1995;16(10): 71 Carvalho DZ, Hughes JD, Liebo GB, et al. Venous
2029-2043. congestive myelopathy due to chronic inferior
vena cava thrombosis treated with endovascular
59 Rodriguez FJ, Crum BA, Krauss WE, et al. Venous
stenting: case report and review of the literature.
congestive myelopathy: a mimic of neoplasia.
J Vasc Interv Neurol 2015;8(1):49-53.
Mod Pathol 2005;18(5):710-718.
58 FEBRUARY 2021
CONTINUUMJOURNAL.COM 59
98 Rodesch G, Hurth M, Alvarez H, et al. 110 Lann MA, Lovell MA, Kleinschmidt-DeMasters
Angio-architecture of spinal cord arteriovenous BK. Acute hemorrhagic leukoencephalitis: a
shunts at presentation. Clinical correlations in critical entity for forensic pathologists to
adults and children. The Bicetre experience recognize. Am J Forensic Med Pathol 2010;31(1):
on 155 consecutive patients seen between 7-11. doi:10.1097/PAF.0b013e3181c6be92
1981-1999. Acta Neurochir (Wien) 2004;146(3):
111 Faragò G, Rossi S, Erbetta A. Visualization of a
217-226; discussion 226-217. doi:10.1007/
spinal capillary telangiectasia with 2D DSA and
s00701-003-0192-1
cone-beam CT. Neurology 2017;89(23):
99 Kim LJ, Spetzler RF. Classification and surgical 2395-2396. doi:10.1212/WNL.0000000000004719
management of spinal arteriovenous lesions:
112 Kao FC, Tsai TT, Chen LH, et al. Symptomatic
arteriovenous fistulae and arteriovenous
epidural hematoma after lumbar
malformations. Neurosurgery 2006;59:S195-S201;
decompression surgery. Eur Spine J 2015;24(2):
discussion S193-S113. doi:10.1227/01.
348-357. doi:10.1007/s00586-014-3297-8
NEU.0000237335.82234.CE
113 Cramer DE, Maher PC, Pettigrew DB, Kuntz Ct.
100 Ducruet AF, Crowley RW, McDougall CG,
Major neurologic deficit immediately after adult
Albuquerque FC. Endovascular management of
spinal surgery: incidence and etiology over 10
spinal arteriovenous malformations.
years at a single training institution. J Spinal
J Neurointerv Surg 2013;5(6):605-611. doi:10.1136/
Disord Tech 2009;22(8):565-570. doi:10.1097/
neurintsurg-2012-010487
BSD.0b013e318193452a
101 Endo T, Endo H, Sato K, et al. Surgical and
114 Sokolowski MJ, Garvey TA, Perl J 2nd, et al.
endovascular treatment for spinal arteriovenous
Prospective study of postoperative lumbar
malformations. Review Neurol Med Chir (Tokyo)
epidural hematoma: incidence and risk factors.
2016;56(8):457-464. doi:10.2176/nmc.ra.2015-
Spine 2008;33(1):108-113. doi:10.1097/
0327
BRS.0b013e31815e39af
102 Kalani MA, Choudhri O, Gibbs IC, et al.
115 Holtås S, Heiling M, Lönntoft M. Spontaneous
Stereotactic radiosurgery for intramedullary
spinal epidural hematoma: findings at MR
spinal arteriovenous malformations. J Clin
imaging and clinical correlation. Radiology 1996;
Neurosci 2016;29:162-167. doi:10.1016/
199(2):409-413. doi:10.1148/radiology.199.
j.jocn.2015.12.005
2.8668786
103 Constantini S, Ashkenazi E, Shoshan Y, et al.
116 Mélé N, Boulouis G, Bozier E, et al. Thoracic
Thoracic hematomyelia secondary to coumadin
outlet syndrome causing epidural hematoma:
anticoagulant therapy: a case report. Eur Neurol
case illustration. J Neurosurg 2020:1-2. doi:
1992;32(2):109-111. doi:10.1159/000116804
10.3171/2019.12.JNS192397
104 Zeidman SM, Olivi A. Cervical intramedullary
117 Yu JX, Hong T, Ma YJ, et al. A new type of spinal
hemorrhage as a result of anticoagulant therapy.
epidural arteriovenous fistulas causes spinal
J Spinal Disord 1993;6(5):456-457; discussion
epidural hemorrhage: an analysis of five cases
457-458.
and natural history consideration. World
105 Sedzimir CB, Roberts JR, Occleshaw JV, Buxton Neurosurg 2017;103:371-379. doi:10.1016/
PH. Gowers' syringal haemorrhage. J Neurol j.wneu.2017.04.036
Neurosurg Psychiatry 1974;37(3):312-315.
118 Rispoli R, Mastrostefano R, Passalacqua G, et al.
doi:10.1136/jnnp.37.3.312
Epidural hematoma caused by a spinal osseous
106 Wu CY, Riangwiwat T, Nakamoto BK. epidural arteriovenous fistula in a 14-year-old
Hemorrhagic longitudinally extensive transverse patient. A case report. Neuroradiol J 2009;22(4):
myelitis. Case Rep Neurol Med 2016;2016: 452-457. doi:10.1177/197140090902200416
1596864. doi:10.1155/2016/1596864
119 Lawton MT, Porter RW, Heiserman JE, et al.
107 Chang CC, McLean C, Vujovic O, et al. Fatal Surgical management of spinal epidural
acute varicella-zoster virus hemorrhagic hematoma: relationship between surgical timing
meningomyelitis with necrotizing vasculitis in an and neurological outcome. J Neurosurg 1995;
HIV-infected patient. Clin Infect Dis 2009;48(3): 83(1):1-7. doi:10.3171/jns.1995.83.1.0001
372-373. doi:10.1086/595894
120 Bakker NA, Veeger NJ, Vergeer RA, Groen RJ.
108 Wang Y, Yu CY, Huang L, et al. Acute longitudinal Prognosis after spinal cord and cauda
and hemorrhagic myelitis caused by compression in spontaneous spinal epidural
varicella-zoster virus in an immunocompetent hematomas. Neurology 2015;84(18):1894-1903.
adolescent. Neurologist 2015;19(4):93-95. doi:10.1212/WNL.0000000000001545
doi:10.1097/NRL.0000000000000016
121 Akiyama Y, Koyanagi I, Mikuni N. Chronic spinal
109 Nakajima H, Furutama D, Kimura F, et al. Herpes subdural hematoma associated with antiplatelet
simplex virus myelitis: clinical manifestations therapy. World Neurosurg 2017;105:1032.
and diagnosis by the polymerase chain reaction e1031-1032.e1035. doi:10.1016/j.wneu.2016.11.128
method. Eur Neurol 1998;39(3):163-167.
122 Ma H, Kim I. Idiopathic lumbosacral spinal
doi:10.1159/000007927
chronic subdural hematoma. Korean J Spine
2012;9(1):41-43. doi:10.14245/kjs.2012.9.1.41
60 FEBRUARY 2021
CONTINUUMJOURNAL.COM 61